cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
TGCT	cis	1	rs1000113	chr5:150240076	LOC134466	chr5:150310000-150326146:-	0.59	4.35	2.76E-5	Crohn's disease	
TGCT	cis	1	rs10002332	chr4:129875301	C4orf33	chr4:130014829-130033842:+	0.51	4.56	1.2E-5	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs10008757	chr4:76903036	NAAA	chr4:76831809-76862166:-	-0.31	-5.82	4.53E-8	Longevity	
TGCT	cis	1	rs10019835	chr4:156633186	GUCY1A3	chr4:156587862-156658212:+	-0.24	-4.2	5.03E-5	Diabetic kidney disease	
TGCT	cis	1	rs10023907	chr4:88772535	SPP1	chr4:88896802-88904562:+	-0.35	-5.15	9.63E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
TGCT	cis	1	rs1003719	chr21:38491095	TTC3	chr21:38445571-38575406:+	0.19	4.3	3.44E-5	Eye color traits	
TGCT	cis	1	rs1004467	chr10:104594507	SFXN2	chr10:104474298-104498946:+	-0.81	-4.85	3.6E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
TGCT	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.83	9.34	4.5E-16	Type 2 diabetes	
TGCT	cis	1	rs10063647	chr5:127371588	FLJ33630	chr5:127276135-127419299:-	-0.18	-4.2	4.98E-5	Height	
TGCT	cis	1	rs10088439	chr8:8576699	FLJ10661	chr8:8086092-8102386:+	0.47	4.29	3.57E-5	Obesity-related traits	
TGCT	cis	1	rs10095733	chr8:8574646	FLJ10661	chr8:8086092-8102386:+	0.47	4.31	3.26E-5	Obesity-related traits	
TGCT	cis	1	rs10098234	chr8:8576692	FLJ10661	chr8:8086092-8102386:+	0.47	4.29	3.57E-5	Obesity-related traits	
TGCT	cis	1	rs10110591	chr8:8576608	FLJ10661	chr8:8086092-8102386:+	-0.48	-4.35	2.78E-5	Obesity-related traits	
TGCT	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.44	-4.41	2.2E-5	Rheumatoid arthritis	
TGCT	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.28	-4.32	3.14E-5	Homocysteine levels	
TGCT	cis	1	rs1016669	chr3:41894440	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs10169714	chr2:73808773	ALMS1P	chr2:73872046-73912692:+	0.42	4.97	2.18E-6	Metabolite levels	
TGCT	cis	1	rs10175180	chr2:73673123	ALMS1P	chr2:73872046-73912692:+	0.38	4.61	9.55E-6	Metabolite levels	
TGCT	cis	1	rs10175180	chr2:73673123	TPRKB	chr2:73956957-73964517:-	-0.3	-4.14	6.22E-5	Metabolite levels	
TGCT	cis	1	rs10178409	chr2:73855507	ALMS1P	chr2:73872046-73912692:+	0.38	4.51	1.48E-5	Urinary metabolites	
TGCT	cis	1	rs10179134	chr2:73637519	ALMS1P	chr2:73872046-73912692:+	0.43	5.12	1.13E-6	Metabolite levels	
TGCT	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.77	8.04	5.74E-13	Response to antipsychotic treatment	
TGCT	cis	1	rs10184268	chr2:73627044	ALMS1P	chr2:73872046-73912692:+	0.37	4.33	3.01E-5	Metabolite levels	
TGCT	cis	1	rs10186501	chr2:73697844	ALMS1P	chr2:73872046-73912692:+	0.38	4.61	9.55E-6	Metabolite levels	
TGCT	cis	1	rs10186501	chr2:73697844	TPRKB	chr2:73956957-73964517:-	-0.3	-4.14	6.22E-5	Metabolite levels	
TGCT	cis	1	rs10187192	chr2:73713500	ALMS1P	chr2:73872046-73912692:+	0.45	5.33	4.35E-7	Metabolite levels	
TGCT	cis	1	rs10187416	chr2:73713741	ALMS1P	chr2:73872046-73912692:+	0.38	4.61	9.55E-6	Metabolite levels	
TGCT	cis	1	rs10187416	chr2:73713741	TPRKB	chr2:73956957-73964517:-	-0.3	-4.14	6.22E-5	Metabolite levels	
TGCT	cis	1	rs10188442	chr2:133189239	GPR39	chr2:133174147-133404168:+	-0.31	-4.15	5.98E-5	Hypertension	
TGCT	cis	1	rs10189574	chr2:73698518	ALMS1P	chr2:73872046-73912692:+	0.39	4.64	8.66E-6	Metabolite levels	
TGCT	cis	1	rs10190219	chr2:73658331	ALMS1P	chr2:73872046-73912692:+	0.44	5.17	8.97E-7	Metabolite levels	
TGCT	cis	1	rs10193972	chr2:73717656	ALMS1P	chr2:73872046-73912692:+	0.38	4.61	9.55E-6	Metabolite levels	
TGCT	cis	1	rs10193972	chr2:73717656	TPRKB	chr2:73956957-73964517:-	-0.3	-4.14	6.22E-5	Metabolite levels	
TGCT	cis	1	rs10207220	chr2:73785046	ALMS1P	chr2:73872046-73912692:+	0.42	4.97	2.18E-6	Metabolite levels	
TGCT	cis	1	rs10212536	chr3:41827026	ULK4	chr3:41288091-42003660:-	0.52	5.66	9.82E-8	Diastolic blood pressure	
TGCT	cis	1	rs10216533	chr8:143763690	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs10228845	chr7:21583617	DNAH11	chr7:21582833-21941455:+	-0.46	-5.04	1.61E-6	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
TGCT	cis	1	rs10229224	chr7:21583921	DNAH11	chr7:21582833-21941455:+	-0.45	-4.98	2.02E-6	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
TGCT	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.64	5.15	9.56E-7	Paget's disease	
TGCT	cis	1	rs1025646	chr3:41754422	ULK4	chr3:41288091-42003660:-	0.48	4.96	2.27E-6	Diastolic blood pressure	
TGCT	cis	1	rs10256972	chr7:1039003	ZFAND2A	chr7:1192544-1199855:-	0.35	4.44	1.98E-5	Longevity;Endometriosis	
TGCT	cis	1	rs1030831	chr4:130025037	C4orf33	chr4:130014829-130033842:+	-0.48	-4.78	4.9E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs1037147	chr4:130025873	C4orf33	chr4:130014829-130033842:+	-0.48	-4.78	4.9E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs10402468	chr19:17384003	C19orf62	chr19:17378232-17393811:+	-0.38	-4.28	3.66E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs10402727	chr19:52370379	ZNF577	chr19:52359056-52394145:-	-0.31	-4.47	1.75E-5	Breast cancer	
TGCT	cis	1	rs10402988	chr19:52363104	ZNF577	chr19:52359056-52394145:-	-0.31	-4.47	1.75E-5	Breast cancer	
TGCT	cis	1	rs10406920	chr19:17389648	C19orf62	chr19:17378232-17393811:+	-0.38	-4.28	3.61E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs10409331	chr19:52370962	ZNF577	chr19:52359056-52394145:-	-0.31	-4.47	1.75E-5	Breast cancer	
TGCT	cis	1	rs10412080	chr19:52373508	ZNF577	chr19:52359056-52394145:-	-0.3	-4.22	4.57E-5	Breast cancer	
TGCT	cis	1	rs10414104	chr19:52368132	ZNF577	chr19:52359056-52394145:-	-0.31	-4.47	1.75E-5	Breast cancer	
TGCT	cis	1	rs10416654	chr19:17385176	C19orf62	chr19:17378232-17393811:+	-0.38	-4.28	3.66E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs10418154	chr19:17386006	C19orf62	chr19:17378232-17393811:+	-0.38	-4.28	3.66E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs10418362	chr19:17386107	C19orf62	chr19:17378232-17393811:+	-0.38	-4.28	3.66E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs10425939	chr19:17397244	C19orf62	chr19:17378232-17393811:+	-0.38	-4.29	3.57E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs1042658	chr17:38173902	GSDMA	chr17:38119226-38134019:+	-0.62	-7.87	1.37E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs10431058	chr11:107481518	LOC643923	chr11:107462471-107463949:+	0.31	4.27	3.89E-5	Common traits (Other)	
TGCT	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.26	4.17	5.65E-5	Multiple sclerosis	
TGCT	cis	1	rs1043515	chr17:36922196	PSMB3	chr17:36909002-36920477:+	0.22	5.58	1.42E-7	Height	
TGCT	cis	1	rs10439607	chr20:30258541	TM9SF4	chr20:30697309-30755061:+	0.42	4.61	9.64E-6	Subcortical brain region volumes	
TGCT	cis	1	rs10439608	chr20:30258814	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs10439971	chr3:186434188	KNG1	chr3:186435120-186461741:+	0.3	4.38	2.49E-5	Adiponectin levels	
TGCT	cis	1	rs10445300	chr17:2114587	SRR	chr17:2207248-2228553:+	-0.35	-5.51	1.92E-7	Esophageal cancer (squamous cell)	
TGCT	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.29	-4.46	1.77E-5	Homocysteine levels	
TGCT	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.82	-9.49	1.95E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs1045531	chr8:143763547	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.82	-9.49	1.96E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.81	-9.35	4.21E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs1045547	chr8:143763757	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs1045605	chr8:143764101	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs10456622	chr6:49396453	MUT	chr6:49398994-49431031:-	0.32	5.28	5.52E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs1046073	chr20:25281333	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.79	9.14	1.31E-15	Type 2 diabetes	
TGCT	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.28	-5.64	1.05E-7	Longevity	
TGCT	cis	1	rs1047171	chr20:25428786	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs10496191	chr2:73673798	ALMS1P	chr2:73872046-73912692:+	0.38	4.61	9.55E-6	Metabolite levels	
TGCT	cis	1	rs10496191	chr2:73673798	TPRKB	chr2:73956957-73964517:-	-0.3	-4.14	6.22E-5	Metabolite levels	
TGCT	cis	1	rs10496193	chr2:73773503	ALMS1P	chr2:73872046-73912692:+	0.39	4.62	9.4E-6	Metabolite levels	
TGCT	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.81	9.35	4.21E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs1050274	chr3:186435370	KNG1	chr3:186435120-186461741:+	0.3	4.38	2.49E-5	Adiponectin levels	
TGCT	cis	1	rs10509744	chr10:102271579	SEC31B	chr10:102246403-102289636:-	-0.31	-4.75	5.42E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs1051931	chr6:46672943	PLA2G7	chr6:46672054-46703151:-	-0.2	-4.5	1.53E-5	Lipoprotein-associated phospholipase A2 activity and mass	
TGCT	cis	1	rs1052501	chr3:41925398	ULK4	chr3:41288091-42003660:-	-0.49	-5.61	1.23E-7	Diastolic blood pressure	
TGCT	cis	1	rs1054399	chr10:102312565	SEC31B	chr10:102246403-102289636:-	-0.3	-4.58	1.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs1062794	chr20:30381758	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs10734259	chr11:18314865	GTF2H1	chr11:18343816-18388590:+	0.45	4.62	9.44E-6	Pancreatic cancer	
TGCT	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.28	4.52	1.43E-5	Homocysteine levels	
TGCT	cis	1	rs10741741	chr11:18342081	GTF2H1	chr11:18343816-18388590:+	-0.42	-4.73	5.83E-6	Pancreatic cancer	
TGCT	cis	1	rs10741742	chr11:18342160	GTF2H1	chr11:18343816-18388590:+	0.41	4.32	3.16E-5	Pancreatic cancer	
TGCT	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.26	4.14	6.28E-5	Multiple sclerosis	
TGCT	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.42	-4.27	3.86E-5	Rheumatoid arthritis	
TGCT	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.41	-4.29	3.49E-5	Rheumatoid arthritis	
TGCT	cis	1	rs10765688	chr11:94309859	MRE11A	chr11:94150469-94227040:-	-0.37	-4.19	5.11E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
TGCT	cis	1	rs1077889	chr20:25267893	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.26	4.17	5.65E-5	Multiple sclerosis	
TGCT	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.26	4.17	5.65E-5	Multiple sclerosis	
TGCT	cis	1	rs10786596	chr10:102282126	SEC31B	chr10:102246403-102289636:-	-0.31	-4.72	6.24E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10786597	chr10:102291287	SEC31B	chr10:102246403-102289636:-	-0.29	-4.53	1.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10786598	chr10:102291579	SEC31B	chr10:102246403-102289636:-	-0.29	-4.53	1.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10806375	chr6:87252456	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs10806376	chr6:87252969	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs1080698	chr10:102295114	SEC31B	chr10:102246403-102289636:-	-0.28	-4.24	4.24E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.42	-4.27	3.88E-5	Rheumatoid arthritis	
TGCT	cis	1	rs10819861	chr9:98867813	C9orf130	chr9:98568372-98638259:-	-0.31	-4.14	6.34E-5	Electrocardiographic traits	
TGCT	cis	1	rs10832921	chr11:18380835	GTF2H1	chr11:18343816-18388590:+	0.41	4.17	5.66E-5	Pancreatic cancer	
TGCT	cis	1	rs10853029	chr17:59396449	MED13	chr17:60019967-60142643:-	0.29	4.48	1.66E-5	Breast cancer	
TGCT	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-0.47	-5.36	3.89E-7	Diastolic blood pressure	
TGCT	cis	1	rs10874122	chr1:75235866	CRYZ	chr1:75171175-75199092:-	-0.44	-4.35	2.76E-5	Resistin levels	
TGCT	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.26	4.24	4.26E-5	Multiple sclerosis	
TGCT	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.26	4.27	3.86E-5	Multiple sclerosis	
TGCT	cis	1	rs10882644	chr10:97388579	ENTPD1	chr10:97471536-97637022:+	0.29	4.48	1.65E-5	Blood metabolite levels	
TGCT	cis	1	rs10883492	chr10:102206089	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883493	chr10:102208188	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883496	chr10:102221931	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883497	chr10:102228519	SEC31B	chr10:102246403-102289636:-	-0.31	-4.99	1.92E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883499	chr10:102232188	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883500	chr10:102238324	SEC31B	chr10:102246403-102289636:-	-0.3	-4.76	5.2E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883501	chr10:102238326	SEC31B	chr10:102246403-102289636:-	-0.3	-4.76	5.2E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883502	chr10:102238343	SEC31B	chr10:102246403-102289636:-	-0.3	-4.76	5.2E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883503	chr10:102275504	SEC31B	chr10:102246403-102289636:-	-0.29	-4.45	1.86E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883504	chr10:102280687	SEC31B	chr10:102246403-102289636:-	-0.3	-4.55	1.26E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883505	chr10:102280772	SEC31B	chr10:102246403-102289636:-	-0.29	-4.53	1.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883506	chr10:102289743	SEC31B	chr10:102246403-102289636:-	-0.29	-4.53	1.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883507	chr10:102291275	SEC31B	chr10:102246403-102289636:-	-0.29	-4.53	1.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883508	chr10:102294413	SEC31B	chr10:102246403-102289636:-	-0.31	-4.75	5.42E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883509	chr10:102296461	SEC31B	chr10:102246403-102289636:-	-0.29	-4.48	1.68E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883510	chr10:102297018	SEC31B	chr10:102246403-102289636:-	-0.32	-4.71	6.49E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883511	chr10:102299407	SEC31B	chr10:102246403-102289636:-	-0.32	-4.87	3.32E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10883512	chr10:102308516	SEC31B	chr10:102246403-102289636:-	-0.3	-4.58	1.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs10895275	chr11:102083608	ANGPTL5	chr11:101761406-101787253:-	0.34	4.36	2.68E-5	Migraine	
TGCT	cis	1	rs10927875	chr1:16299312	CLCNKA	chr1:16345370-16360544:+	-0.45	-5.3	5.03E-7	Dilated cardiomyopathy	
TGCT	cis	1	rs10937266	chr3:186433075	KNG1	chr3:186435120-186461741:+	0.3	4.27	3.78E-5	Adiponectin levels	
TGCT	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.81	-9.35	4.21E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.82	-9.35	4.27E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs10944242	chr6:87232214	SNHG5	chr6:86386726-86388451:-	-0.44	-4.48	1.63E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs10966	chr20:25282944	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs10988125	chr9:131572903	ENDOG	chr9:131580779-131584954:+	0.33	4.81	4.29E-6	Blood metabolite levels	
TGCT	cis	1	rs11020840	chr11:94313514	MRE11A	chr11:94150469-94227040:-	-0.38	-4.26	3.97E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
TGCT	cis	1	rs11020847	chr11:94323912	MRE11A	chr11:94150469-94227040:-	0.42	5.11	1.15E-6	Attention deficit hyperactivity disorder symptoms (interaction)	
TGCT	cis	1	rs1106565	chr10:102211613	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11067231	chr12:109993603	MYO1H	chr12:109826524-109886176:+	0.38	4.26	3.89E-5	HDL cholesterol	
TGCT	cis	1	rs11087520	chr20:25436827	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs11087521	chr20:25440648	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs1109227	chr3:48479207	TREX1	chr3:48501186-48509043:+	-0.28	-5.67	9.47E-8	Longevity	
TGCT	cis	1	rs1109619	chr8:8571616	FLJ10661	chr8:8086092-8102386:+	0.48	4.39	2.37E-5	Obesity-related traits	
TGCT	cis	1	rs11100	chr20:25281184	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs11123170	chr2:113978940	LOC654433	chr2:113993107-114024579:+	-0.64	-6.07	1.38E-8	Renal function-related traits (BUN)	
TGCT	cis	1	rs11123170	chr2:113978940	PAX8	chr2:113973575-114036498:-	-0.49	-5.66	9.77E-8	Renal function-related traits (BUN)	
TGCT	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.28	-5.64	1.05E-7	Longevity	
TGCT	cis	1	rs11130171	chr3:48462461	TREX1	chr3:48501186-48509043:+	-0.29	-5.75	6.26E-8	Longevity	
TGCT	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-0.85	-7.23	4.02E-11	Triptolide cytotoxicity	
TGCT	cis	1	rs11132254	chr4:185611592	MLF1IP	chr4:185615220-185655286:-	-0.6	-7.89	1.27E-12	Kawasaki disease	
TGCT	cis	1	rs1114380	chr2:73804708	ALMS1P	chr2:73872046-73912692:+	0.42	4.97	2.18E-6	Metabolite levels	
TGCT	cis	1	rs11145549	chr9:80357550	CEP78	chr9:80850991-80886799:+	-0.31	-4.21	4.81E-5	IgG glycosylation	
TGCT	cis	1	rs111596617	chr6:26191678	HIST1H3E	chr6:26224427-26226589:+	0.47	4.19	5.14E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs11167515	chr5:150239471	LOC134466	chr5:150310000-150326146:-	0.6	4.42	2.12E-5	Crohn's disease	
TGCT	cis	1	rs11167526	chr5:150332481	LOC134466	chr5:150310000-150326146:-	0.81	4.48	1.63E-5	Crohn's disease	
TGCT	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.25	4.18	5.36E-5	Multiple sclerosis	
TGCT	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.26	4.14	6.28E-5	Multiple sclerosis	
TGCT	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.26	4.17	5.65E-5	Multiple sclerosis	
TGCT	cis	1	rs11188394	chr10:97365458	ENTPD1	chr10:97471536-97637022:+	0.29	4.48	1.66E-5	Blood metabolite levels	
TGCT	cis	1	rs11188396	chr10:97367510	ENTPD1	chr10:97471536-97637022:+	0.27	4.31	3.31E-5	Blood metabolite levels	
TGCT	cis	1	rs11188398	chr10:97369093	ENTPD1	chr10:97471536-97637022:+	0.28	4.41	2.16E-5	Blood metabolite levels	
TGCT	cis	1	rs11188400	chr10:97371327	ENTPD1	chr10:97471536-97637022:+	0.28	4.41	2.16E-5	Blood metabolite levels	
TGCT	cis	1	rs11188406	chr10:97390195	ENTPD1	chr10:97471536-97637022:+	0.29	4.48	1.65E-5	Blood metabolite levels	
TGCT	cis	1	rs11188407	chr10:97390533	ENTPD1	chr10:97471536-97637022:+	0.29	4.48	1.65E-5	Blood metabolite levels	
TGCT	cis	1	rs11188417	chr10:97411680	ENTPD1	chr10:97471536-97637022:+	-0.28	-4.45	1.87E-5	Blood metabolite levels	
TGCT	cis	1	rs11190540	chr10:102202629	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190541	chr10:102203071	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190551	chr10:102204734	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190552	chr10:102206607	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190555	chr10:102209160	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190556	chr10:102209223	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190557	chr10:102209369	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190558	chr10:102209397	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190569	chr10:102227409	SEC31B	chr10:102246403-102289636:-	-0.31	-4.87	3.25E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190570	chr10:102227702	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190572	chr10:102232879	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190578	chr10:102238953	SEC31B	chr10:102246403-102289636:-	-0.3	-4.76	5.2E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190587	chr10:102266638	SEC31B	chr10:102246403-102289636:-	-0.29	-4.25	4.15E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190589	chr10:102275471	SEC31B	chr10:102246403-102289636:-	-0.31	-4.72	6.24E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190592	chr10:102291059	SEC31B	chr10:102246403-102289636:-	-0.29	-4.53	1.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190595	chr10:102291761	SEC31B	chr10:102246403-102289636:-	-0.29	-4.53	1.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190597	chr10:102293676	SEC31B	chr10:102246403-102289636:-	-0.3	-4.57	1.16E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190599	chr10:102295420	SEC31B	chr10:102246403-102289636:-	-0.3	-4.57	1.16E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190601	chr10:102296730	SEC31B	chr10:102246403-102289636:-	-0.3	-4.57	1.16E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190602	chr10:102297256	SEC31B	chr10:102246403-102289636:-	-0.31	-4.67	7.45E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190604	chr10:102302457	SEC31B	chr10:102246403-102289636:-	-0.31	-4.63	9.04E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190607	chr10:102303614	SEC31B	chr10:102246403-102289636:-	-0.32	-4.72	6.18E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11190613	chr10:102313997	SEC31B	chr10:102246403-102289636:-	0.31	4.77	5.0E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11191416	chr10:104604916	SFXN2	chr10:104474298-104498946:+	0.8	4.73	5.9E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
TGCT	cis	1	rs11191425	chr10:104625970	SFXN2	chr10:104474298-104498946:+	-0.85	-4.62	9.44E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
TGCT	cis	1	rs11203031	chr10:90964395	IFIT5	chr10:91174325-91180758:+	-0.35	-4.23	4.47E-5	Heart failure	
TGCT	cis	1	rs112062277	chr11:94314273	MRE11A	chr11:94150469-94227040:-	-0.38	-4.22	4.65E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
TGCT	cis	1	rs1120655	chr6:87253047	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.28	-4.32	3.14E-5	Homocysteine levels	
TGCT	cis	1	rs1125203	chr3:41760895	ULK4	chr3:41288091-42003660:-	0.49	5.6	1.28E-7	Diastolic blood pressure	
TGCT	cis	1	rs112751982	chr6:26191958	HIST1H3E	chr6:26224427-26226589:+	0.47	4.19	5.14E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs1127857	chr9:95883865	NINJ1	chr9:95883772-95896570:-	-0.31	-4.83	3.88E-6	Obesity (early onset extreme)	
TGCT	cis	1	rs11292	chr10:102313607	SEC31B	chr10:102246403-102289636:-	-0.3	-4.6	1.0E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs113269636	chr16:77780610	NUDT7	chr16:77756411-77776153:+	0.45	4.36	2.62E-5	Obesity-related traits	
TGCT	cis	1	rs113333037	chr17:2200106	SRR	chr17:2207248-2228553:+	-0.34	-5.36	3.87E-7	Esophageal cancer (squamous cell)	
TGCT	cis	1	rs113450334	chr16:77780609	NUDT7	chr16:77756411-77776153:+	0.45	4.36	2.62E-5	Obesity-related traits	
TGCT	cis	1	rs113848378	chr5:132192372	LEAP2	chr5:132209358-132210581:+	0.5	4.25	4.1E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs1140047	chr11:18327684	GTF2H1	chr11:18343816-18388590:+	0.43	4.46	1.8E-5	Pancreatic cancer	
TGCT	cis	1	rs1141321	chr6:49412433	MUT	chr6:49398994-49431031:-	0.31	5.13	1.07E-6	Folate pathway vitamin levels	
TGCT	cis	1	rs114960066	chr3:41882323	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs11592213	chr10:97396103	ENTPD1	chr10:97471536-97637022:+	0.27	4.21	4.9E-5	Blood metabolite levels	
TGCT	cis	1	rs11632465	chr15:85282045	LOC388152	chr15:84867600-84898920:-	-0.45	-6.23	6.29E-9	Schizophrenia	
TGCT	cis	1	rs11637142	chr15:85295927	LOC388152	chr15:84867600-84898920:-	-0.44	-6.11	1.15E-8	Schizophrenia	
TGCT	cis	1	rs11637852	chr15:63397151	TPM1	chr15:63334838-63364111:+	0.43	4.51	1.44E-5	HDL cholesterol	
TGCT	cis	1	rs11638290	chr15:85227636	LOC388152	chr15:84867600-84898920:-	-0.44	-6.12	1.08E-8	Schizophrenia	
TGCT	cis	1	rs11638297	chr15:84782417	LOC388152	chr15:84867600-84898920:-	-0.38	-5.34	4.21E-7	Schizophrenia	
TGCT	cis	1	rs11638394	chr15:84778928	LOC388152	chr15:84867600-84898920:-	-0.38	-5.37	3.63E-7	Schizophrenia	
TGCT	cis	1	rs116418977	chr6:25365888	BTN3A2	chr6:26365398-26378546:+	-0.54	-5.29	5.19E-7	Schizophrenia	
TGCT	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.68	-7.91	1.15E-12	Eye color traits	
TGCT	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.68	7.91	1.15E-12	Eye color traits	
TGCT	cis	1	rs11674602	chr2:73723185	ALMS1P	chr2:73872046-73912692:+	0.42	5.1	1.2E-6	Metabolite levels	
TGCT	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.73	-9.56	1.29E-16	Body mass index	
TGCT	cis	1	rs11689392	chr2:73622026	ALMS1P	chr2:73872046-73912692:+	0.37	4.33	3.01E-5	Metabolite levels	
TGCT	cis	1	rs11702374	chr21:43829758	ZNF295	chr21:43406941-43430496:-	0.19	4.54	1.3E-5	Type 1 diabetes	
TGCT	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.26	-5.41	3.02E-7	Longevity	
TGCT	cis	1	rs1172822	chr19:55819845	TMEM150B	chr19:55824227-55845416:-	0.26	5.63	1.13E-7	Menopause (age at onset);Menarche and menopause (age at onset)	
TGCT	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs11739677	chr5:150294883	LOC134466	chr5:150310000-150326146:-	0.64	4.72	6.13E-6	Crohn's disease	
TGCT	cis	1	rs11740172	chr5:150300278	LOC134466	chr5:150310000-150326146:-	0.64	4.72	6.13E-6	Crohn's disease	
TGCT	cis	1	rs11741861	chr5:150277909	LOC134466	chr5:150310000-150326146:-	-0.71	-5.16	9.15E-7	Crohn's disease	
TGCT	cis	1	rs11743488	chr5:150279218	LOC134466	chr5:150310000-150326146:-	0.71	5.16	9.15E-7	Crohn's disease	
TGCT	cis	1	rs11746128	chr5:156421250	TIMD4	chr5:156346293-156390266:-	-0.38	-4.28	3.67E-5	Hypertriglyceridemia	
TGCT	cis	1	rs11746560	chr5:150185925	LOC134466	chr5:150310000-150326146:-	0.7	5.1	1.2E-6	Crohn's disease	
TGCT	cis	1	rs11746807	chr5:150300419	LOC134466	chr5:150310000-150326146:-	0.64	4.72	6.13E-6	Crohn's disease	
TGCT	cis	1	rs11747065	chr5:150295486	LOC134466	chr5:150310000-150326146:-	0.64	4.72	6.13E-6	Crohn's disease	
TGCT	cis	1	rs11748553	chr5:150184553	LOC134466	chr5:150310000-150326146:-	0.7	5.1	1.2E-6	Crohn's disease	
TGCT	cis	1	rs11751618	chr6:87236328	SNHG5	chr6:86386726-86388451:-	-0.43	-4.39	2.37E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.81	-9.66	7.31E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs11782652	chr8:82653644	CHMP4C	chr8:82644688-82671746:+	-0.4	-4.16	5.9E-5	Epithelial ovarian cancer;Ovarian cancer	
TGCT	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.87	-10.48	7.11E-19	Response to antipsychotic treatment	
TGCT	cis	1	rs11816840	chr10:102309220	SEC31B	chr10:102246403-102289636:-	-0.3	-4.58	1.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.45	7.31	2.68E-11	Schizophrenia	
TGCT	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.55	-4.36	2.69E-5	Plasma clusterin levels	
TGCT	cis	1	rs11893881	chr2:73824373	ALMS1P	chr2:73872046-73912692:+	0.42	4.9	2.86E-6	Metabolite levels	
TGCT	cis	1	rs11899740	chr2:73631212	ALMS1P	chr2:73872046-73912692:+	0.43	5.02	1.74E-6	Metabolite levels	
TGCT	cis	1	rs11899902	chr2:73631564	ALMS1P	chr2:73872046-73912692:+	0.4	4.75	5.47E-6	Metabolite levels	
TGCT	cis	1	rs11901272	chr2:73720444	ALMS1P	chr2:73872046-73912692:+	0.39	4.65	8.41E-6	Metabolite levels	
TGCT	cis	1	rs11903916	chr2:73815328	ALMS1P	chr2:73872046-73912692:+	0.37	4.43	2.0E-5	Metabolite levels	
TGCT	cis	1	rs11903916	chr2:73815328	TPRKB	chr2:73956957-73964517:-	-0.3	-4.17	5.68E-5	Metabolite levels	
TGCT	cis	1	rs11919484	chr3:186432839	KNG1	chr3:186435120-186461741:+	0.3	4.28	3.72E-5	Adiponectin levels	
TGCT	cis	1	rs11923562	chr3:41760331	ULK4	chr3:41288091-42003660:-	0.45	4.63	9.09E-6	Diastolic blood pressure	
TGCT	cis	1	rs11924390	chr3:186433099	KNG1	chr3:186435120-186461741:+	0.3	4.28	3.66E-5	Adiponectin levels	
TGCT	cis	1	rs11927941	chr3:186433046	KNG1	chr3:186435120-186461741:+	0.3	4.28	3.72E-5	Adiponectin levels	
TGCT	cis	1	rs11928580	chr3:41885722	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs11957134	chr5:150230950	LOC134466	chr5:150310000-150326146:-	-0.59	-4.38	2.45E-5	Crohn's disease	
TGCT	cis	1	rs11975942	chr7:143740580	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.22	4.67E-5	Obesity-related traits	
TGCT	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	0.68	8.04	5.55E-13	Educational attainment (years of education)	
TGCT	cis	1	rs11976037	chr7:143741024	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.22	4.67E-5	Obesity-related traits	
TGCT	cis	1	rs11976180	chr7:143741580	ARHGEF35	chr7:143883677-143892736:-	-0.37	-4.3	3.44E-5	Obesity-related traits	
TGCT	cis	1	rs12081206	chr1:16087731	CLCNKA	chr1:16345370-16360544:+	0.44	4.33	3.02E-5	Gut microbiota (bacterial taxa)	
TGCT	cis	1	rs12091731	chr1:16087824	CLCNKA	chr1:16345370-16360544:+	-0.44	-4.38	2.5E-5	Gut microbiota (bacterial taxa)	
TGCT	cis	1	rs12130219	chr1:152162106	FLG	chr1:152274651-152297679:-	0.46	4.84	3.66E-6	Inflammatory skin disease	
TGCT	cis	1	rs12138117	chr1:16305279	CLCNKA	chr1:16345370-16360544:+	0.48	5.63	1.13E-7	Dilated cardiomyopathy	
TGCT	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12171333	chr4:129879711	C4orf33	chr4:130014829-130033842:+	0.49	4.35	2.74E-5	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.83	-9.5	1.84E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.79	-9.17	1.11E-15	Response to antipsychotic treatment	
TGCT	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.81	-9.35	4.21E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.82	-9.51	1.72E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs12196937	chr6:49382808	MUT	chr6:49398994-49431031:-	0.33	5.29	5.29E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.83	-9.78	3.66E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.79	-9.17	1.11E-15	Response to antipsychotic treatment	
TGCT	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.84	-9.93	1.65E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12202075	chr6:49427655	MUT	chr6:49398994-49431031:-	0.31	5.31	4.78E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.8	-9.33	4.71E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.81	-9.45	2.41E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.85	-10.11	5.95E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.79	-9.17	1.11E-15	Response to antipsychotic treatment	
TGCT	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.82	-9.51	1.72E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.83	-9.78	3.66E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.83	-9.78	3.66E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.79	-9.17	1.11E-15	Response to antipsychotic treatment	
TGCT	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.79	-9.17	1.11E-15	Response to antipsychotic treatment	
TGCT	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.79	-9.17	1.11E-15	Response to antipsychotic treatment	
TGCT	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.83	-9.78	3.66E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.81	-9.35	4.21E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.82	-9.49	1.95E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.82	-9.49	1.95E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12219158	chr10:102302923	SEC31B	chr10:102246403-102289636:-	-0.32	-4.72	6.18E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs12219789	chr10:102213778	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs12286683	chr11:18348662	GTF2H1	chr11:18343816-18388590:+	0.43	4.46	1.8E-5	Pancreatic cancer	
TGCT	cis	1	rs12294369	chr11:5567068	OR51B4	chr11:5322245-5323176:-	-0.3	-4.16	5.78E-5	QRS duration in Tripanosoma cruzi seropositivity	
TGCT	cis	1	rs12294921	chr11:46915192	LRP4	chr11:46878419-46940076:-	0.53	4.71	6.37E-6	Schizophrenia	
TGCT	cis	1	rs12299278	chr12:70749632	YEATS4	chr12:69753532-69784575:+	-0.5	-4.51	1.48E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs12300190	chr12:70753020	YEATS4	chr12:69753532-69784575:+	0.43	4.23	4.51E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs12324912	chr15:75361006	SCAMP5	chr15:75287901-75313836:+	0.31	4.24	4.33E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs12354411	chr10:102294537	SEC31B	chr10:102246403-102289636:-	-0.3	-4.57	1.16E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs12355721	chr10:102244911	SEC31B	chr10:102246403-102289636:-	-0.3	-4.76	5.2E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs12358187	chr10:102284449	SEC31B	chr10:102246403-102289636:-	-0.29	-4.53	1.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs12359272	chr10:97365163	ENTPD1	chr10:97471536-97637022:+	0.29	4.58	1.11E-5	Blood metabolite levels	
TGCT	cis	1	rs12414891	chr10:81690385	LOC219347	chr10:81805991-81838949:-	0.79	4.96	2.25E-6	Chronic obstructive pulmonary disease-related biomarkers	
TGCT	cis	1	rs12416687	chr10:104629011	NEURL	chr10:105253735-105352308:+	0.3	4.21	4.85E-5	Arsenic metabolism	
TGCT	cis	1	rs12428	chr20:25433821	NINL	chr20:25433338-25566153:-	0.4	6.09	1.25E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs12469351	chr2:133193137	GPR39	chr2:133174147-133404168:+	0.32	4.24	4.37E-5	Hypertension	
TGCT	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.55	-4.18	5.4E-5	Plasma clusterin levels	
TGCT	cis	1	rs12479491	chr20:30265450	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.26	-5.41	3.02E-7	Longevity	
TGCT	cis	1	rs12510966	chr4:106983604	TBCK	chr4:106967233-107237861:-	0.37	4.51	1.45E-5	Airflow obstruction	
TGCT	cis	1	rs12528955	chr6:87231866	SNHG5	chr6:86386726-86388451:-	-0.44	-4.48	1.63E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs12545771	chr8:8567977	FLJ10661	chr8:8086092-8102386:+	0.48	4.39	2.37E-5	Obesity-related traits	
TGCT	cis	1	rs12547721	chr8:8570671	FLJ10661	chr8:8086092-8102386:+	0.48	4.39	2.37E-5	Obesity-related traits	
TGCT	cis	1	rs12550458	chr8:8567832	FLJ10661	chr8:8086092-8102386:+	0.48	4.39	2.37E-5	Obesity-related traits	
TGCT	cis	1	rs12550762	chr8:8576535	FLJ10661	chr8:8086092-8102386:+	0.48	4.42	2.14E-5	Obesity-related traits	
TGCT	cis	1	rs12583	chr3:49571462	SEMA3F	chr3:50192848-50226507:+	-0.3	-4.19	5.12E-5	Menarche (age at onset)	
TGCT	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	0.46	5	1.92E-6	Diastolic blood pressure	
TGCT	cis	1	rs12652003	chr5:150231945	LOC134466	chr5:150310000-150326146:-	0.6	4.37	2.54E-5	Crohn's disease	
TGCT	cis	1	rs12656538	chr5:150251380	LOC134466	chr5:150310000-150326146:-	0.67	4.83	3.81E-6	Crohn's disease	
TGCT	cis	1	rs12656600	chr5:150311872	LOC134466	chr5:150310000-150326146:-	0.67	4.98	2.03E-6	Crohn's disease	
TGCT	cis	1	rs12659118	chr5:150324622	LOC134466	chr5:150310000-150326146:-	0.7	4.93	2.59E-6	Crohn's disease	
TGCT	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.8	-9.22	8.71E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.83	9.78	3.66E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.74	8.6	2.59E-14	Response to antipsychotic treatment	
TGCT	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.82	-9.51	1.72E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs12711517	chr1:8394236	H6PD	chr1:9294863-9331392:+	-0.23	-4.19	5.22E-5	Breast cancer	
TGCT	cis	1	rs12733173	chr1:152173972	FLG	chr1:152274651-152297679:-	0.46	4.84	3.66E-6	Inflammatory skin disease	
TGCT	cis	1	rs12898259	chr15:75369780	SCAMP5	chr15:75287901-75313836:+	0.32	4.42	2.11E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs12899981	chr15:85302373	LOC388152	chr15:84867600-84898920:-	-0.45	-6.27	5.19E-9	Schizophrenia	
TGCT	cis	1	rs12901243	chr15:75374233	SCAMP5	chr15:75287901-75313836:+	0.32	4.42	2.11E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs12902672	chr15:84716986	LOC388152	chr15:84867600-84898920:-	-0.38	-5.4	3.26E-7	Schizophrenia	
TGCT	cis	1	rs12903134	chr15:85337699	LOC388152	chr15:84867600-84898920:-	-0.46	-6.47	2.0E-9	Schizophrenia	
TGCT	cis	1	rs12903201	chr15:75370776	SCAMP5	chr15:75287901-75313836:+	0.32	4.42	2.11E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs12903820	chr15:84723820	LOC388152	chr15:84867600-84898920:-	-0.38	-5.4	3.19E-7	Schizophrenia	
TGCT	cis	1	rs12905057	chr15:85210765	LOC388152	chr15:84867600-84898920:-	-0.45	-6.11	1.13E-8	Schizophrenia	
TGCT	cis	1	rs12906542	chr15:78269472	LOC91450	chr15:78285576-78286567:-	-0.44	-5.55	1.59E-7	Breast cancer	
TGCT	cis	1	rs12908161	chr15:85207825	LOC388152	chr15:84867600-84898920:-	-0.44	-6.12	1.08E-8	Schizophrenia	
TGCT	cis	1	rs12908549	chr15:85322351	LOC388152	chr15:84867600-84898920:-	-0.45	-6.28	5.07E-9	Schizophrenia	
TGCT	cis	1	rs12910012	chr15:85298662	LOC388152	chr15:84867600-84898920:-	-0.45	-6.27	5.19E-9	Schizophrenia	
TGCT	cis	1	rs12910644	chr15:75358388	SCAMP5	chr15:75287901-75313836:+	0.32	4.3	3.46E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs12910992	chr15:90372465	AP3S2	chr15:90373832-90456222:-	-0.63	-6.03	1.7E-8	Type 2 diabetes	
TGCT	cis	1	rs12911736	chr15:85240008	LOC388152	chr15:84867600-84898920:-	-0.44	-6.12	1.08E-8	Schizophrenia	
TGCT	cis	1	rs12912388	chr15:85344550	LOC388152	chr15:84867600-84898920:-	-0.46	-6.47	2.0E-9	Schizophrenia	
TGCT	cis	1	rs12915234	chr15:84758301	LOC388152	chr15:84867600-84898920:-	-0.38	-5.36	3.86E-7	Schizophrenia	
TGCT	cis	1	rs12916348	chr15:84765527	LOC388152	chr15:84867600-84898920:-	-0.38	-5.37	3.63E-7	Schizophrenia	
TGCT	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.69	7.79	2.16E-12	Eye color traits	
TGCT	cis	1	rs13003464	chr2:61186829	C2orf74	chr2:61372243-61391964:+	0.49	5.07	1.4E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
TGCT	cis	1	rs13016963	chr2:202162811	ALS2CR12	chr2:202153148-202222101:-	-0.39	-4.14	6.23E-5	Melanoma;Esophageal squamous cell carcinoma	
TGCT	cis	1	rs13038834	chr20:25441433	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs13069724	chr3:48478039	TREX1	chr3:48501186-48509043:+	-0.26	-5.07	1.4E-6	Longevity	
TGCT	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.26	-5.41	3.02E-7	Longevity	
TGCT	cis	1	rs13076076	chr3:48479039	TREX1	chr3:48501186-48509043:+	-0.29	-5.75	6.26E-8	Longevity	
TGCT	cis	1	rs13087719	chr3:41951576	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs13091785	chr3:48494098	TREX1	chr3:48501186-48509043:+	-0.27	-5.47	2.29E-7	Longevity	
TGCT	cis	1	rs13095338	chr3:186435583	KNG1	chr3:186435120-186461741:+	0.3	4.38	2.49E-5	Adiponectin levels	
TGCT	cis	1	rs13109003	chr4:129975969	C4orf33	chr4:130014829-130033842:+	-0.49	-4.68	7.17E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs13130762	chr4:130022875	C4orf33	chr4:130014829-130033842:+	-0.48	-4.78	4.9E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs13195401	chr6:26463574	BTN3A2	chr6:26365398-26378546:+	-0.66	-8.62	2.39E-14	Schizophrenia	
TGCT	cis	1	rs13195402	chr6:26463575	BTN3A2	chr6:26365398-26378546:+	-0.66	-8.62	2.39E-14	Schizophrenia	
TGCT	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.81	-9.35	4.21E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.86	-10.21	3.31E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs1320893	chr7:143752112	ARHGEF35	chr7:143883677-143892736:-	-0.38	-4.48	1.66E-5	Obesity-related traits	
TGCT	cis	1	rs1320894	chr7:143751802	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.76	-9.46	2.25E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs13219760	chr6:110761189	SLC22A16	chr6:110745907-110797844:-	0.67	4.17	5.6E-5	Glucose homeostasis traits	
TGCT	cis	1	rs13220495	chr6:26441640	BTN3A2	chr6:26365398-26378546:+	-0.66	-8.62	2.39E-14	Schizophrenia	
TGCT	cis	1	rs13226728	chr7:143746578	ARHGEF35	chr7:143883677-143892736:-	-0.4	-4.67	7.68E-6	Obesity-related traits	
TGCT	cis	1	rs13243677	chr7:143746572	ARHGEF35	chr7:143883677-143892736:-	-0.4	-4.67	7.68E-6	Obesity-related traits	
TGCT	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	0.79	10.32	1.81E-18	Bone mineral density	
TGCT	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	0.79	10.59	4.0E-19	Bone mineral density	
TGCT	cis	1	rs13256369	chr8:8577379	FLJ10661	chr8:8086092-8102386:+	0.48	4.42	2.14E-5	Obesity-related traits	
TGCT	cis	1	rs13266699	chr8:8570313	FLJ10661	chr8:8086092-8102386:+	-0.48	-4.5	1.5E-5	Obesity-related traits	
TGCT	cis	1	rs13267501	chr8:8574058	FLJ10661	chr8:8086092-8102386:+	0.47	4.31	3.26E-5	Obesity-related traits	
TGCT	cis	1	rs13271966	chr8:8575472	FLJ10661	chr8:8086092-8102386:+	0.47	4.31	3.26E-5	Obesity-related traits	
TGCT	cis	1	rs13282915	chr8:8570891	FLJ10661	chr8:8086092-8102386:+	0.48	4.49	1.58E-5	Obesity-related traits	
TGCT	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.28	5.64	1.05E-7	Longevity	
TGCT	cis	1	rs13317089	chr3:186436217	KNG1	chr3:186435120-186461741:+	0.3	4.38	2.49E-5	Adiponectin levels	
TGCT	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.44	4.47	1.71E-5	Diastolic blood pressure	
TGCT	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.83	-9.66	7.33E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.79	-9.17	1.11E-15	Response to antipsychotic treatment	
TGCT	cis	1	rs13383871	chr2:73631779	ALMS1P	chr2:73872046-73912692:+	0.42	4.83	3.86E-6	Metabolite levels	
TGCT	cis	1	rs13384952	chr2:73723959	ALMS1P	chr2:73872046-73912692:+	-0.46	-4.8	4.34E-6	Metabolite levels	
TGCT	cis	1	rs1338714	chr6:87243683	SNHG5	chr6:86386726-86388451:-	-0.44	-4.48	1.63E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs13387221	chr2:44135314	LRPPRC	chr2:44113363-44223144:-	-0.36	-5.53	1.73E-7	Intelligence (childhood)	
TGCT	cis	1	rs13398956	chr2:73720258	ALMS1P	chr2:73872046-73912692:+	0.44	5.17	8.97E-7	Metabolite levels	
TGCT	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.61	-4.24	4.35E-5	Rheumatoid arthritis	
TGCT	cis	1	rs1341759	chr6:26195502	HIST1H3E	chr6:26224427-26226589:+	0.47	4.19	5.14E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs13421462	chr2:73719875	ALMS1P	chr2:73872046-73912692:+	0.43	5.14	1.0E-6	Metabolite levels	
TGCT	cis	1	rs13428235	chr2:73633430	ALMS1P	chr2:73872046-73912692:+	0.41	5.03	1.67E-6	Metabolite levels	
TGCT	cis	1	rs13431267	chr2:73782200	ALMS1P	chr2:73872046-73912692:+	0.42	4.97	2.18E-6	Metabolite levels	
TGCT	cis	1	rs13432605	chr2:73810981	ALMS1P	chr2:73872046-73912692:+	0.42	4.97	2.18E-6	Metabolite levels	
TGCT	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.52	-6.37	3.28E-9	Cognitive function	
TGCT	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.52	-6.42	2.57E-9	Cognitive function	
TGCT	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.51	-6.28	5.09E-9	Cognitive function	
TGCT	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.53	-6.6	1.02E-9	Cognitive function	
TGCT	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.54	-6.82	3.37E-10	Cognitive function	
TGCT	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.67	-6.27	5.18E-9	Type 2 diabetes	
TGCT	cis	1	rs1393244	chr5:132186007	LEAP2	chr5:132209358-132210581:+	0.5	4.25	4.1E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs1396256	chr6:87249122	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs1403284	chr2:73726662	ALMS1P	chr2:73872046-73912692:+	-0.36	-4.14	6.29E-5	Metabolite levels	
TGCT	cis	1	rs1403284	chr2:73726662	TPRKB	chr2:73956957-73964517:-	0.34	4.65	8.4E-6	Metabolite levels	
TGCT	cis	1	rs1404124	chr12:70713299	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs1412444	chr10:91002927	LIPA	chr10:90973328-91174382:-	0.32	5.36	3.9E-7	Fibrinogen levels	
TGCT	cis	1	rs1412445	chr10:91002804	LIPA	chr10:90973328-91174382:-	0.33	5.27	5.82E-7	Fibrinogen levels	
TGCT	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.8	-9.33	4.71E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs1417823	chr10:102227886	SEC31B	chr10:102246403-102289636:-	0.29	4.48	1.63E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs1421371	chr6:46670822	PLA2G7	chr6:46672054-46703151:-	-0.21	-4.85	3.54E-6	Lipoprotein-associated phospholipase A2 activity and mass	
TGCT	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.86	9.82	2.95E-17	Type 2 diabetes	
TGCT	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.78	9.06	2.05E-15	Type 2 diabetes	
TGCT	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.26	5.52	1.89E-7	Longevity	
TGCT	cis	1	rs1466389	chr17:2096384	SRR	chr17:2207248-2228553:+	-0.32	-5.07	1.37E-6	Esophageal cancer (squamous cell)	
TGCT	cis	1	rs1471399	chr4:88774073	SPP1	chr4:88896802-88904562:+	-0.35	-5.15	9.63E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
TGCT	cis	1	rs1471401	chr4:88774340	SPP1	chr4:88896802-88904562:+	-0.35	-5.15	9.63E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
TGCT	cis	1	rs1471403	chr4:88775243	SPP1	chr4:88896802-88904562:+	0.35	5.23	6.89E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
TGCT	cis	1	rs1484994	chr20:30305975	TM9SF4	chr20:30697309-30755061:+	0.4	4.31	3.31E-5	Subcortical brain region volumes	
TGCT	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.26	-5.46	2.45E-7	Ankylosing spondylitis	
TGCT	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.46	5.58	1.38E-7	Ankylosing spondylitis	
TGCT	cis	1	rs1520884	chr11:18309700	GTF2H1	chr11:18343816-18388590:+	-0.47	-5.04	1.58E-6	Pancreatic cancer	
TGCT	cis	1	rs1523435	chr3:186436306	KNG1	chr3:186435120-186461741:+	0.3	4.38	2.49E-5	Adiponectin levels	
TGCT	cis	1	rs1524245	chr12:70658828	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs1533266	chr7:143766714	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs1533267	chr7:143766440	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs1533268	chr7:143766358	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs1534471	chr2:73647508	ALMS1P	chr2:73872046-73912692:+	0.39	4.65	8.41E-6	Metabolite levels	
TGCT	cis	1	rs1540894	chr7:143767676	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.65	8.11E-6	Obesity-related traits	
TGCT	cis	1	rs1552994	chr1:152171461	FLG	chr1:152274651-152297679:-	0.46	4.84	3.66E-6	Inflammatory skin disease	
TGCT	cis	1	rs1555569	chr17:2149425	SRR	chr17:2207248-2228553:+	-0.35	-5.45	2.52E-7	Esophageal cancer (squamous cell)	
TGCT	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.79	9.16	1.21E-15	Type 2 diabetes	
TGCT	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.26	-5.41	3.02E-7	Longevity	
TGCT	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	0.46	5	1.92E-6	Diastolic blood pressure	
TGCT	cis	1	rs1567265	chr6:87247180	SNHG5	chr6:86386726-86388451:-	-0.44	-4.48	1.63E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs15676	chr9:131572027	ENDOG	chr9:131580779-131584954:+	-0.33	-4.77	4.92E-6	Blood metabolite levels	
TGCT	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.78	-9.06	2.11E-15	Response to antipsychotic treatment	
TGCT	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.8	-9.33	4.71E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.26	4.14	6.28E-5	Multiple sclerosis	
TGCT	cis	1	rs1600678	chr15:100579450	FLJ42289	chr15:100884662-100890923:-	-0.31	-4.16	5.94E-5	Gastroesophageal reflux disease	
TGCT	cis	1	rs1607908	chr3:41905196	ULK4	chr3:41288091-42003660:-	0.46	5.3	4.95E-7	Diastolic blood pressure	
TGCT	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.42	-4.27	3.88E-5	Rheumatoid arthritis	
TGCT	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.47	-5.26	5.94E-7	Diastolic blood pressure	
TGCT	cis	1	rs1613759	chr3:41906183	ULK4	chr3:41288091-42003660:-	0.46	5.3	4.95E-7	Diastolic blood pressure	
TGCT	cis	1	rs1615243	chr3:41965234	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1615543	chr3:41906404	ULK4	chr3:41288091-42003660:-	0.46	5.3	4.95E-7	Diastolic blood pressure	
TGCT	cis	1	rs1628874	chr3:41955714	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1629460	chr3:41927449	ULK4	chr3:41288091-42003660:-	-0.49	-5.61	1.23E-7	Diastolic blood pressure	
TGCT	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.66	4.45	1.89E-5	Rheumatoid arthritis	
TGCT	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.87	-10.48	7.11E-19	Response to antipsychotic treatment	
TGCT	cis	1	rs16891378	chr6:26188864	HIST1H3E	chr6:26224427-26226589:+	0.46	4.38	2.46E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs16928809	chr11:2936952	SLC22A18	chr11:2920951-2946475:+	-0.37	-4.94	2.38E-6	Bilirubin levels	
TGCT	cis	1	rs16952009	chr17:2102437	SRR	chr17:2207248-2228553:+	-0.34	-5.37	3.74E-7	Esophageal cancer (squamous cell)	
TGCT	cis	1	rs1699379	chr4:129992337	C4orf33	chr4:130014829-130033842:+	-0.49	-4.68	7.17E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs1699389	chr4:130004079	C4orf33	chr4:130014829-130033842:+	-0.48	-4.53	1.37E-5	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs1699391	chr4:130005096	C4orf33	chr4:130014829-130033842:+	-0.48	-4.53	1.37E-5	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs1699392	chr4:130022347	C4orf33	chr4:130014829-130033842:+	-0.48	-4.78	4.9E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs1699393	chr4:130019352	C4orf33	chr4:130014829-130033842:+	-0.49	-4.61	9.84E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs1699394	chr4:130019312	C4orf33	chr4:130014829-130033842:+	-0.49	-4.72	6.24E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs17061431	chr3:41792655	ULK4	chr3:41288091-42003660:-	0.5	5.46	2.38E-7	Diastolic blood pressure	
TGCT	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	0.55	5.95	2.5E-8	Diastolic blood pressure	
TGCT	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	0.47	5.11	1.17E-6	Diastolic blood pressure	
TGCT	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	0.46	5	1.92E-6	Diastolic blood pressure	
TGCT	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	0.46	5	1.92E-6	Diastolic blood pressure	
TGCT	cis	1	rs17064124	chr3:41890803	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs17107924	chr12:70674655	YEATS4	chr12:69753532-69784575:+	0.49	4.29	3.58E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs17107926	chr12:70676030	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs17107935	chr12:70679864	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs17107947	chr12:70689469	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs17107996	chr12:70728077	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs17108018	chr12:70736946	YEATS4	chr12:69753532-69784575:+	-0.51	-4.62	9.16E-6	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs17108038	chr12:70741608	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs17113137	chr10:102241998	SEC31B	chr10:102246403-102289636:-	-0.3	-4.67	7.7E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs17115100	chr10:104591393	SFXN2	chr10:104474298-104498946:+	-0.81	-4.79	4.66E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
TGCT	cis	1	rs17164851	chr7:130003487	CPA5	chr7:129984630-130008571:+	0.69	6.1	1.19E-8	Age-related hearing impairment (interaction)	
TGCT	cis	1	rs17166268	chr5:132180990	LEAP2	chr5:132209358-132210581:+	-0.5	-4.52	1.39E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs1716642	chr3:41965865	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.47	-5.26	5.94E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716651	chr3:41975099	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-0.47	-5.36	3.89E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716660	chr3:41929960	ULK4	chr3:41288091-42003660:-	-0.49	-5.61	1.23E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716661	chr3:41962818	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1716664	chr3:41948378	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1716668	chr3:41907850	ULK4	chr3:41288091-42003660:-	0.46	5.3	4.95E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716669	chr3:41908681	ULK4	chr3:41288091-42003660:-	0.46	5.3	4.95E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716676	chr3:41903208	ULK4	chr3:41288091-42003660:-	0.46	5.3	4.95E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716683	chr3:41923074	ULK4	chr3:41288091-42003660:-	-0.47	-5.36	3.89E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	0.52	6.04	1.59E-8	Diastolic blood pressure	
TGCT	cis	1	rs1716688	chr3:41926546	ULK4	chr3:41288091-42003660:-	-0.49	-5.61	1.23E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716690	chr3:41922102	ULK4	chr3:41288091-42003660:-	-0.47	-5.36	3.89E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716692	chr3:41983786	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1716693	chr3:41985600	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1716696	chr3:41935811	ULK4	chr3:41288091-42003660:-	-0.49	-5.61	1.23E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716984	chr3:41965532	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.48	-5.36	3.77E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.48	-5.36	3.77E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716997	chr3:41924333	ULK4	chr3:41288091-42003660:-	-0.48	-5.51	1.94E-7	Diastolic blood pressure	
TGCT	cis	1	rs1716999	chr3:41930041	ULK4	chr3:41288091-42003660:-	-0.49	-5.61	1.23E-7	Diastolic blood pressure	
TGCT	cis	1	rs1717000	chr3:41930219	ULK4	chr3:41288091-42003660:-	-0.49	-5.61	1.23E-7	Diastolic blood pressure	
TGCT	cis	1	rs1717001	chr3:41934949	ULK4	chr3:41288091-42003660:-	-0.49	-5.61	1.23E-7	Diastolic blood pressure	
TGCT	cis	1	rs1717006	chr3:41940448	ULK4	chr3:41288091-42003660:-	0.53	5.95	2.45E-8	Diastolic blood pressure	
TGCT	cis	1	rs1717009	chr3:41946308	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1717011	chr3:41980199	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1717014	chr3:41917395	ULK4	chr3:41288091-42003660:-	0.47	5.36	3.89E-7	Diastolic blood pressure	
TGCT	cis	1	rs1717017	chr3:41915616	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	0.53	5.95	2.51E-8	Diastolic blood pressure	
TGCT	cis	1	rs1717021	chr3:41983860	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1717024	chr3:41984888	ULK4	chr3:41288091-42003660:-	-0.47	-5.58	1.39E-7	Diastolic blood pressure	
TGCT	cis	1	rs1717027	chr3:41987920	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs1717031	chr3:41905791	ULK4	chr3:41288091-42003660:-	0.46	5.3	4.95E-7	Diastolic blood pressure	
TGCT	cis	1	rs1717033	chr3:41910216	ULK4	chr3:41288091-42003660:-	0.46	5.3	4.95E-7	Diastolic blood pressure	
TGCT	cis	1	rs17194770	chr8:130996692	FAM49B	chr8:130853718-131028897:-	-0.58	-4.24	4.25E-5	Protein quantitative trait loci	
TGCT	cis	1	rs17205407	chr15:62372827	C2CD4A	chr15:62359176-62363109:+	-0.39	-4.19	5.26E-5	Height	
TGCT	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.63	16.99	2.12E-34	Carotid intima media thickness	
TGCT	cis	1	rs17516673	chr5:132196711	LEAP2	chr5:132209358-132210581:+	0.5	4.25	4.1E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs1757924	chr4:130019599	C4orf33	chr4:130014829-130033842:+	-0.46	-4.64	8.66E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs1757925	chr4:130020791	C4orf33	chr4:130014829-130033842:+	0.43	4.14	6.31E-5	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs1757927	chr4:130022069	C4orf33	chr4:130014829-130033842:+	-0.48	-4.78	4.9E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs1757928	chr4:130022161	C4orf33	chr4:130014829-130033842:+	-0.48	-4.78	4.9E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs1757930	chr4:130022356	C4orf33	chr4:130014829-130033842:+	-0.49	-4.72	6.24E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs1757935	chr4:130023759	C4orf33	chr4:130014829-130033842:+	-0.48	-4.78	4.9E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs17594964	chr5:132188712	LEAP2	chr5:132209358-132210581:+	0.5	4.25	4.1E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs17600551	chr15:85319258	LOC388152	chr15:84867600-84898920:-	-0.45	-6.28	5.07E-9	Schizophrenia	
TGCT	cis	1	rs17601029	chr15:85347709	LOC388152	chr15:84867600-84898920:-	-0.44	-6.15	9.57E-9	Schizophrenia	
TGCT	cis	1	rs17696958	chr16:77785013	NUDT7	chr16:77756411-77776153:+	0.49	4.58	1.1E-5	Obesity-related traits	
TGCT	cis	1	rs17716830	chr16:77771999	NUDT7	chr16:77756411-77776153:+	0.44	4.21	4.75E-5	Obesity-related traits	
TGCT	cis	1	rs17727568	chr5:150244688	LOC134466	chr5:150310000-150326146:-	0.7	5.1	1.2E-6	Crohn's disease	
TGCT	cis	1	rs17746014	chr10:102315354	SEC31B	chr10:102246403-102289636:-	-0.3	-4.55	1.25E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs17761723	chr17:2107090	SRR	chr17:2207248-2228553:+	0.35	5.48	2.19E-7	Esophageal cancer (squamous cell)	
TGCT	cis	1	rs17761864	chr17:2171637	SRR	chr17:2207248-2228553:+	-0.34	-5.3	4.9E-7	Esophageal cancer (squamous cell)	
TGCT	cis	1	rs17769643	chr16:77784975	NUDT7	chr16:77756411-77776153:+	0.48	4.68	7.14E-6	Obesity-related traits	
TGCT	cis	1	rs17800886	chr5:150309539	LOC134466	chr5:150310000-150326146:-	0.67	4.94	2.41E-6	Crohn's disease	
TGCT	cis	1	rs17800987	chr5:150323428	LOC134466	chr5:150310000-150326146:-	0.63	4.49	1.59E-5	Crohn's disease	
TGCT	cis	1	rs17818399	chr2:46826026	PIGF	chr2:46808414-46844251:-	0.36	4.72	6.25E-6	Height	
TGCT	cis	1	rs17834627	chr17:2198892	SRR	chr17:2207248-2228553:+	-0.34	-5.36	3.87E-7	Esophageal cancer (squamous cell)	
TGCT	cis	1	rs17878846	chr10:104630412	SFXN2	chr10:104474298-104498946:+	-0.85	-4.62	9.44E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
TGCT	cis	1	rs1800662	chr10:102289078	SEC31B	chr10:102246403-102289636:-	-0.29	-4.53	1.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs1818950	chr15:84722521	LOC388152	chr15:84867600-84898920:-	-0.4	-5.54	1.66E-7	Schizophrenia	
TGCT	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.79	9.16	1.21E-15	Type 2 diabetes	
TGCT	cis	1	rs1836860	chr3:186436604	KNG1	chr3:186435120-186461741:+	-0.29	-4.18	5.48E-5	Adiponectin levels	
TGCT	cis	1	rs1848093	chr15:84755527	LOC388152	chr15:84867600-84898920:-	-0.38	-5.4	3.19E-7	Schizophrenia	
TGCT	cis	1	rs1851664	chr3:186436503	KNG1	chr3:186435120-186461741:+	0.3	4.38	2.49E-5	Adiponectin levels	
TGCT	cis	1	rs1851665	chr3:186436398	KNG1	chr3:186435120-186461741:+	0.3	4.38	2.49E-5	Adiponectin levels	
TGCT	cis	1	rs1854774	chr4:129988405	C4orf33	chr4:130014829-130033842:+	-0.49	-4.68	7.17E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs1856421	chr6:87243128	SNHG5	chr6:86386726-86388451:-	-0.44	-4.48	1.63E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.79	9.16	1.21E-15	Type 2 diabetes	
TGCT	cis	1	rs1867146	chr15:75354971	SCAMP5	chr15:75287901-75313836:+	0.32	4.3	3.46E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs1881245	chr2:73649928	ALMS1P	chr2:73872046-73912692:+	0.39	4.65	8.41E-6	Metabolite levels	
TGCT	cis	1	rs1885986	chr17:2203175	SRR	chr17:2207248-2228553:+	-0.33	-4.99	1.99E-6	Esophageal cancer (squamous cell)	
TGCT	cis	1	rs1888997	chr20:25298988	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs1888998	chr20:25291826	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs1888999	chr20:25291848	NINL	chr20:25433338-25566153:-	-0.43	-6.57	1.21E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs1911155	chr15:84787635	LOC388152	chr15:84867600-84898920:-	-0.39	-5.51	1.95E-7	Schizophrenia	
TGCT	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.86	-10.21	3.31E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.83	-9.78	3.66E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs1919948	chr7:143762843	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs1919949	chr7:143767723	ARHGEF35	chr7:143883677-143892736:-	-0.38	-4.52	1.4E-5	Obesity-related traits	
TGCT	cis	1	rs1919950	chr7:143767898	ARHGEF35	chr7:143883677-143892736:-	-0.38	-4.52	1.4E-5	Obesity-related traits	
TGCT	cis	1	rs1919951	chr7:143768891	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.29	3.54E-5	Obesity-related traits	
TGCT	cis	1	rs1953126	chr9:123640500	LOC253039	chr9:123605320-123616644:+	-0.43	-4.37	2.6E-5	Rheumatoid arthritis	
TGCT	cis	1	rs1960815	chr6:87253074	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.78	-8.75	1.14E-14	Response to antipsychotic treatment	
TGCT	cis	1	rs1977472	chr9:80351444	CEP78	chr9:80850991-80886799:+	-0.31	-4.21	4.81E-5	IgG glycosylation	
TGCT	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-0.7	-11.17	1.49E-20	Schizophrenia	
TGCT	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.83	-9.78	3.66E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs2003284	chr10:102202338	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2020079	chr6:87291817	SNHG5	chr6:86386726-86388451:-	0.46	4.62	9.51E-6	Gut microbiome composition (winter)	
TGCT	cis	1	rs202053	chr6:13273643	TBC1D7	chr6:13266774-13328770:-	-0.52	-5.54	1.68E-7	HIV-1 viral setpoint	
TGCT	cis	1	rs202070	chr6:13267938	TBC1D7	chr6:13266774-13328770:-	-0.51	-5.77	5.92E-8	HIV-1 viral setpoint	
TGCT	cis	1	rs202072	chr6:13268211	TBC1D7	chr6:13266774-13328770:-	0.51	5.68	8.86E-8	HIV-1 viral setpoint	
TGCT	cis	1	rs202073	chr6:13268605	TBC1D7	chr6:13266774-13328770:-	0.47	5.13	1.07E-6	HIV-1 viral setpoint	
TGCT	cis	1	rs202074	chr6:13269363	TBC1D7	chr6:13266774-13328770:-	-0.43	-4.51	1.49E-5	HIV-1 viral setpoint	
TGCT	cis	1	rs202077	chr6:13271438	TBC1D7	chr6:13266774-13328770:-	-0.5	-5.33	4.29E-7	HIV-1 viral setpoint	
TGCT	cis	1	rs2027003	chr20:25350498	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2027004	chr20:25350618	NINL	chr20:25433338-25566153:-	0.4	5.93	2.76E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2028299	chr15:90374257	AP3S2	chr15:90373832-90456222:-	-0.67	-6.26	5.56E-9	Type 2 diabetes	
TGCT	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.26	5.18	8.36E-7	Longevity	
TGCT	cis	1	rs2056486	chr2:73717567	ALMS1P	chr2:73872046-73912692:+	0.38	4.61	9.55E-6	Metabolite levels	
TGCT	cis	1	rs2056486	chr2:73717567	TPRKB	chr2:73956957-73964517:-	-0.3	-4.14	6.22E-5	Metabolite levels	
TGCT	cis	1	rs2058805	chr12:109998591	MYO1H	chr12:109826524-109886176:+	0.38	4.26	3.89E-5	HDL cholesterol	
TGCT	cis	1	rs2061164	chr11:18329006	GTF2H1	chr11:18343816-18388590:+	0.43	4.46	1.8E-5	Pancreatic cancer	
TGCT	cis	1	rs2074038	chr11:44087989	ACCS	chr11:44087475-44105569:+	0.79	7.7	3.53E-12	IgA nephropathy	
TGCT	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.28	-4.42	2.1E-5	Homocysteine levels	
TGCT	cis	1	rs2081302	chr2:23945355	C2orf84	chr2:24397531-24414566:+	-0.4	-4.36	2.65E-5	Obesity-related traits	
TGCT	cis	1	rs2083634	chr4:129976478	C4orf33	chr4:130014829-130033842:+	-0.49	-4.68	7.17E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs2083731	chr15:75368538	SCAMP5	chr15:75287901-75313836:+	0.32	4.31	3.25E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs2091131	chr12:70688614	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.73	6.11	1.16E-8	Type 2 diabetes	
TGCT	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	0.78	8.55	3.52E-14	Type 2 diabetes	
TGCT	cis	1	rs2113422	chr2:23939007	C2orf84	chr2:24397531-24414566:+	-0.38	-4.2	5.07E-5	Obesity-related traits	
TGCT	cis	1	rs2113423	chr2:23942287	C2orf84	chr2:24397531-24414566:+	-0.38	-4.2	5.07E-5	Obesity-related traits	
TGCT	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	0.44	4.85	3.56E-6	Diastolic blood pressure	
TGCT	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	0.46	5	1.92E-6	Diastolic blood pressure	
TGCT	cis	1	rs2130392	chr4:185639169	MLF1IP	chr4:185615220-185655286:-	-0.58	-8.12	3.68E-13	Kawasaki disease	
TGCT	cis	1	rs2134265	chr15:63398196	TPM1	chr15:63334838-63364111:+	0.45	4.86	3.41E-6	HDL cholesterol	
TGCT	cis	1	rs2136026	chr6:87233045	SNHG5	chr6:86386726-86388451:-	-0.42	-4.25	4.14E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs2136027	chr6:87233047	SNHG5	chr6:86386726-86388451:-	-0.44	-4.48	1.63E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs2136029	chr6:87233253	SNHG5	chr6:86386726-86388451:-	-0.42	-4.25	4.14E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs2140195	chr2:73702344	ALMS1P	chr2:73872046-73912692:+	0.38	4.61	9.55E-6	Metabolite levels	
TGCT	cis	1	rs2140195	chr2:73702344	TPRKB	chr2:73956957-73964517:-	-0.3	-4.14	6.22E-5	Metabolite levels	
TGCT	cis	1	rs2143346	chr6:26198449	HIST1H3E	chr6:26224427-26226589:+	-0.52	-4.24	4.33E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs2143347	chr6:26198494	HIST1H3E	chr6:26224427-26226589:+	0.47	4.14	6.25E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs2152916	chr10:97392265	ENTPD1	chr10:97471536-97637022:+	0.29	4.48	1.65E-5	Blood metabolite levels	
TGCT	cis	1	rs2154536	chr21:38492147	TTC3	chr21:38445571-38575406:+	0.19	4.42	2.13E-5	Eye color traits	
TGCT	cis	1	rs2155098	chr11:94322052	MRE11A	chr11:94150469-94227040:-	-0.4	-4.45	1.89E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
TGCT	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.87	-10.31	1.86E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs2174907	chr6:87230468	SNHG5	chr6:86386726-86388451:-	-0.44	-4.48	1.63E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs2184000	chr20:25395878	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2198042	chr4:129885499	C4orf33	chr4:130014829-130033842:+	0.49	4.67	7.75E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs2216464	chr6:46662577	PLA2G7	chr6:46672054-46703151:-	-0.21	-4.9	2.88E-6	Lipoprotein-associated phospholipase A2 activity and mass	
TGCT	cis	1	rs2227336	chr17:38174855	GSDMA	chr17:38119226-38134019:+	-0.62	-7.87	1.37E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs2229384	chr6:49425521	CENPQ	chr6:49431096-49460820:+	0.48	6.09	1.26E-8	Homocysteine levels	
TGCT	cis	1	rs2235542	chr1:209807815	C1orf107	chr1:210001333-210030908:+	0.59	4.94	2.44E-6	Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)	
TGCT	cis	1	rs2236352	chr14:24610733	FAM158A	chr14:24608175-24610797:-	-0.41	-8.11	3.75E-13	IgG glycosylation	
TGCT	cis	1	rs2241107	chr1:156182710	PMF1	chr1:156182784-156209831:+	0.24	4.18	5.36E-5	Testicular germ cell tumor	
TGCT	cis	1	rs2242150	chr3:48505964	TREX1	chr3:48501186-48509043:+	0.28	5.55	1.61E-7	Longevity	
TGCT	cis	1	rs2242471	chr4:76878716	NAAA	chr4:76831809-76862166:-	0.29	5.52	1.82E-7	Longevity	
TGCT	cis	1	rs2242473	chr4:76878956	NAAA	chr4:76831809-76862166:-	0.29	5.52	1.82E-7	Longevity	
TGCT	cis	1	rs2242474	chr4:76878982	NAAA	chr4:76831809-76862166:-	0.29	5.52	1.82E-7	Longevity	
TGCT	cis	1	rs2245715	chr15:43818052	ADAL	chr15:43622872-43646094:+	-0.4	-5.14	1.0E-6	Tumor biomarkers	
TGCT	cis	1	rs2246833	chr10:91005854	LIPA	chr10:90973328-91174382:-	0.31	5.22	7.13E-7	Fibrinogen levels	
TGCT	cis	1	rs2250644	chr10:91008879	LIPA	chr10:90973328-91174382:-	0.31	5.27	5.61E-7	Fibrinogen levels	
TGCT	cis	1	rs2251115	chr6:49446509	CENPQ	chr6:49431096-49460820:+	-0.46	-6.23	6.32E-9	Homocysteine levels	
TGCT	cis	1	rs2251844	chr15:43836478	ADAL	chr15:43622872-43646094:+	-0.42	-5.41	3.09E-7	Tumor biomarkers	
TGCT	cis	1	rs2255042	chr15:43834318	ADAL	chr15:43622872-43646094:+	0.42	5.41	3.09E-7	Tumor biomarkers	
TGCT	cis	1	rs2255051	chr15:43846161	ADAL	chr15:43622872-43646094:+	-0.42	-5.41	3.09E-7	Tumor biomarkers	
TGCT	cis	1	rs2255440	chr15:43830467	ADAL	chr15:43622872-43646094:+	-0.4	-5.14	1.0E-6	Tumor biomarkers	
TGCT	cis	1	rs2257420	chr20:25275890	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2257432	chr20:25271086	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2257496	chr20:25279315	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2257808	chr20:25266450	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2257809	chr20:25266476	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2257982	chr20:25269630	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2257985	chr20:25269743	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2257988	chr20:25270003	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2257991	chr20:25270339	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2258066	chr20:25271326	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2258135	chr20:25272323	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2258201	chr20:25272490	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2258563	chr20:25273435	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2258617	chr20:25274318	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2258719	chr20:25275843	NINL	chr20:25433338-25566153:-	-0.42	-6.29	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2258769	chr20:25276680	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2258879	chr20:25279213	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2258884	chr20:25279539	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2259837	chr20:25280205	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2259873	chr20:25280781	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2259926	chr20:25281733	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2259928	chr20:25281834	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2259956	chr20:25282433	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2260160	chr15:43895643	ADAL	chr15:43622872-43646094:+	-0.39	-4.64	8.75E-6	Tumor biomarkers	
TGCT	cis	1	rs2269558	chr16:682250	WFIKKN1	chr16:679239-684116:+	0.34	4.58	1.09E-5	Height	
TGCT	cis	1	rs2272006	chr3:41997059	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-0.52	-6.04	1.59E-8	Diastolic blood pressure	
TGCT	cis	1	rs2273694	chr10:102256496	SEC31B	chr10:102246403-102289636:-	-0.29	-4.43	2.03E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2273	chr4:76889388	NAAA	chr4:76831809-76862166:-	0.31	5.69	8.3E-8	Longevity	
TGCT	cis	1	rs2279077	chr3:48474249	TREX1	chr3:48501186-48509043:+	-0.28	-5.67	9.47E-8	Longevity	
TGCT	cis	1	rs2285946	chr7:21583329	DNAH11	chr7:21582833-21941455:+	-0.45	-4.98	2.02E-6	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
TGCT	cis	1	rs2285947	chr7:21584088	DNAH11	chr7:21582833-21941455:+	0.45	5.05	1.5E-6	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
TGCT	cis	1	rs2285949	chr7:21584243	DNAH11	chr7:21582833-21941455:+	-0.45	-4.98	2.02E-6	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
TGCT	cis	1	rs2285950	chr7:21584432	DNAH11	chr7:21582833-21941455:+	0.48	5.2	7.7E-7	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
TGCT	cis	1	rs2288073	chr2:24413298	C2orf84	chr2:24397531-24414566:+	-0.5	-5.6	1.28E-7	Venous thromboembolism (SNP x SNP interaction)	
TGCT	cis	1	rs2290822	chr3:48473204	TREX1	chr3:48501186-48509043:+	-0.29	-5.75	6.26E-8	Longevity	
TGCT	cis	1	rs2292030	chr5:132161294	LEAP2	chr5:132209358-132210581:+	0.56	4.96	2.21E-6	Apolipoprotein A-IV levels	
TGCT	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.76	11.35	5.42E-21	Cognitive function	
TGCT	cis	1	rs2294008	chr8:143761931	LYNX1	chr8:143845758-143859640:-	-0.25	-4.18	5.43E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2294010	chr8:143762430	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2295770	chr10:102239829	SEC31B	chr10:102246403-102289636:-	-0.3	-4.76	5.2E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2295772	chr10:102265183	SEC31B	chr10:102246403-102289636:-	-0.3	-4.58	1.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2295773	chr10:102265815	SEC31B	chr10:102246403-102289636:-	-0.3	-4.58	1.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2295774	chr10:102265847	SEC31B	chr10:102246403-102289636:-	-0.29	-4.25	4.15E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2295776	chr10:102295629	SEC31B	chr10:102246403-102289636:-	-0.3	-4.57	1.16E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2295780	chr10:102305965	SEC31B	chr10:102246403-102289636:-	-0.29	-4.27	3.76E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2296691	chr10:97370989	ENTPD1	chr10:97471536-97637022:+	0.28	4.41	2.16E-5	Blood metabolite levels	
TGCT	cis	1	rs2297496	chr20:25295787	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2297497	chr20:25297909	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2298074	chr10:102247526	SEC31B	chr10:102246403-102289636:-	-0.28	-4.25	4.17E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2298075	chr10:102247408	SEC31B	chr10:102246403-102289636:-	-0.3	-4.76	5.2E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2303759	chr19:49869051	DKKL1	chr19:49867042-49878371:+	-0.46	-6.75	4.96E-10	Multiple sclerosis	
TGCT	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.81	-9.4	3.16E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs2324934	chr6:87236867	SNHG5	chr6:86386726-86388451:-	-0.44	-4.48	1.63E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.61	-5.72	7.35E-8	Type 2 diabetes	
TGCT	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.61	-5.72	7.35E-8	Type 2 diabetes	
TGCT	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.28	-4.22	4.63E-5	Homocysteine levels	
TGCT	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.29	-4.57	1.16E-5	Homocysteine levels	
TGCT	cis	1	rs236104	chr20:5958960	MCM8	chr20:5931298-5975829:+	-0.29	-4.24	4.36E-5	HIV-1 viral setpoint	
TGCT	cis	1	rs236121	chr20:5972594	MCM8	chr20:5931298-5975829:+	-0.29	-4.2	4.98E-5	HIV-1 viral setpoint	
TGCT	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.28	-5.66	9.9E-8	Longevity	
TGCT	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.26	5.4	3.26E-7	Longevity	
TGCT	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.55	-4.17	5.52E-5	Plasma clusterin levels	
TGCT	cis	1	rs2371244	chr7:143757611	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2371247	chr7:143764179	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2371248	chr7:143764189	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2371623	chr3:41761083	ULK4	chr3:41288091-42003660:-	0.49	5.6	1.28E-7	Diastolic blood pressure	
TGCT	cis	1	rs2371627	chr3:41839219	ULK4	chr3:41288091-42003660:-	0.53	5.97	2.23E-8	Diastolic blood pressure	
TGCT	cis	1	rs2387880	chr20:25377787	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2387881	chr20:25378172	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2387884	chr20:25379069	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2415253	chr15:75375699	SCAMP5	chr15:75287901-75313836:+	0.32	4.42	2.11E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs2421555	chr2:73816955	ALMS1P	chr2:73872046-73912692:+	0.37	4.46	1.79E-5	Metabolite levels	
TGCT	cis	1	rs2421555	chr2:73816955	TPRKB	chr2:73956957-73964517:-	-0.31	-4.28	3.64E-5	Metabolite levels	
TGCT	cis	1	rs2424700	chr20:25266513	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2424704	chr20:25273929	NINL	chr20:25433338-25566153:-	-0.41	-6.08	1.31E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2424710	chr20:25283886	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2424712	chr20:25416942	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2424713	chr20:25418482	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2424716	chr20:25423538	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.36	4.43	2.02E-5	Tumor biomarkers	
TGCT	cis	1	rs2448704	chr6:49453672	CENPQ	chr6:49431096-49460820:+	0.45	6.01	1.9E-8	Homocysteine levels	
TGCT	cis	1	rs2448707	chr6:49446951	MUT	chr6:49398994-49431031:-	-0.31	-5.29	5.36E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.26	-5.52	1.82E-7	Ankylosing spondylitis	
TGCT	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.46	5.61	1.25E-7	Ankylosing spondylitis	
TGCT	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.38	4.45	1.9E-5	Tumor biomarkers	
TGCT	cis	1	rs2474777	chr20:25272633	NINL	chr20:25433338-25566153:-	-0.38	-5.73	7.16E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2482911	chr20:25395528	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2482919	chr20:25299756	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2482927	chr20:25327151	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2482928	chr20:25331530	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2482930	chr20:25334115	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2482931	chr20:25334445	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2482937	chr20:25340786	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2482940	chr20:25349830	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2482941	chr20:25361216	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2482943	chr20:25380593	NINL	chr20:25433338-25566153:-	0.4	6.08	1.31E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2489034	chr10:102319192	SEC31B	chr10:102246403-102289636:-	-0.29	-4.45	1.89E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2489035	chr10:102319395	SEC31B	chr10:102246403-102289636:-	-0.29	-4.45	1.89E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2489036	chr10:102319581	SEC31B	chr10:102246403-102289636:-	-0.29	-4.45	1.89E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2489039	chr10:102328036	SEC31B	chr10:102246403-102289636:-	-0.29	-4.4	2.28E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2489040	chr10:102331298	SEC31B	chr10:102246403-102289636:-	-0.29	-4.4	2.28E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2489043	chr10:102334327	SEC31B	chr10:102246403-102289636:-	-0.3	-4.57	1.13E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2489045	chr10:102344754	SEC31B	chr10:102246403-102289636:-	-0.3	-4.39	2.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2489046	chr10:102346282	SEC31B	chr10:102246403-102289636:-	-0.3	-4.65	8.2E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2489047	chr10:102347028	SEC31B	chr10:102246403-102289636:-	-0.3	-4.66	7.98E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2489048	chr10:102348497	SEC31B	chr10:102246403-102289636:-	-0.28	-4.15	6.12E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2489049	chr10:102350732	SEC31B	chr10:102246403-102289636:-	-0.3	-4.66	7.98E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2489050	chr10:102350898	SEC31B	chr10:102246403-102289636:-	-0.28	-4.15	6.12E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2489053	chr10:102353341	SEC31B	chr10:102246403-102289636:-	-0.3	-4.29	3.57E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2495732	chr10:102357780	SEC31B	chr10:102246403-102289636:-	-0.32	-4.64	8.57E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2495741	chr10:102331795	SEC31B	chr10:102246403-102289636:-	-0.29	-4.24	4.28E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2495742	chr10:102331364	SEC31B	chr10:102246403-102289636:-	-0.3	-4.39	2.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2495745	chr10:102329075	SEC31B	chr10:102246403-102289636:-	-0.29	-4.4	2.28E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2495747	chr10:102328247	SEC31B	chr10:102246403-102289636:-	-0.29	-4.4	2.28E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2495750	chr10:102327708	SEC31B	chr10:102246403-102289636:-	-0.29	-4.4	2.28E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2495751	chr10:102327260	SEC31B	chr10:102246403-102289636:-	-0.29	-4.4	2.28E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2495752	chr10:102326115	SEC31B	chr10:102246403-102289636:-	-0.29	-4.39	2.38E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2495754	chr10:102324812	SEC31B	chr10:102246403-102289636:-	-0.29	-4.39	2.38E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2495755	chr10:102324649	SEC31B	chr10:102246403-102289636:-	-0.3	-4.39	2.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2495758	chr10:102321900	SEC31B	chr10:102246403-102289636:-	-0.3	-4.39	2.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2495760	chr10:102318771	SEC31B	chr10:102246403-102289636:-	-0.3	-4.45	1.84E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2500404	chr20:25359758	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2500405	chr20:25360826	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2500418	chr20:25382268	NINL	chr20:25433338-25566153:-	0.4	6.08	1.31E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2500424	chr20:25391969	NINL	chr20:25433338-25566153:-	0.41	6.18	8.21E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2500432	chr20:25290512	NINL	chr20:25433338-25566153:-	-0.4	-6.04	1.63E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2500436	chr20:25406366	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2500443	chr20:25331442	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2500446	chr20:25339664	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2500448	chr20:25404027	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2501962	chr6:49453636	MUT	chr6:49398994-49431031:-	-0.32	-5.33	4.45E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs2501963	chr6:49454281	MUT	chr6:49398994-49431031:-	-0.32	-5.33	4.45E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs2524005	chr6:29899677	HCG4	chr6:29758809-29760850:-	-0.5	-4.97	2.13E-6	Bipolar disorder and schizophrenia	
TGCT	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.27	4.4	2.26E-5	Bipolar disorder and schizophrenia	
TGCT	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	0.76	8.26	1.71E-13	Type 2 diabetes	
TGCT	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	0.74	7.56	7.27E-12	Type 2 diabetes	
TGCT	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	0.79	9	2.89E-15	Type 2 diabetes	
TGCT	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.78	8.63	2.22E-14	Type 2 diabetes	
TGCT	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.8	-9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs2540173	chr1:156188214	PMF1	chr1:156182784-156209831:+	-0.24	-4.16	5.82E-5	Testicular germ cell tumor	
TGCT	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs2572910	chr8:143770135	LYNX1	chr8:143845758-143859640:-	-0.25	-4.15	6.02E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2585179	chr8:143774193	LYNX1	chr8:143845758-143859640:-	-0.25	-4.15	6.02E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2625667	chr3:41900951	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs2625668	chr3:41905930	ULK4	chr3:41288091-42003660:-	0.46	5.3	4.95E-7	Diastolic blood pressure	
TGCT	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.26	-5.52	1.82E-7	Ankylosing spondylitis	
TGCT	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.46	5.61	1.25E-7	Ankylosing spondylitis	
TGCT	cis	1	rs2652816	chr15:63403368	TPM1	chr15:63334838-63364111:+	0.42	4.44	1.97E-5	HDL cholesterol	
TGCT	cis	1	rs2652832	chr15:63396928	TPM1	chr15:63334838-63364111:+	0.45	4.86	3.41E-6	HDL cholesterol	
TGCT	cis	1	rs2652833	chr15:63396885	TPM1	chr15:63334838-63364111:+	0.45	4.86	3.41E-6	HDL cholesterol	
TGCT	cis	1	rs2652834	chr15:63396867	TPM1	chr15:63334838-63364111:+	0.45	4.86	3.41E-6	HDL cholesterol	
TGCT	cis	1	rs2652835	chr15:63396408	TPM1	chr15:63334838-63364111:+	0.46	4.93	2.56E-6	HDL cholesterol	
TGCT	cis	1	rs2652838	chr15:63396088	TPM1	chr15:63334838-63364111:+	0.46	4.93	2.56E-6	HDL cholesterol	
TGCT	cis	1	rs2652840	chr15:63393220	LACTB	chr15:63414032-63434254:+	0.29	4.41	2.23E-5	HDL cholesterol	
TGCT	cis	1	rs2652840	chr15:63393220	TPM1	chr15:63334838-63364111:+	0.5	5.38	3.5E-7	HDL cholesterol	
TGCT	cis	1	rs2655310	chr4:130017919	C4orf33	chr4:130014829-130033842:+	-0.48	-4.78	4.9E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs2683695	chr3:41914928	ULK4	chr3:41288091-42003660:-	0.46	5.3	4.95E-7	Diastolic blood pressure	
TGCT	cis	1	rs2683696	chr3:41914898	ULK4	chr3:41288091-42003660:-	0.48	5.46	2.43E-7	Diastolic blood pressure	
TGCT	cis	1	rs2717562	chr8:143776668	LYNX1	chr8:143845758-143859640:-	-0.25	-4.15	6.02E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2729780	chr15:63404639	TPM1	chr15:63334838-63364111:+	0.45	4.88	3.16E-6	HDL cholesterol	
TGCT	cis	1	rs2729781	chr15:63404265	TPM1	chr15:63334838-63364111:+	0.44	4.78	4.82E-6	HDL cholesterol	
TGCT	cis	1	rs2729782	chr15:63403354	TPM1	chr15:63334838-63364111:+	0.42	4.44	1.97E-5	HDL cholesterol	
TGCT	cis	1	rs2729783	chr15:63403316	TPM1	chr15:63334838-63364111:+	0.41	4.2	5.1E-5	HDL cholesterol	
TGCT	cis	1	rs2729784	chr15:63402735	TPM1	chr15:63334838-63364111:+	0.44	4.78	4.82E-6	HDL cholesterol	
TGCT	cis	1	rs2729785	chr15:63402574	TPM1	chr15:63334838-63364111:+	0.44	4.78	4.82E-6	HDL cholesterol	
TGCT	cis	1	rs2729788	chr15:63400378	TPM1	chr15:63334838-63364111:+	0.45	4.86	3.41E-6	HDL cholesterol	
TGCT	cis	1	rs2729830	chr15:63395812	TPM1	chr15:63334838-63364111:+	0.46	4.93	2.56E-6	HDL cholesterol	
TGCT	cis	1	rs2729833	chr15:63397044	TPM1	chr15:63334838-63364111:+	0.43	4.51	1.44E-5	HDL cholesterol	
TGCT	cis	1	rs2739330	chr22:24295286	GSTT1	chr22:24376141-24384284:-	0.56	7.37	2.03E-11	Liver enzyme levels (gamma-glutamyl transferase)	
TGCT	cis	1	rs2739330	chr22:24295286	GSTT2	chr22:24322314-24326104:+;chr22	-0.61	-10.41	1.1E-18	Liver enzyme levels (gamma-glutamyl transferase)	
TGCT	cis	1	rs2739330	chr22:24295286	LOC391322	chr22:24373117-24374043:+	0.56	6.31	4.3E-9	Liver enzyme levels (gamma-glutamyl transferase)	
TGCT	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.26	-5.44	2.72E-7	Ankylosing spondylitis	
TGCT	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.47	5.77	5.77E-8	Ankylosing spondylitis	
TGCT	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.27	5.62	1.14E-7	Ankylosing spondylitis	
TGCT	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.45	-5.47	2.35E-7	Ankylosing spondylitis	
TGCT	cis	1	rs280603	chr4:129915063	C4orf33	chr4:130014829-130033842:+	-0.48	-4.5	1.53E-5	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs280604	chr4:129921170	C4orf33	chr4:130014829-130033842:+	-0.48	-4.5	1.53E-5	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.86	-10.21	3.31E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.86	-10.34	1.6E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.86	-10.21	3.31E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs2835607	chr21:38491973	TTC3	chr21:38445571-38575406:+	0.19	4.31	3.22E-5	Eye color traits	
TGCT	cis	1	rs2835608	chr21:38493455	TTC3	chr21:38445571-38575406:+	0.19	4.42	2.13E-5	Eye color traits	
TGCT	cis	1	rs28380602	chr15:24778146	PWRN1	chr15:24778839-24832924:+	0.36	4.39	2.38E-5	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
TGCT	cis	1	rs28391259	chr4:107014012	TBCK	chr4:106967233-107237861:-	0.35	4.32	3.16E-5	Airflow obstruction	
TGCT	cis	1	rs28522614	chr10:102323141	SEC31B	chr10:102246403-102289636:-	-0.28	-4.17	5.72E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs2856	chr20:25433536	NINL	chr20:25433338-25566153:-	-0.41	-6.08	1.31E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs2867318	chr19:52363472	ZNF577	chr19:52359056-52394145:-	-0.31	-4.47	1.75E-5	Breast cancer	
TGCT	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	0.46	5	1.92E-6	Diastolic blood pressure	
TGCT	cis	1	rs28755797	chr3:41774446	ULK4	chr3:41288091-42003660:-	0.43	4.37	2.61E-5	Diastolic blood pressure	
TGCT	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.26	-5.41	3.02E-7	Longevity	
TGCT	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.26	5.44	2.68E-7	Longevity	
TGCT	cis	1	rs2901438	chr2:73665656	ALMS1P	chr2:73872046-73912692:+	0.39	4.65	8.41E-6	Metabolite levels	
TGCT	cis	1	rs2904524	chr12:70690085	YEATS4	chr12:69753532-69784575:+	-0.5	-4.41	2.21E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs2920292	chr8:143765699	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2920293	chr8:143765414	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2920294	chr8:143765326	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2920295	chr8:143764937	LYNX1	chr8:143845758-143859640:-	-0.26	-4.26	3.98E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2920296	chr8:143763109	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2920297	chr8:143763083	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2920298	chr8:143763043	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2945232	chr8:8098038	FLJ10661	chr8:8086092-8102386:+	0.73	8.7	1.58E-14	Schizophrenia	
TGCT	cis	1	rs2951308	chr7:143767149	ARHGEF35	chr7:143883677-143892736:-	0.39	4.59	1.05E-5	Obesity-related traits	
TGCT	cis	1	rs2951353	chr7:143761116	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2951354	chr7:143761001	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2951360	chr7:143757349	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2951363	chr7:143754724	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2951364	chr7:143754483	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2951368	chr7:143752821	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2951369	chr7:143752638	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2951372	chr7:143749503	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2961115	chr7:143753371	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2961117	chr7:143755253	ARHGEF35	chr7:143883677-143892736:-	-0.35	-4.34	2.88E-5	Obesity-related traits	
TGCT	cis	1	rs2961118	chr7:143755443	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.58	1.11E-5	Obesity-related traits	
TGCT	cis	1	rs2961119	chr7:143755852	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.58	1.11E-5	Obesity-related traits	
TGCT	cis	1	rs2961120	chr7:143756585	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2961125	chr7:143761770	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2961126	chr7:143762736	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2961128	chr7:143763483	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs2961132	chr7:143768128	ARHGEF35	chr7:143883677-143892736:-	-0.38	-4.52	1.4E-5	Obesity-related traits	
TGCT	cis	1	rs2961134	chr7:143771062	ARHGEF35	chr7:143883677-143892736:-	-0.35	-4.23	4.51E-5	Obesity-related traits	
TGCT	cis	1	rs2961144	chr7:143747870	ARHGEF35	chr7:143883677-143892736:-	0.39	4.66	7.82E-6	Obesity-related traits	
TGCT	cis	1	rs2967678	chr19:8790198	ELAVL1	chr19:8023458-8070529:-	-0.41	-4.21	4.74E-5	Atopic dermatitis	
TGCT	cis	1	rs2976392	chr8:143762932	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.69E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2976394	chr8:143763622	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2976396	chr8:143764001	LYNX1	chr8:143845758-143859640:-	0.25	4.15	6.18E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2976398	chr8:143764879	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2977993	chr9:131608786	ENDOG	chr9:131580779-131584954:+	0.35	4.81	4.15E-6	Schizophrenia	
TGCT	cis	1	rs2978982	chr8:143763490	LYNX1	chr8:143845758-143859640:-	-0.25	-4.17	5.57E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
TGCT	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.27	-4.21	4.76E-5	Homocysteine levels	
TGCT	cis	1	rs3002702	chr20:25268920	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs3003214	chr1:244605036	C1orf101	chr1:244617679-244803660:+	0.32	5.64	1.08E-7	Dementia and core Alzheimer's disease neuropathologic changes	
TGCT	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.26	-5.52	1.82E-7	Ankylosing spondylitis	
TGCT	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.46	5.61	1.25E-7	Ankylosing spondylitis	
TGCT	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.26	-5.46	2.4E-7	Ankylosing spondylitis	
TGCT	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.45	5.46	2.46E-7	Ankylosing spondylitis	
TGCT	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.26	-5.5	2.07E-7	Ankylosing spondylitis	
TGCT	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.46	5.52	1.83E-7	Ankylosing spondylitis	
TGCT	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.26	-5.5	2.07E-7	Ankylosing spondylitis	
TGCT	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.46	5.52	1.83E-7	Ankylosing spondylitis	
TGCT	cis	1	rs3091242	chr1:25674785	RHCE	chr1:25688741-25756683:-	0.59	8.7	1.54E-14	Erythrocyte sedimentation rate	
TGCT	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs3099899	chr4:129917368	C4orf33	chr4:130014829-130033842:+	-0.48	-4.5	1.53E-5	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.36	-4.19	5.25E-5	Tumor biomarkers	
TGCT	cis	1	rs3105369	chr4:130022448	C4orf33	chr4:130014829-130033842:+	-0.48	-4.78	4.9E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs3113489	chr4:129961179	C4orf33	chr4:130014829-130033842:+	-0.49	-4.67	7.75E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs3204270	chr17:79682051	ARL16	chr17:79648234-79650954:-	-0.56	-5.56	1.56E-7	Dental caries	
TGCT	cis	1	rs3213762	chr17:38178627	GSDMA	chr17:38119226-38134019:+	-0.63	-8.02	6.21E-13	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.28	-5.64	1.08E-7	Longevity	
TGCT	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	0.78	8.65	2.04E-14	Type 2 diabetes	
TGCT	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs34084277	chr19:17387176	C19orf62	chr19:17378232-17393811:+	-0.38	-4.36	2.71E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.83	-9.66	7.33E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs34237279	chr15:75361121	SCAMP5	chr15:75287901-75313836:+	0.31	4.24	4.33E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs34428306	chr1:152184316	FLG	chr1:152274651-152297679:-	0.46	4.85	3.62E-6	Inflammatory skin disease	
TGCT	cis	1	rs34570071	chr15:85280212	LOC388152	chr15:84867600-84898920:-	-0.46	-6.39	2.99E-9	Schizophrenia	
TGCT	cis	1	rs34575783	chr15:63397686	TPM1	chr15:63334838-63364111:+	0.45	4.86	3.41E-6	HDL cholesterol	
TGCT	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs34592321	chr5:132181675	LEAP2	chr5:132209358-132210581:+	0.5	4.53	1.32E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.83	-9.78	3.66E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs34645895	chr20:25368373	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs34751999	chr15:84758419	LOC388152	chr15:84867600-84898920:-	-0.38	-5.37	3.63E-7	Schizophrenia	
TGCT	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.83	-9.78	3.66E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs34900908	chr15:85257599	LOC388152	chr15:84867600-84898920:-	-0.44	-6.1	1.22E-8	Schizophrenia	
TGCT	cis	1	rs35006492	chr4:129878342	C4orf33	chr4:130014829-130033842:+	0.5	4.53	1.34E-5	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs35106985	chr10:102307542	SEC31B	chr10:102246403-102289636:-	-0.3	-4.62	9.49E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs35297609	chr15:84772896	LOC388152	chr15:84867600-84898920:-	-0.38	-5.37	3.63E-7	Schizophrenia	
TGCT	cis	1	rs35316992	chr15:85248133	LOC388152	chr15:84867600-84898920:-	-0.44	-6.1	1.22E-8	Schizophrenia	
TGCT	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.86	-10.21	3.31E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.68	7.91	1.15E-12	Eye color traits	
TGCT	cis	1	rs35524990	chr15:85258203	LOC388152	chr15:84867600-84898920:-	-0.44	-6.1	1.22E-8	Schizophrenia	
TGCT	cis	1	rs35577967	chr15:75354621	SCAMP5	chr15:75287901-75313836:+	0.32	4.3	3.46E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs35630683	chr15:85349231	LOC388152	chr15:84867600-84898920:-	-0.46	-6.47	2.0E-9	Schizophrenia	
TGCT	cis	1	rs35648189	chr15:84740748	LOC388152	chr15:84867600-84898920:-	-0.38	-5.4	3.19E-7	Schizophrenia	
TGCT	cis	1	rs35658069	chr15:84780146	LOC388152	chr15:84867600-84898920:-	-0.38	-5.37	3.63E-7	Schizophrenia	
TGCT	cis	1	rs35726233	chr15:85337800	LOC388152	chr15:84867600-84898920:-	-0.46	-6.47	2.0E-9	Schizophrenia	
TGCT	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.86	-10.21	3.31E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.81	-9.35	4.21E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs35808647	chr15:85377441	LOC388152	chr15:84867600-84898920:-	-0.49	-6.6	1.04E-9	Schizophrenia	
TGCT	cis	1	rs35960805	chr15:85343980	LOC388152	chr15:84867600-84898920:-	-0.46	-6.47	2.0E-9	Schizophrenia	
TGCT	cis	1	rs36033486	chr15:85319692	LOC388152	chr15:84867600-84898920:-	-0.45	-6.28	5.07E-9	Schizophrenia	
TGCT	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs36116701	chr15:63397494	TPM1	chr15:63334838-63364111:+	0.45	4.86	3.41E-6	HDL cholesterol	
TGCT	cis	1	rs3734530	chr6:26195408	HIST1H3E	chr6:26224427-26226589:+	0.47	4.19	5.14E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs3738848	chr2:73761881	ALMS1P	chr2:73872046-73912692:+	0.39	4.62	9.4E-6	Metabolite levels	
TGCT	cis	1	rs3740711	chr11:18379839	GTF2H1	chr11:18343816-18388590:+	0.41	4.17	5.66E-5	Pancreatic cancer	
TGCT	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.41	-7.95	9.19E-13	IgG glycosylation	
TGCT	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.47	7.6	6.03E-12	Schizophrenia	
TGCT	cis	1	rs3750626	chr10:102266316	SEC31B	chr10:102246403-102289636:-	-0.3	-4.58	1.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs3750627	chr10:102275642	SEC31B	chr10:102246403-102289636:-	-0.3	-4.66	7.87E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs3750629	chr10:102275727	SEC31B	chr10:102246403-102289636:-	-0.3	-4.64	8.7E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs3750630	chr10:102275780	SEC31B	chr10:102246403-102289636:-	-0.31	-4.72	6.24E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs3750720	chr10:102248884	SEC31B	chr10:102246403-102289636:-	-0.28	-4.34	2.88E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs3751972	chr17:26206414	C17orf108	chr17:26205341-26220409:-	0.43	8.24	1.88E-13	Fractional exhaled nitric oxide (childhood)	
TGCT	cis	1	rs3757241	chr6:46623698	PLA2G7	chr6:46672054-46703151:-	-0.22	-5.05	1.5E-6	Lipoprotein-associated phospholipase A2 activity and mass	
TGCT	cis	1	rs3761117	chr20:25388070	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs3761378	chr21:43832918	ZNF295	chr21:43406941-43430496:-	-0.18	-4.39	2.33E-5	Type 1 diabetes	
TGCT	cis	1	rs3762464	chr2:133194030	GPR39	chr2:133174147-133404168:+	0.32	4.24	4.37E-5	Hypertension	
TGCT	cis	1	rs3763695	chr10:102269206	SEC31B	chr10:102246403-102289636:-	-0.3	-4.58	1.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs3774291	chr3:186433471	KNG1	chr3:186435120-186461741:+	0.3	4.38	2.49E-5	Adiponectin levels	
TGCT	cis	1	rs3774292	chr3:186433574	KNG1	chr3:186435120-186461741:+	0.3	4.38	2.49E-5	Adiponectin levels	
TGCT	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs3774808	chr3:48481647	TREX1	chr3:48501186-48509043:+	-0.28	-5.67	9.47E-8	Longevity	
TGCT	cis	1	rs3793706	chr10:102269085	SEC31B	chr10:102246403-102289636:-	0.29	4.42	2.08E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs3793771	chr10:102222957	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs3793772	chr10:102222825	SEC31B	chr10:102246403-102289636:-	-0.32	-5.05	1.54E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs3796689	chr4:185649866	MLF1IP	chr4:185615220-185655286:-	-0.57	-7.79	2.16E-12	Kawasaki disease	
TGCT	cis	1	rs3799277	chr6:46657057	PLA2G7	chr6:46672054-46703151:-	-0.21	-4.9	2.88E-6	Lipoprotein-associated phospholipase A2 activity and mass	
TGCT	cis	1	rs3806689	chr3:186435077	KNG1	chr3:186435120-186461741:+	0.3	4.38	2.49E-5	Adiponectin levels	
TGCT	cis	1	rs3806988	chr6:49431569	MUT	chr6:49398994-49431031:-	0.3	5.12	1.13E-6	Folate pathway vitamin levels	
TGCT	cis	1	rs3813227	chr2:73651967	ALMS1P	chr2:73872046-73912692:+	-0.4	-4.67	7.63E-6	Metabolite levels	
TGCT	cis	1	rs3815304	chr2:242050761	MTERFD2	chr2:242034545-242041747:-	0.72	4.19	5.2E-5	Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	
TGCT	cis	1	rs3821815	chr3:186434262	KNG1	chr3:186435120-186461741:+	0.31	4.55	1.22E-5	Adiponectin levels	
TGCT	cis	1	rs3823114	chr6:49431720	MUT	chr6:49398994-49431031:-	0.31	5.31	4.78E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs3824754	chr10:104614350	SFXN2	chr10:104474298-104498946:+	-0.85	-4.62	9.44E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
TGCT	cis	1	rs3824755	chr10:104595849	SFXN2	chr10:104474298-104498946:+	-0.79	-4.68	7.38E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
TGCT	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.27	4.23	4.54E-5	Multiple sclerosis	
TGCT	cis	1	rs3825932	chr15:79235446	CTSH	chr15:79214092-79237420:-	0.18	4.32	3.08E-5	Type 1 diabetes	
TGCT	cis	1	rs3826061	chr16:88927221	TRAPPC2L	chr16:88922628-88927591:+	-0.42	-6.25	5.86E-9	Parkinson disease and lewy body pathology	
TGCT	cis	1	rs3826331	chr17:38150492	GSDMA	chr17:38119226-38134019:+	0.61	7.8	1.99E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs3827066	chr20:44586023	WFDC3	chr20:44402847-44420547:-	-0.72	-5.64	1.05E-7	Abdominal aortic aneurysm	
TGCT	cis	1	rs3846771	chr6:87237048	SNHG5	chr6:86386726-86388451:-	-0.44	-4.48	1.63E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs3846772	chr6:87237249	SNHG5	chr6:86386726-86388451:-	-0.51	-4.18	5.49E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs3848562	chr19:52379835	ZNF577	chr19:52359056-52394145:-	0.3	4.22	4.57E-5	Breast cancer	
TGCT	cis	1	rs3856807	chr3:12527600	TSEN2	chr3:12525931-12581122:+	0.44	4.23	4.45E-5	Prostate cancer (gene x gene interaction)	
TGCT	cis	1	rs3857482	chr6:87236780	SNHG5	chr6:86386726-86388451:-	-0.44	-4.48	1.63E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs3870341	chr3:49584745	SEMA3F	chr3:50192848-50226507:+	0.29	4.31	3.24E-5	Menarche (age at onset)	
TGCT	cis	1	rs3890604	chr3:41760625	ULK4	chr3:41288091-42003660:-	0.49	5.6	1.28E-7	Diastolic blood pressure	
TGCT	cis	1	rs391396	chr4:130037653	C4orf33	chr4:130014829-130033842:+	-0.49	-4.72	6.24E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.48	-5.36	3.77E-7	Diastolic blood pressure	
TGCT	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.68	7.91	1.15E-12	Eye color traits	
TGCT	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.61	-5.72	7.35E-8	Type 2 diabetes	
TGCT	cis	1	rs397119	chr20:25440187	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs3979179	chr1:16306846	CLCNKA	chr1:16345370-16360544:+	-0.5	-5.94	2.56E-8	Dilated cardiomyopathy	
TGCT	cis	1	rs398036	chr20:25439850	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs39841	chr5:96120170	ERAP1	chr5:96096515-96149837:-	-0.21	-4.26	4.04E-5	Inflammatory skin disease	
TGCT	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.41	4.78	4.79E-6	Inflammatory skin disease	
TGCT	cis	1	rs401166	chr20:25446308	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4037	chr10:97365820	ENTPD1	chr10:97471536-97637022:+	0.3	4.72	6.08E-6	Blood metabolite levels	
TGCT	cis	1	rs404394	chr20:25447896	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.68	-7.91	1.15E-12	Eye color traits	
TGCT	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.67	-7.6	6.02E-12	Eye color traits	
TGCT	cis	1	rs4077468	chr1:205914757	PM20D1	chr1:205797154-205819245:-	0.5	4.94	2.43E-6	Cystic fibrosis-related diabetes	
TGCT	cis	1	rs4077469	chr1:205914885	PM20D1	chr1:205797154-205819245:-	0.5	4.94	2.43E-6	Cystic fibrosis-related diabetes	
TGCT	cis	1	rs41266807	chr6:26199822	HIST1H3E	chr6:26224427-26226589:+	0.47	4.14	6.25E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs41266839	chr6:26409890	BTN3A2	chr6:26365398-26378546:+	-0.66	-8.62	2.39E-14	Schizophrenia	
TGCT	cis	1	rs4150550	chr11:18350898	GTF2H1	chr11:18343816-18388590:+	0.43	4.49	1.58E-5	Pancreatic cancer	
TGCT	cis	1	rs4150562	chr11:18354995	GTF2H1	chr11:18343816-18388590:+	0.41	4.32	3.16E-5	Pancreatic cancer	
TGCT	cis	1	rs4150564	chr11:18355308	GTF2H1	chr11:18343816-18388590:+	0.43	4.51	1.44E-5	Pancreatic cancer	
TGCT	cis	1	rs4150566	chr11:18355599	GTF2H1	chr11:18343816-18388590:+	0.43	4.55	1.26E-5	Pancreatic cancer	
TGCT	cis	1	rs4150575	chr11:18356466	GTF2H1	chr11:18343816-18388590:+	0.43	4.55	1.26E-5	Pancreatic cancer	
TGCT	cis	1	rs4150579	chr11:18357180	GTF2H1	chr11:18343816-18388590:+	-0.41	-4.24	4.23E-5	Pancreatic cancer	
TGCT	cis	1	rs4150610	chr11:18364140	GTF2H1	chr11:18343816-18388590:+	0.43	4.51	1.44E-5	Pancreatic cancer	
TGCT	cis	1	rs4150612	chr11:18364358	GTF2H1	chr11:18343816-18388590:+	0.43	4.55	1.26E-5	Pancreatic cancer	
TGCT	cis	1	rs4150615	chr11:18365028	GTF2H1	chr11:18343816-18388590:+	-0.47	-4.2	5.05E-5	Pancreatic cancer	
TGCT	cis	1	rs4150622	chr11:18365710	GTF2H1	chr11:18343816-18388590:+	0.43	4.58	1.1E-5	Pancreatic cancer	
TGCT	cis	1	rs4150641	chr11:18370739	GTF2H1	chr11:18343816-18388590:+	0.43	4.55	1.26E-5	Pancreatic cancer	
TGCT	cis	1	rs4150650	chr11:18374279	GTF2H1	chr11:18343816-18388590:+	0.42	4.38	2.51E-5	Pancreatic cancer	
TGCT	cis	1	rs4150651	chr11:18374425	GTF2H1	chr11:18343816-18388590:+	0.41	4.16	5.79E-5	Pancreatic cancer	
TGCT	cis	1	rs4150655	chr11:18375164	GTF2H1	chr11:18343816-18388590:+	-0.43	-4.44	1.94E-5	Pancreatic cancer	
TGCT	cis	1	rs4150661	chr11:18379629	GTF2H1	chr11:18343816-18388590:+	0.43	4.34	2.86E-5	Pancreatic cancer	
TGCT	cis	1	rs4150673	chr11:18383449	GTF2H1	chr11:18343816-18388590:+	0.41	4.18	5.43E-5	Pancreatic cancer	
TGCT	cis	1	rs422424	chr20:25445446	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs422844	chr20:25445591	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4244338	chr10:102272802	SEC31B	chr10:102246403-102289636:-	-0.29	-4.43	1.99E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs4267943	chr6:49439805	MUT	chr6:49398994-49431031:-	-0.31	-5.18	8.71E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs4282209	chr4:76919536	NAAA	chr4:76831809-76862166:-	-0.31	-5.61	1.21E-7	Longevity	
TGCT	cis	1	rs4294134	chr7:135293128	PL-5283	chr7:135347221-135378160:+	0.61	4.9	2.83E-6	Paget's disease	
TGCT	cis	1	rs4307563	chr1:16313788	CLCNKA	chr1:16345370-16360544:+	0.51	6.06	1.47E-8	Dilated cardiomyopathy	
TGCT	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.41	-4.21	4.8E-5	Rheumatoid arthritis	
TGCT	cis	1	rs4344684	chr15:63397318	TPM1	chr15:63334838-63364111:+	0.45	4.84	3.77E-6	HDL cholesterol	
TGCT	cis	1	rs4353250	chr11:18323517	GTF2H1	chr11:18343816-18388590:+	0.43	4.55	1.24E-5	Pancreatic cancer	
TGCT	cis	1	rs4394010	chr4:129894649	C4orf33	chr4:130014829-130033842:+	0.49	4.67	7.75E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs4408846	chr3:41753679	ULK4	chr3:41288091-42003660:-	0.48	4.8	4.49E-6	Diastolic blood pressure	
TGCT	cis	1	rs4409766	chr10:104616663	SFXN2	chr10:104474298-104498946:+	-0.78	-4.56	1.18E-5	Hypertension;Systolic blood pressure;Diastolic blood pressure	
TGCT	cis	1	rs4466058	chr4:129923879	C4orf33	chr4:130014829-130033842:+	-0.48	-4.5	1.53E-5	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs4469291	chr6:49440614	MUT	chr6:49398994-49431031:-	0.31	5.29	5.36E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs447722	chr20:25443510	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs448396	chr20:25440269	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4490383	chr3:48484683	TREX1	chr3:48501186-48509043:+	-0.28	-5.55	1.61E-7	Longevity	
TGCT	cis	1	rs4514789	chr19:52365654	ZNF577	chr19:52359056-52394145:-	-0.31	-4.47	1.75E-5	Breast cancer	
TGCT	cis	1	rs453329	chr20:25440593	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4579248	chr5:150268151	LOC134466	chr5:150310000-150326146:-	0.71	5.17	8.99E-7	Crohn's disease	
TGCT	cis	1	rs4604805	chr10:102261409	SEC31B	chr10:102246403-102289636:-	-0.29	-4.35	2.81E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs4643294	chr15:85250253	LOC388152	chr15:84867600-84898920:-	-0.44	-6.1	1.22E-8	Schizophrenia	
TGCT	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.26	4.18	5.36E-5	Multiple sclerosis	
TGCT	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.28	4.31	3.26E-5	Homocysteine levels	
TGCT	cis	1	rs4660870	chr1:45995231	CCDC163P	chr1:45960581-45965646:-	-0.28	-4.4	2.28E-5	Homocysteine levels	
TGCT	cis	1	rs4665238	chr2:23942446	C2orf84	chr2:24397531-24414566:+	-0.38	-4.2	5.07E-5	Obesity-related traits	
TGCT	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.26	-5.46	2.4E-7	Ankylosing spondylitis	
TGCT	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.45	5.46	2.46E-7	Ankylosing spondylitis	
TGCT	cis	1	rs4705972	chr5:132179237	LEAP2	chr5:132209358-132210581:+	0.56	4.92	2.67E-6	Apolipoprotein A-IV levels	
TGCT	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.87	-10.35	1.51E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.86	-10.21	3.31E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs4715129	chr6:49415043	MUT	chr6:49398994-49431031:-	0.31	5.26	5.96E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs4715130	chr6:49416825	MUT	chr6:49398994-49431031:-	0.3	5.11	1.18E-6	Folate pathway vitamin levels	
TGCT	cis	1	rs4726669	chr7:143758191	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs4728142	chr7:128573967	IRF5	chr7:128577769-128590086:+	0.22	5.6	1.28E-7	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease	
TGCT	cis	1	rs473073	chr10:131429646	MGMT	chr10:131265454-131565783:+	0.35	4.96	2.24E-6	Response to temozolomide	
TGCT	cis	1	rs473771	chr10:131408155	MGMT	chr10:131265454-131565783:+	0.35	5	1.85E-6	Response to temozolomide	
TGCT	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.36	-5.05	1.51E-6	Response to temozolomide	
TGCT	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.76	-11.25	9.56E-21	Cognitive function	
TGCT	cis	1	rs4761191	chr12:70662374	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs4761195	chr12:70700747	YEATS4	chr12:69753532-69784575:+	-0.5	-4.41	2.21E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs477692	chr10:131426022	MGMT	chr10:131265454-131565783:+	0.35	4.86	3.47E-6	Response to temozolomide	
TGCT	cis	1	rs4794202	chr17:45930539	SCRN2	chr17:45915049-45918699:-	-0.34	-5.87	3.62E-8	Alzheimer's disease (cognitive decline)	
TGCT	cis	1	rs479478	chr10:131428959	MGMT	chr10:131265454-131565783:+	0.35	4.96	2.24E-6	Response to temozolomide	
TGCT	cis	1	rs4794823	chr17:38166265	GSDMA	chr17:38119226-38134019:+	-0.61	-7.78	2.22E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs4794824	chr17:38179290	GSDMA	chr17:38119226-38134019:+	-0.63	-8.04	5.76E-13	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs4795412	chr17:38150604	GSDMA	chr17:38119226-38134019:+	-0.61	-7.81	1.96E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs4795415	chr17:38157995	GSDMA	chr17:38119226-38134019:+	-0.61	-7.82	1.87E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs4795416	chr17:38158133	GSDMA	chr17:38119226-38134019:+	-0.61	-7.82	1.87E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs4795418	chr17:38164851	GSDMA	chr17:38119226-38134019:+	-0.61	-7.78	2.22E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.41	6.78	4.23E-10	Schizophrenia	
TGCT	cis	1	rs480643	chr10:131400308	MGMT	chr10:131265454-131565783:+	0.35	5	1.85E-6	Response to temozolomide	
TGCT	cis	1	rs4813562	chr20:25352588	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4813563	chr20:25365340	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4813566	chr20:25386465	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815404	chr20:25301845	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815405	chr20:25317492	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815406	chr20:25341316	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815407	chr20:25341478	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815408	chr20:25346678	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815409	chr20:25346697	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815411	chr20:25350223	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815412	chr20:25350325	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815417	chr20:25379526	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815418	chr20:25382211	NINL	chr20:25433338-25566153:-	0.4	6.08	1.31E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815420	chr20:25383979	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815421	chr20:25386509	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815424	chr20:25390284	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4815426	chr20:25405186	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs4841017	chr8:8577093	FLJ10661	chr8:8086092-8102386:+	0.47	4.29	3.57E-5	Obesity-related traits	
TGCT	cis	1	rs485576	chr10:131425496	MGMT	chr10:131265454-131565783:+	0.35	4.86	3.47E-6	Response to temozolomide	
TGCT	cis	1	rs4858793	chr3:48415007	TREX1	chr3:48501186-48509043:+	0.23	4.45	1.9E-5	Longevity	
TGCT	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.27	5.54	1.69E-7	Longevity	
TGCT	cis	1	rs4859413	chr4:76898250	NAAA	chr4:76831809-76862166:-	0.28	5.24	6.5E-7	Longevity	
TGCT	cis	1	rs4859581	chr4:76906974	NAAA	chr4:76831809-76862166:-	-0.29	-5.5	2.04E-7	Longevity	
TGCT	cis	1	rs4859582	chr4:76907213	NAAA	chr4:76831809-76862166:-	-0.31	-5.82	4.53E-8	Longevity	
TGCT	cis	1	rs4862406	chr4:185629339	MLF1IP	chr4:185615220-185655286:-	0.59	7.8	2.0E-12	Kawasaki disease	
TGCT	cis	1	rs486301	chr15:43836949	ADAL	chr15:43622872-43646094:+	-0.42	-5.35	3.98E-7	Tumor biomarkers	
TGCT	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-0.82	-18.18	5.07E-37	Pediatric autoimmune diseases	
TGCT	cis	1	rs4888668	chr16:77779481	NUDT7	chr16:77756411-77776153:+	0.44	4.18	5.34E-5	Obesity-related traits	
TGCT	cis	1	rs4888671	chr16:77783580	NUDT7	chr16:77756411-77776153:+	0.46	4.48	1.63E-5	Obesity-related traits	
TGCT	cis	1	rs4888672	chr16:77783666	NUDT7	chr16:77756411-77776153:+	0.46	4.48	1.63E-5	Obesity-related traits	
TGCT	cis	1	rs4888673	chr16:77783703	NUDT7	chr16:77756411-77776153:+	0.46	4.48	1.63E-5	Obesity-related traits	
TGCT	cis	1	rs4888674	chr16:77783749	NUDT7	chr16:77756411-77776153:+	0.46	4.48	1.63E-5	Obesity-related traits	
TGCT	cis	1	rs4888675	chr16:77783757	NUDT7	chr16:77756411-77776153:+	0.46	4.48	1.63E-5	Obesity-related traits	
TGCT	cis	1	rs4888676	chr16:77783896	NUDT7	chr16:77756411-77776153:+	0.46	4.48	1.63E-5	Obesity-related traits	
TGCT	cis	1	rs4917901	chr10:102201773	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs4919464	chr10:102221195	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs4919465	chr10:102221703	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs4919466	chr10:102241213	SEC31B	chr10:102246403-102289636:-	-0.28	-4.42	2.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs4919468	chr10:102288343	SEC31B	chr10:102246403-102289636:-	-0.3	-4.55	1.27E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs4919469	chr10:102298855	SEC31B	chr10:102246403-102289636:-	-0.31	-4.67	7.45E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs4919470	chr10:102298920	SEC31B	chr10:102246403-102289636:-	-0.32	-4.71	6.49E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs4919471	chr10:102299239	SEC31B	chr10:102246403-102289636:-	-0.33	-4.53	1.36E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs4919472	chr10:102315864	SEC31B	chr10:102246403-102289636:-	-0.3	-4.55	1.25E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs4932143	chr15:90372067	AP3S2	chr15:90373832-90456222:-	-0.63	-5.94	2.54E-8	Type 2 diabetes	
TGCT	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.62	-5.81	4.88E-8	Type 2 diabetes	
TGCT	cis	1	rs4951261	chr1:205717823	PM20D1	chr1:205797154-205819245:-	0.42	4.31	3.29E-5	Menarche (age at onset)	
TGCT	cis	1	rs4958422	chr5:150186734	LOC134466	chr5:150310000-150326146:-	0.7	5.1	1.2E-6	Crohn's disease	
TGCT	cis	1	rs4958426	chr5:150278346	LOC134466	chr5:150310000-150326146:-	0.71	5.16	9.15E-7	Crohn's disease	
TGCT	cis	1	rs4958842	chr5:150224877	LOC134466	chr5:150310000-150326146:-	0.61	4.39	2.4E-5	Crohn's disease	
TGCT	cis	1	rs4958852	chr5:150330631	LOC134466	chr5:150310000-150326146:-	0.81	4.48	1.67E-5	Crohn's disease	
TGCT	cis	1	rs4965557	chr15:100583717	FLJ42289	chr15:100884662-100890923:-	0.31	4.14	6.27E-5	Gastroesophageal reflux disease	
TGCT	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.43	-5.54	1.66E-7	Tumor biomarkers	
TGCT	cis	1	rs4973991	chr3:41927273	ULK4	chr3:41288091-42003660:-	-0.49	-5.61	1.23E-7	Diastolic blood pressure	
TGCT	cis	1	rs4975193	chr4:129980630	C4orf33	chr4:130014829-130033842:+	-0.49	-4.68	7.17E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs4975194	chr4:129982377	C4orf33	chr4:130014829-130033842:+	-0.49	-4.68	7.17E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs501220	chr6:25873025	BTN3A2	chr6:26365398-26378546:+	-0.27	-4.27	3.84E-5	Homocysteine levels	
TGCT	cis	1	rs5029969	chr3:186434405	KNG1	chr3:186435120-186461741:+	0.3	4.38	2.49E-5	Adiponectin levels	
TGCT	cis	1	rs5029970	chr3:186434491	KNG1	chr3:186435120-186461741:+	0.3	4.38	2.49E-5	Adiponectin levels	
TGCT	cis	1	rs5029975	chr3:186436918	KNG1	chr3:186435120-186461741:+	-0.3	-4.35	2.77E-5	Adiponectin levels	
TGCT	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.35	5.22	7.28E-7	Response to temozolomide	
TGCT	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.35	5	1.88E-6	Response to temozolomide	
TGCT	cis	1	rs508303	chr10:131424996	MGMT	chr10:131265454-131565783:+	-0.35	-4.76	5.27E-6	Response to temozolomide	
TGCT	cis	1	rs513736	chr10:131406489	MGMT	chr10:131265454-131565783:+	0.36	5.04	1.58E-6	Response to temozolomide	
TGCT	cis	1	rs516704	chr10:131419879	MGMT	chr10:131265454-131565783:+	0.35	4.91	2.82E-6	Response to temozolomide	
TGCT	cis	1	rs522891	chr10:131430916	MGMT	chr10:131265454-131565783:+	-0.35	-4.96	2.24E-6	Response to temozolomide	
TGCT	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.35	4.84	3.72E-6	Response to temozolomide	
TGCT	cis	1	rs531572	chr10:131427569	MGMT	chr10:131265454-131565783:+	-0.34	-4.91	2.78E-6	Response to temozolomide	
TGCT	cis	1	rs538969	chr10:131410608	MGMT	chr10:131265454-131565783:+	0.35	5	1.88E-6	Response to temozolomide	
TGCT	cis	1	rs548390	chr10:131417427	MGMT	chr10:131265454-131565783:+	0.35	4.97	2.14E-6	Response to temozolomide	
TGCT	cis	1	rs553371	chr10:131413676	MGMT	chr10:131265454-131565783:+	0.35	4.97	2.14E-6	Response to temozolomide	
TGCT	cis	1	rs554792	chr10:131423181	MGMT	chr10:131265454-131565783:+	0.35	5.14	1.02E-6	Response to temozolomide	
TGCT	cis	1	rs557675	chr11:65566719	B3GNT1	chr11:66112844-66115161:-	-0.25	-4.46	1.78E-5	Urate levels	
TGCT	cis	1	rs558764	chr10:131426957	MGMT	chr10:131265454-131565783:+	-0.34	-4.99	1.94E-6	Response to temozolomide	
TGCT	cis	1	rs55976357	chr5:132194565	LEAP2	chr5:132209358-132210581:+	0.5	4.25	4.1E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs56028644	chr19:17388790	C19orf62	chr19:17378232-17393811:+	-0.4	-4.56	1.21E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs56043407	chr17:2166078	SRR	chr17:2207248-2228553:+	-0.33	-5.23	6.76E-7	Esophageal cancer (squamous cell)	
TGCT	cis	1	rs56097052	chr5:132194430	LEAP2	chr5:132209358-132210581:+	0.5	4.25	4.1E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs56145559	chr2:73623439	ALMS1P	chr2:73872046-73912692:+	0.41	4.56	1.18E-5	Schizophrenia	
TGCT	cis	1	rs56154726	chr2:73721767	ALMS1P	chr2:73872046-73912692:+	0.44	5.17	8.97E-7	Metabolite levels	
TGCT	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs56317427	chr10:81861934	LOC219347	chr10:81805991-81838949:-	0.73	4.88	3.2E-6	Chronic obstructive pulmonary disease-related biomarkers	
TGCT	cis	1	rs56322409	chr10:97395962	ENTPD1	chr10:97471536-97637022:+	0.27	4.21	4.9E-5	Blood metabolite levels	
TGCT	cis	1	rs565974	chr10:131423274	MGMT	chr10:131265454-131565783:+	0.35	5.14	1.02E-6	Response to temozolomide	
TGCT	cis	1	rs56672945	chr2:73622663	ALMS1P	chr2:73872046-73912692:+	0.4	4.75	5.47E-6	Metabolite levels	
TGCT	cis	1	rs567700	chr10:131423126	MGMT	chr10:131265454-131565783:+	0.35	5.14	1.02E-6	Response to temozolomide	
TGCT	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	0.46	5	1.92E-6	Diastolic blood pressure	
TGCT	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.56	-9.27	6.63E-16	Crohn's disease	
TGCT	cis	1	rs568617	chr11:65653242	SNX32	chr11:65601410-65621170:+	0.4	5.17	8.86E-7	Crohn's disease	
TGCT	cis	1	rs56864281	chr15:85357649	LOC388152	chr15:84867600-84898920:-	-0.46	-6.5	1.69E-9	Schizophrenia	
TGCT	cis	1	rs56922390	chr17:38157021	GSDMA	chr17:38119226-38134019:+	-0.61	-7.82	1.87E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs569235	chr10:131411620	MGMT	chr10:131265454-131565783:+	0.35	5	1.85E-6	Response to temozolomide	
TGCT	cis	1	rs56970859	chr12:70664356	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs57025426	chr10:102205868	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs57110085	chr16:77783313	NUDT7	chr16:77756411-77776153:+	0.45	4.42	2.13E-5	Obesity-related traits	
TGCT	cis	1	rs57406211	chr5:150170966	LOC134466	chr5:150310000-150326146:-	0.65	4.37	2.52E-5	Crohn's disease	
TGCT	cis	1	rs57479675	chr3:41798038	ULK4	chr3:41288091-42003660:-	0.54	5.79	5.34E-8	Diastolic blood pressure	
TGCT	cis	1	rs5751255	chr22:42648408	CYP2D6	chr22:42522502-42526883:-	-0.51	-6.3	4.52E-9	Cognitive function	
TGCT	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.52	-6.45	2.16E-9	Cognitive function	
TGCT	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.52	-6.48	1.89E-9	Cognitive function	
TGCT	cis	1	rs5758677	chr22:42643039	CYP2D6	chr22:42522502-42526883:-	-0.52	-6.41	2.63E-9	Cognitive function	
TGCT	cis	1	rs57678958	chr16:77785315	NUDT7	chr16:77756411-77776153:+	0.49	4.59	1.04E-5	Obesity-related traits	
TGCT	cis	1	rs577227	chr10:131404528	MGMT	chr10:131265454-131565783:+	0.35	5	1.88E-6	Response to temozolomide	
TGCT	cis	1	rs57935196	chr16:77785314	NUDT7	chr16:77756411-77776153:+	0.49	4.59	1.04E-5	Obesity-related traits	
TGCT	cis	1	rs580745	chr10:131414401	MGMT	chr10:131265454-131565783:+	0.35	4.97	2.14E-6	Response to temozolomide	
TGCT	cis	1	rs58416181	chr15:85264461	LOC388152	chr15:84867600-84898920:-	-0.44	-6.1	1.22E-8	Schizophrenia	
TGCT	cis	1	rs58484838	chr16:77783137	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs58603761	chr2:73726605	ALMS1P	chr2:73872046-73912692:+	0.39	4.65	8.41E-6	Metabolite levels	
TGCT	cis	1	rs58612372	chr12:70670346	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs58717741	chr5:150284936	LOC134466	chr5:150310000-150326146:-	0.68	5.11	1.16E-6	Crohn's disease	
TGCT	cis	1	rs58729171	chr16:77786018	NUDT7	chr16:77756411-77776153:+	0.49	4.59	1.04E-5	Obesity-related traits	
TGCT	cis	1	rs58749629	chr20:44571317	WFDC3	chr20:44402847-44420547:-	-0.74	-6.02	1.77E-8	Abdominal aortic aneurysm	
TGCT	cis	1	rs58828627	chr12:70711293	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs59045389	chr16:77782863	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs59150578	chr11:18340862	GTF2H1	chr11:18343816-18388590:+	0.43	4.49	1.58E-5	Pancreatic cancer	
TGCT	cis	1	rs59181394	chr16:77785955	NUDT7	chr16:77756411-77776153:+	0.49	4.59	1.04E-5	Obesity-related traits	
TGCT	cis	1	rs59321715	chr5:150313480	LOC134466	chr5:150310000-150326146:-	0.68	4.79	4.66E-6	Crohn's disease	
TGCT	cis	1	rs59531858	chr5:150247063	LOC134466	chr5:150310000-150326146:-	0.67	4.83	3.81E-6	Crohn's disease	
TGCT	cis	1	rs59682592	chr5:132196800	LEAP2	chr5:132209358-132210581:+	0.5	4.25	4.1E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs59690351	chr5:132151751	LEAP2	chr5:132209358-132210581:+	0.56	4.61	9.6E-6	Apolipoprotein A-IV levels	
TGCT	cis	1	rs59715748	chr5:150189287	LOC134466	chr5:150310000-150326146:-	0.7	5.1	1.2E-6	Crohn's disease	
TGCT	cis	1	rs59925331	chr17:38169273	GSDMA	chr17:38119226-38134019:+	-0.62	-7.87	1.37E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs59945106	chr16:77780154	NUDT7	chr16:77756411-77776153:+	0.45	4.36	2.62E-5	Obesity-related traits	
TGCT	cis	1	rs6003958	chr22:24264089	GSTT1	chr22:24376141-24384284:-	-0.59	-6.27	5.2E-9	S-phenylmercapturic acid levels in smokers	
TGCT	cis	1	rs6003958	chr22:24264089	GSTT2	chr22:24322314-24326104:+;chr22	0.43	4.97	2.12E-6	S-phenylmercapturic acid levels in smokers	
TGCT	cis	1	rs6003958	chr22:24264089	LOC391322	chr22:24373117-24374043:+	-0.7	-6.75	4.91E-10	S-phenylmercapturic acid levels in smokers	
TGCT	cis	1	rs601338	chr19:49206674	FUT2	chr19:49199228-49209190:+	-0.36	-5.32	4.58E-7	Blood metabolite levels;Blood metabolite ratios	
TGCT	cis	1	rs60140609	chr12:113977330	TBX5	chr12:114791736-114846247:-	-0.61	-4.19	5.26E-5	Quantitative traits	
TGCT	cis	1	rs6037086	chr20:25306338	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6037095	chr20:25335687	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6037099	chr20:25356876	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6037105	chr20:25374199	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6037121	chr20:25428311	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050542	chr20:25318879	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050544	chr20:25320228	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050547	chr20:25326012	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050559	chr20:25329915	NINL	chr20:25433338-25566153:-	-0.42	-6.29	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050561	chr20:25334855	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050562	chr20:25336186	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050564	chr20:25344231	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050565	chr20:25347563	NINL	chr20:25433338-25566153:-	0.39	5.91	3.05E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050566	chr20:25351071	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050573	chr20:25366065	NINL	chr20:25433338-25566153:-	-0.4	-5.94	2.58E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050590	chr20:25384994	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050598	chr20:25397257	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050599	chr20:25400240	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050602	chr20:25401203	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050609	chr20:25411751	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050617	chr20:25421648	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050626	chr20:25428261	NINL	chr20:25433338-25566153:-	-0.41	-6.05	1.54E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050629	chr20:25430680	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050630	chr20:25430745	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050631	chr20:25431749	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6050632	chr20:25432601	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs60512868	chr3:48483445	TREX1	chr3:48501186-48509043:+	-0.28	-5.55	1.61E-7	Longevity	
TGCT	cis	1	rs6053815	chr20:5970438	MCM8	chr20:5931298-5975829:+	-0.31	-4.26	3.93E-5	HIV-1 viral setpoint	
TGCT	cis	1	rs6053816	chr20:5970750	MCM8	chr20:5931298-5975829:+	-0.29	-4.24	4.36E-5	HIV-1 viral setpoint	
TGCT	cis	1	rs6058352	chr20:30269179	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6058465	chr20:30397691	TM9SF4	chr20:30697309-30755061:+	0.4	4.31	3.31E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6058468	chr20:30406448	TM9SF4	chr20:30697309-30755061:+	0.39	4.19	5.17E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6060599	chr20:30257754	TM9SF4	chr20:30697309-30755061:+	0.4	4.27	3.81E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6060621	chr20:30261562	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6060716	chr20:30274847	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6060857	chr20:30300222	TM9SF4	chr20:30697309-30755061:+	0.4	4.31	3.31E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6060915	chr20:30330306	TM9SF4	chr20:30697309-30755061:+	0.4	4.33	2.99E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6060919	chr20:30331922	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6060922	chr20:30333909	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6060932	chr20:30350545	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6060933	chr20:30351903	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6060944	chr20:30372114	TM9SF4	chr20:30697309-30755061:+	0.4	4.35	2.76E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6060950	chr20:30378031	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6060962	chr20:30397847	TM9SF4	chr20:30697309-30755061:+	0.4	4.31	3.31E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6076336	chr20:25319212	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6076339	chr20:25348712	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6076345	chr20:25381895	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6083804	chr20:25317060	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6083805	chr20:25317356	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6083809	chr20:25329309	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6083813	chr20:25337671	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6083825	chr20:25366424	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6083828	chr20:25369918	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6083844	chr20:25386832	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6083856	chr20:25407585	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6083862	chr20:25411086	NINL	chr20:25433338-25566153:-	0.39	5.9	3.16E-8	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs60844734	chr2:73623205	ALMS1P	chr2:73872046-73912692:+	0.4	4.75	5.47E-6	Metabolite levels	
TGCT	cis	1	rs6087771	chr20:30306724	TM9SF4	chr20:30697309-30755061:+	0.44	4.7	6.85E-6	Subcortical brain region volumes	
TGCT	cis	1	rs6087779	chr20:30370566	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6087782	chr20:30391580	TM9SF4	chr20:30697309-30755061:+	0.4	4.31	3.31E-5	Subcortical brain region volumes	
TGCT	cis	1	rs60923631	chr16:77783369	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs60957376	chr15:85280792	LOC388152	chr15:84867600-84898920:-	-0.45	-6.23	6.29E-9	Schizophrenia	
TGCT	cis	1	rs60982898	chr6:49385806	MUT	chr6:49398994-49431031:-	0.33	5.29	5.29E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs6107033	chr20:25363591	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6107045	chr20:25441936	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6107046	chr20:25442049	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6107047	chr20:25442097	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6115140	chr20:25285507	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6115146	chr20:25304507	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6115153	chr20:25325567	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6115159	chr20:25350944	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6115168	chr20:25372891	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6115182	chr20:25410259	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6115191	chr20:25440478	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6119650	chr20:30258480	TM9SF4	chr20:30697309-30755061:+	0.39	4.28	3.61E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6119652	chr20:30259445	TM9SF4	chr20:30697309-30755061:+	0.41	4.46	1.78E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6121038	chr20:30254773	TM9SF4	chr20:30697309-30755061:+	0.39	4.2	4.99E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6121172	chr20:30296095	TM9SF4	chr20:30697309-30755061:+	0.4	4.31	3.31E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6121243	chr20:30415094	TM9SF4	chr20:30697309-30755061:+	0.4	4.31	3.31E-5	Subcortical brain region volumes	
TGCT	cis	1	rs6132835	chr20:25434667	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs61382645	chr11:46923107	LRP4	chr11:46878419-46940076:-	0.46	4.21	4.74E-5	Schizophrenia	
TGCT	cis	1	rs6138572	chr20:25435934	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6138575	chr20:25438952	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs61402842	chr16:77780398	NUDT7	chr16:77756411-77776153:+	0.45	4.36	2.62E-5	Obesity-related traits	
TGCT	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-0.71	-6.67	7.12E-10	Blood metabolite levels	
TGCT	cis	1	rs61530785	chr5:150261364	LOC134466	chr5:150310000-150326146:-	0.65	4.69	7.11E-6	Crohn's disease	
TGCT	cis	1	rs61634114	chr19:17387254	C19orf62	chr19:17378232-17393811:+	-0.4	-4.53	1.36E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs617219	chr5:78429594	BHMT	chr5:78407604-78428112:+	-0.43	-4.7	6.59E-6	Betaine levels in individuals undergoing cardiac evaluation	
TGCT	cis	1	rs61744385	chr3:41756986	ULK4	chr3:41288091-42003660:-	0.48	4.96	2.27E-6	Diastolic blood pressure	
TGCT	cis	1	rs61744388	chr3:41756965	ULK4	chr3:41288091-42003660:-	0.48	4.96	2.27E-6	Diastolic blood pressure	
TGCT	cis	1	rs61871790	chr10:97391223	ENTPD1	chr10:97471536-97637022:+	0.29	4.54	1.3E-5	Blood metabolite levels	
TGCT	cis	1	rs61871792	chr10:97397586	ENTPD1	chr10:97471536-97637022:+	0.27	4.21	4.85E-5	Blood metabolite levels	
TGCT	cis	1	rs62008532	chr15:62365877	C2CD4A	chr15:62359176-62363109:+	0.39	4.34	2.95E-5	Height	
TGCT	cis	1	rs62019464	chr15:85294469	LOC388152	chr15:84867600-84898920:-	-0.44	-6.07	1.38E-8	Schizophrenia	
TGCT	cis	1	rs62019469	chr15:85321220	LOC388152	chr15:84867600-84898920:-	-0.45	-6.28	5.07E-9	Schizophrenia	
TGCT	cis	1	rs62021219	chr15:85256159	LOC388152	chr15:84867600-84898920:-	-0.44	-6.1	1.22E-8	Schizophrenia	
TGCT	cis	1	rs62026530	chr15:84775840	LOC388152	chr15:84867600-84898920:-	-0.38	-5.37	3.63E-7	Schizophrenia	
TGCT	cis	1	rs62103177	chr18:77624479	KCNG2	chr18:77623668-77659815:+	0.86	7.3	2.89E-11	Opioid sensitivity	
TGCT	cis	1	rs62136864	chr2:46829124	PIGF	chr2:46808414-46844251:-	0.36	4.7	6.72E-6	Height	
TGCT	cis	1	rs62151652	chr2:73700131	ALMS1P	chr2:73872046-73912692:+	0.43	5.14	1.0E-6	Metabolite levels	
TGCT	cis	1	rs62167387	chr2:133192096	GPR39	chr2:133174147-133404168:+	0.32	4.21	4.73E-5	Hypertension	
TGCT	cis	1	rs62321365	chr4:107013723	TBCK	chr4:106967233-107237861:-	0.34	4.2	5.08E-5	Airflow obstruction	
TGCT	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.56	-9.27	6.63E-16	Crohn's disease	
TGCT	cis	1	rs641018	chr11:65655393	SNX32	chr11:65601410-65621170:+	0.4	5.17	8.86E-7	Crohn's disease	
TGCT	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.29	-4.37	2.53E-5	Homocysteine levels	
TGCT	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.28	-4.42	2.06E-5	Homocysteine levels	
TGCT	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.26	5.32	4.55E-7	Longevity	
TGCT	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.26	-5.41	3.03E-7	Longevity	
TGCT	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.28	-5.67	9.07E-8	Longevity	
TGCT	cis	1	rs6442120	chr3:48464503	TREX1	chr3:48501186-48509043:+	-0.28	-5.67	9.47E-8	Longevity	
TGCT	cis	1	rs6442123	chr3:48500286	TREX1	chr3:48501186-48509043:+	-0.28	-5.56	1.56E-7	Longevity	
TGCT	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.8	9.2	9.84E-16	Type 2 diabetes	
TGCT	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.79	9.16	1.21E-15	Type 2 diabetes	
TGCT	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.86	10.26	2.56E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs6454551	chr6:87252211	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs6458685	chr6:49379536	CENPQ	chr6:49431096-49460820:+	-0.44	-5.71	7.66E-8	Homocysteine levels	
TGCT	cis	1	rs6458688	chr6:49406056	CENPQ	chr6:49431096-49460820:+	-0.45	-5.92	2.87E-8	Homocysteine levels	
TGCT	cis	1	rs6458690	chr6:49411619	MUT	chr6:49398994-49431031:-	0.32	5.28	5.54E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs6458694	chr6:49445306	MUT	chr6:49398994-49431031:-	0.31	5.29	5.36E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs6464573	chr7:143748098	ARHGEF35	chr7:143883677-143892736:-	0.36	4.29	3.53E-5	Obesity-related traits	
TGCT	cis	1	rs6464574	chr7:143748257	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.63	8.88E-6	Obesity-related traits	
TGCT	cis	1	rs646867	chr1:25709258	RHCE	chr1:25688741-25756683:-	0.6	9.15	1.28E-15	Erythrocyte sedimentation rate	
TGCT	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.42	-4.26	4.04E-5	Rheumatoid arthritis	
TGCT	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.42	-4.26	3.89E-5	Rheumatoid arthritis	
TGCT	cis	1	rs6496609	chr15:90379632	AP3S2	chr15:90373832-90456222:-	-0.63	-5.89	3.3E-8	Type 2 diabetes	
TGCT	cis	1	rs6503530	chr17:38161823	GSDMA	chr17:38119226-38134019:+	-0.61	-7.78	2.22E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs6509581	chr19:52363882	ZNF577	chr19:52359056-52394145:-	-0.31	-4.47	1.75E-5	Breast cancer	
TGCT	cis	1	rs6515651	chr20:25414539	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs6532022	chr4:88773734	SPP1	chr4:88896802-88904562:+	-0.35	-5.15	9.63E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
TGCT	cis	1	rs6532023	chr4:88773849	SPP1	chr4:88896802-88904562:+	-0.35	-5.15	9.63E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
TGCT	cis	1	rs6532078	chr4:76920809	NAAA	chr4:76831809-76862166:-	-0.31	-5.61	1.21E-7	Longevity	
TGCT	cis	1	rs6546835	chr2:73664715	ALMS1P	chr2:73872046-73912692:+	0.39	4.65	8.41E-6	Metabolite levels	
TGCT	cis	1	rs6546836	chr2:73677833	ALMS1P	chr2:73872046-73912692:+	0.39	4.69	7.03E-6	Metabolite levels	
TGCT	cis	1	rs6546837	chr2:73677898	ALMS1P	chr2:73872046-73912692:+	0.38	4.61	9.55E-6	Metabolite levels	
TGCT	cis	1	rs6546837	chr2:73677898	TPRKB	chr2:73956957-73964517:-	-0.3	-4.14	6.22E-5	Metabolite levels	
TGCT	cis	1	rs6546838	chr2:73679280	ALMS1P	chr2:73872046-73912692:+	0.38	4.61	9.55E-6	Metabolite levels	
TGCT	cis	1	rs6546838	chr2:73679280	TPRKB	chr2:73956957-73964517:-	-0.3	-4.14	6.22E-5	Metabolite levels	
TGCT	cis	1	rs6546839	chr2:73680508	ALMS1P	chr2:73872046-73912692:+	0.38	4.61	9.55E-6	Metabolite levels	
TGCT	cis	1	rs6546839	chr2:73680508	TPRKB	chr2:73956957-73964517:-	-0.3	-4.14	6.22E-5	Metabolite levels	
TGCT	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.56	-9.27	6.63E-16	Crohn's disease	
TGCT	cis	1	rs656980	chr11:65656282	SNX32	chr11:65601410-65621170:+	0.4	5.17	8.86E-7	Crohn's disease	
TGCT	cis	1	rs6584379	chr10:102224490	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs6584383	chr10:102303065	SEC31B	chr10:102246403-102289636:-	-0.32	-4.72	6.19E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs6599170	chr3:41772718	ULK4	chr3:41288091-42003660:-	0.47	5.49	2.16E-7	Diastolic blood pressure	
TGCT	cis	1	rs6599175	chr3:41786009	ULK4	chr3:41288091-42003660:-	-0.52	-5.71	7.75E-8	Diastolic blood pressure	
TGCT	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-0.52	-5.71	7.75E-8	Diastolic blood pressure	
TGCT	cis	1	rs6599178	chr3:41842129	ULK4	chr3:41288091-42003660:-	0.53	5.97	2.23E-8	Diastolic blood pressure	
TGCT	cis	1	rs6599179	chr3:41855284	ULK4	chr3:41288091-42003660:-	0.49	5.68	8.88E-8	Diastolic blood pressure	
TGCT	cis	1	rs66481372	chr5:132179592	LEAP2	chr5:132209358-132210581:+	0.56	4.96	2.21E-6	Apolipoprotein A-IV levels	
TGCT	cis	1	rs66542366	chr5:132159520	LEAP2	chr5:132209358-132210581:+	0.49	4.3	3.36E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs6663552	chr1:230358067	GALNT2	chr1:230193536-230417875:+	0.33	4.31	3.21E-5	Hematology traits	
TGCT	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.29	-4.42	2.1E-5	Homocysteine levels	
TGCT	cis	1	rs66753001	chr19:17394839	C19orf62	chr19:17378232-17393811:+	-0.38	-4.29	3.57E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs6705489	chr2:73648811	ALMS1P	chr2:73872046-73912692:+	0.44	5.17	8.97E-7	Metabolite levels	
TGCT	cis	1	rs6707722	chr2:73654363	ALMS1P	chr2:73872046-73912692:+	0.39	4.65	8.41E-6	Metabolite levels	
TGCT	cis	1	rs6708328	chr2:24412413	C2orf84	chr2:24397531-24414566:+	0.46	5.22	7.07E-7	Venous thromboembolism (SNP x SNP interaction)	
TGCT	cis	1	rs6710438	chr2:73820108	ALMS1P	chr2:73872046-73912692:+	-0.43	-5.03	1.64E-6	Metabolite levels	
TGCT	cis	1	rs6711033	chr2:73746643	ALMS1P	chr2:73872046-73912692:+	0.4	4.72	6.22E-6	Metabolite levels	
TGCT	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.65	-4.41	2.16E-5	Rheumatoid arthritis	
TGCT	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.61	-4.24	4.35E-5	Rheumatoid arthritis	
TGCT	cis	1	rs6715819	chr2:73772309	ALMS1P	chr2:73872046-73912692:+	0.41	4.79	4.66E-6	Metabolite levels	
TGCT	cis	1	rs67173199	chr3:186432858	KNG1	chr3:186435120-186461741:+	0.3	4.28	3.72E-5	Adiponectin levels	
TGCT	cis	1	rs67180937	chr1:222823743	AIDA	chr1:222841357-222886526:-	0.41	5.08	1.33E-6	Coronary artery disease	
TGCT	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.57	-4.2	4.93E-5	Plasma clusterin levels	
TGCT	cis	1	rs67239267	chr7:143745116	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.59	1.06E-5	Obesity-related traits	
TGCT	cis	1	rs6724782	chr2:73679990	ALMS1P	chr2:73872046-73912692:+	0.38	4.61	9.55E-6	Metabolite levels	
TGCT	cis	1	rs6724782	chr2:73679990	TPRKB	chr2:73956957-73964517:-	-0.3	-4.14	6.22E-5	Metabolite levels	
TGCT	cis	1	rs6736866	chr2:73661986	ALMS1P	chr2:73872046-73912692:+	0.45	5.36	3.86E-7	Metabolite levels	
TGCT	cis	1	rs6740223	chr2:73653332	ALMS1P	chr2:73872046-73912692:+	0.39	4.65	8.41E-6	Metabolite levels	
TGCT	cis	1	rs67412075	chr19:17385502	C19orf62	chr19:17378232-17393811:+	-0.38	-4.28	3.66E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.31	-4.86	3.35E-6	Tuberculosis	
TGCT	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.44	4.79	4.57E-6	Tuberculosis	
TGCT	cis	1	rs6745368	chr2:73809974	ALMS1P	chr2:73872046-73912692:+	0.42	4.97	2.18E-6	Metabolite levels	
TGCT	cis	1	rs67504728	chr5:132194045	LEAP2	chr5:132209358-132210581:+	0.5	4.25	4.1E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs67519234	chr5:132199359	LEAP2	chr5:132209358-132210581:+	0.5	4.52	1.39E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs6753344	chr2:73653138	ALMS1P	chr2:73872046-73912692:+	-0.42	-5.02	1.75E-6	Metabolite levels	
TGCT	cis	1	rs67544533	chr15:75361539	SCAMP5	chr15:75287901-75313836:+	0.31	4.21	4.79E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs6755217	chr2:73641285	ALMS1P	chr2:73872046-73912692:+	0.44	5.3	4.99E-7	Metabolite levels	
TGCT	cis	1	rs6755241	chr2:73641364	ALMS1P	chr2:73872046-73912692:+	0.43	5.12	1.13E-6	Metabolite levels	
TGCT	cis	1	rs6756987	chr2:73687077	ALMS1P	chr2:73872046-73912692:+	0.38	4.61	9.55E-6	Metabolite levels	
TGCT	cis	1	rs6756987	chr2:73687077	TPRKB	chr2:73956957-73964517:-	-0.3	-4.14	6.22E-5	Metabolite levels	
TGCT	cis	1	rs6759004	chr2:202004676	CFLAR	chr2:201980816-202029001:+	-0.43	-4.78	4.74E-6	Triptolide cytotoxicity	
TGCT	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.95	-8.73	1.28E-14	Triptolide cytotoxicity	
TGCT	cis	1	rs6763829	chr3:41897046	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	0.46	5	1.92E-6	Diastolic blood pressure	
TGCT	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	0.48	5.21	7.38E-7	Diastolic blood pressure	
TGCT	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	0.48	5.21	7.38E-7	Diastolic blood pressure	
TGCT	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.27	-5.51	1.95E-7	Longevity	
TGCT	cis	1	rs6776700	chr3:48496758	TREX1	chr3:48501186-48509043:+	-0.27	-5.47	2.29E-7	Longevity	
TGCT	cis	1	rs6781326	chr3:41777028	ULK4	chr3:41288091-42003660:-	0.48	5.65	1.0E-7	Diastolic blood pressure	
TGCT	cis	1	rs6783001	chr3:41862232	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs6784322	chr3:48422235	TREX1	chr3:48501186-48509043:+	-0.26	-5.4	3.2E-7	Longevity	
TGCT	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.45	4.55	1.23E-5	Diastolic blood pressure	
TGCT	cis	1	rs6790732	chr3:41864872	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs6791806	chr3:41889995	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs67927699	chr2:61187415	C2orf74	chr2:61372243-61391964:+	0.47	4.52	1.38E-5	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
TGCT	cis	1	rs6794875	chr3:48455626	TREX1	chr3:48501186-48509043:+	-0.29	-5.73	7.1E-8	Longevity	
TGCT	cis	1	rs6796210	chr3:41851718	ULK4	chr3:41288091-42003660:-	0.49	5.69	8.32E-8	Diastolic blood pressure	
TGCT	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.26	-5.41	3.02E-7	Longevity	
TGCT	cis	1	rs6797165	chr3:41887777	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs6801343	chr3:41767234	ULK4	chr3:41288091-42003660:-	0.47	5.49	2.16E-7	Diastolic blood pressure	
TGCT	cis	1	rs6802340	chr3:41894034	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs6803560	chr3:41824480	ULK4	chr3:41288091-42003660:-	0.54	5.87	3.64E-8	Diastolic blood pressure	
TGCT	cis	1	rs6803652	chr3:41824556	ULK4	chr3:41288091-42003660:-	0.54	5.87	3.64E-8	Diastolic blood pressure	
TGCT	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.26	-5.41	3.02E-7	Longevity	
TGCT	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	0.48	5.21	7.38E-7	Diastolic blood pressure	
TGCT	cis	1	rs6807015	chr3:41754514	ULK4	chr3:41288091-42003660:-	0.48	4.92	2.61E-6	Diastolic blood pressure	
TGCT	cis	1	rs68088462	chr15:63397617	TPM1	chr15:63334838-63364111:+	0.45	4.86	3.41E-6	HDL cholesterol	
TGCT	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.27	-5.51	1.95E-7	Longevity	
TGCT	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.79	-9.17	1.11E-15	Response to antipsychotic treatment	
TGCT	cis	1	rs6827617	chr4:76916146	NAAA	chr4:76831809-76862166:-	-0.31	-5.61	1.21E-7	Longevity	
TGCT	cis	1	rs6846579	chr4:107011756	TBCK	chr4:106967233-107237861:-	0.35	4.32	3.16E-5	Airflow obstruction	
TGCT	cis	1	rs6874560	chr5:150182713	LOC134466	chr5:150310000-150326146:-	0.7	5.1	1.2E-6	Crohn's disease	
TGCT	cis	1	rs6875011	chr5:150182710	LOC134466	chr5:150310000-150326146:-	0.66	4.81	4.24E-6	Crohn's disease	
TGCT	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.53	7.95	8.95E-13	Crohn's disease	
TGCT	cis	1	rs687672	chr11:65649984	SNX32	chr11:65601410-65621170:+	-0.39	-4.72	6.08E-6	Crohn's disease	
TGCT	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs6887276	chr5:127378294	FLJ33630	chr5:127276135-127419299:-	-0.18	-4.2	4.98E-5	Height	
TGCT	cis	1	rs6901178	chr6:46631886	PLA2G7	chr6:46672054-46703151:-	0.21	4.9	2.88E-6	Lipoprotein-associated phospholipase A2 activity and mass	
TGCT	cis	1	rs6902429	chr6:49393500	CENPQ	chr6:49431096-49460820:+	-0.44	-5.71	7.66E-8	Homocysteine levels	
TGCT	cis	1	rs6903888	chr6:87248703	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs6904373	chr6:46628067	PLA2G7	chr6:46672054-46703151:-	-0.21	-5.01	1.83E-6	Lipoprotein-associated phospholipase A2 activity and mass	
TGCT	cis	1	rs6907333	chr6:87254239	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.86	-10.21	3.31E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs6915187	chr6:49423547	CENPQ	chr6:49431096-49460820:+	-0.47	-6.36	3.4E-9	Homocysteine levels	
TGCT	cis	1	rs6916888	chr6:49383804	CENPQ	chr6:49431096-49460820:+	-0.44	-5.71	7.66E-8	Homocysteine levels	
TGCT	cis	1	rs6918347	chr6:49406348	CENPQ	chr6:49431096-49460820:+	-0.46	-6.04	1.65E-8	Homocysteine levels	
TGCT	cis	1	rs6923124	chr6:49419864	MUT	chr6:49398994-49431031:-	0.3	5.25	6.28E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.86	10.35	1.51E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.67	-5.99	2.09E-8	Diabetic kidney disease	
TGCT	cis	1	rs6928546	chr6:46632006	PLA2G7	chr6:46672054-46703151:-	-0.22	-5.08	1.31E-6	Lipoprotein-associated phospholipase A2 activity and mass	
TGCT	cis	1	rs6930555	chr6:87254439	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.71	8.22	2.1E-13	Response to antipsychotic treatment	
TGCT	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.56	-9.27	6.63E-16	Crohn's disease	
TGCT	cis	1	rs693824	chr11:65654783	SNX32	chr11:65601410-65621170:+	0.4	5.17	8.86E-7	Crohn's disease	
TGCT	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.83	-9.78	3.66E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.57	-9.46	2.29E-16	Crohn's disease	
TGCT	cis	1	rs694994	chr11:65653309	SNX32	chr11:65601410-65621170:+	0.4	5.12	1.13E-6	Crohn's disease	
TGCT	cis	1	rs6952407	chr7:66045512	RABGEF1	chr7:66093890-66276446:+	-0.42	-4.16	5.84E-5	Cotinine glucuronidation	
TGCT	cis	1	rs6970597	chr7:21583519	DNAH11	chr7:21582833-21941455:+	-0.44	-4.82	3.98E-6	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
TGCT	cis	1	rs6970985	chr7:21583597	DNAH11	chr7:21582833-21941455:+	-0.45	-4.98	2.02E-6	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
TGCT	cis	1	rs698078	chr3:186459227	KNG1	chr3:186435120-186461741:+	-0.29	-4.17	5.63E-5	Activated partial thromboplastin time;Thrombosis	
TGCT	cis	1	rs7004438	chr8:8574379	FLJ10661	chr8:8086092-8102386:+	0.47	4.31	3.26E-5	Obesity-related traits	
TGCT	cis	1	rs7005380	chr8:120953873	DEPDC6	chr8:120885900-121063156:+	-0.41	-4.32	3.09E-5	Interstitial lung disease	
TGCT	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	0.79	10.51	6.18E-19	Bone mineral density	
TGCT	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	0.79	10.51	6.31E-19	Bone mineral density	
TGCT	cis	1	rs7018	chr20:25278261	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs7019	chr20:25278278	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs7020	chr20:25278600	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.42	-4.26	3.89E-5	Rheumatoid arthritis	
TGCT	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.26	-4.54	1.3E-5	Multiple sclerosis	
TGCT	cis	1	rs7045881	chr9:26935996	IFT74	chr9:26947037-27062923:+	0.48	4.33	2.99E-5	Schizophrenia	
TGCT	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.75	10.29	2.14E-18	Cognitive function	
TGCT	cis	1	rs7070776	chr10:102264672	SEC31B	chr10:102246403-102289636:-	-0.29	-4.42	2.08E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7071271	chr10:102264824	SEC31B	chr10:102246403-102289636:-	-0.3	-4.58	1.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.46	7.31	2.67E-11	Metabolite levels	
TGCT	cis	1	rs7073586	chr10:102307671	SEC31B	chr10:102246403-102289636:-	-0.33	-4.69	7.0E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7078799	chr10:102301447	SEC31B	chr10:102246403-102289636:-	-0.31	-4.65	8.23E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7079136	chr10:102292709	SEC31B	chr10:102246403-102289636:-	-0.29	-4.53	1.34E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7079756	chr10:102302105	SEC31B	chr10:102246403-102289636:-	-0.32	-4.84	3.65E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7080356	chr10:102266735	SEC31B	chr10:102246403-102289636:-	-0.29	-4.42	2.08E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7084810	chr10:102297546	SEC31B	chr10:102246403-102289636:-	-0.31	-4.67	7.45E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7085439	chr10:102210100	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7088512	chr10:102303498	SEC31B	chr10:102246403-102289636:-	-0.33	-4.92	2.69E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7088827	chr10:102303865	SEC31B	chr10:102246403-102289636:-	-0.32	-4.72	6.18E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7090431	chr10:102261753	SEC31B	chr10:102246403-102289636:-	-0.29	-4.42	2.08E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs709592	chr17:38175553	GSDMA	chr17:38119226-38134019:+	-0.62	-7.87	1.37E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs7098825	chr10:104628234	SFXN2	chr10:104474298-104498946:+	-0.85	-4.62	9.44E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
TGCT	cis	1	rs7099913	chr10:102314777	SEC31B	chr10:102246403-102289636:-	-0.31	-4.74	5.77E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7099965	chr10:102301165	SEC31B	chr10:102246403-102289636:-	-0.31	-4.65	8.23E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7100386	chr10:102301417	SEC31B	chr10:102246403-102289636:-	-0.31	-4.65	8.23E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7111	chr15:90373873	AP3S2	chr15:90373832-90456222:-	-0.63	-5.92	2.89E-8	Type 2 diabetes	
TGCT	cis	1	rs7134594	chr12:110000193	MYO1H	chr12:109826524-109886176:+	0.38	4.17	5.64E-5	HDL cholesterol	
TGCT	cis	1	rs7144423	chr14:35572547	PPP2R3C	chr14:35554679-35591679:-	0.49	4.14	6.21E-5	Atopic dermatitis	
TGCT	cis	1	rs71562227	chr6:110759274	SLC22A16	chr6:110745907-110797844:-	0.67	4.17	5.6E-5	Glucose homeostasis traits	
TGCT	cis	1	rs7162900	chr15:75368017	SCAMP5	chr15:75287901-75313836:+	0.32	4.31	3.25E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs7167285	chr15:75368769	SCAMP5	chr15:75287901-75313836:+	0.32	4.31	3.25E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs7168680	chr15:75369212	SCAMP5	chr15:75287901-75313836:+	0.32	4.42	2.11E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs7173833	chr15:75369618	SCAMP5	chr15:75287901-75313836:+	0.34	4.55	1.23E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs7181141	chr15:63398552	TPM1	chr15:63334838-63364111:+	0.45	4.86	3.41E-6	HDL cholesterol	
TGCT	cis	1	rs7182618	chr15:63398622	TPM1	chr15:63334838-63364111:+	0.45	4.86	3.41E-6	HDL cholesterol	
TGCT	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.68	7.91	1.15E-12	Eye color traits	
TGCT	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.68	7.91	1.15E-12	Eye color traits	
TGCT	cis	1	rs7214085	chr17:38169095	GSDMA	chr17:38119226-38134019:+	-0.62	-7.87	1.37E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs7215564	chr17:78737287	MRPL12	chr17:79670407-79674548:+	-0.33	-4.79	4.52E-6	Myopia (pathological)	
TGCT	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.68	7.91	1.15E-12	Eye color traits	
TGCT	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.68	-7.91	1.15E-12	Eye color traits	
TGCT	cis	1	rs723685	chr6:110763875	SLC22A16	chr6:110745907-110797844:-	0.67	4.17	5.6E-5	Glucose homeostasis traits	
TGCT	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.26	5.44	2.68E-7	Longevity	
TGCT	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.27	5.68	8.9E-8	Longevity	
TGCT	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.44	6.94	1.81E-10	Schizophrenia	
TGCT	cis	1	rs72677306	chr4:106997678	TBCK	chr4:106967233-107237861:-	0.35	4.32	3.16E-5	Airflow obstruction	
TGCT	cis	1	rs7267979	chr20:25298087	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs7268053	chr20:25328286	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs7270354	chr20:44607661	WFDC3	chr20:44402847-44420547:-	-0.77	-6.45	2.16E-9	Abdominal aortic aneurysm	
TGCT	cis	1	rs727563	chr22:41867377	POLR3H	chr22:41921803-41940479:-	0.36	4.17	5.64E-5	Crohn's disease;Inflammatory bowel disease	
TGCT	cis	1	rs72799458	chr5:132188063	LEAP2	chr5:132209358-132210581:+	0.5	4.25	4.1E-5	Apolipoprotein A-IV levels	
TGCT	cis	1	rs72819593	chr17:2199489	SRR	chr17:2207248-2228553:+	-0.34	-5.36	3.87E-7	Esophageal cancer (squamous cell)	
TGCT	cis	1	rs72840063	chr2:85550396	RETSAT	chr2:85569079-85581821:-	0.31	4.32	3.12E-5	Ear protrusion	
TGCT	cis	1	rs72843784	chr6:26498758	BTN3A2	chr6:26365398-26378546:+	-0.67	-8.43	6.77E-14	Schizophrenia	
TGCT	cis	1	rs728615	chr10:81848089	LOC219347	chr10:81805991-81838949:-	0.74	4.96	2.28E-6	Chronic obstructive pulmonary disease-related biomarkers	
TGCT	cis	1	rs728616	chr10:81847914	LOC219347	chr10:81805991-81838949:-	0.74	4.96	2.28E-6	Chronic obstructive pulmonary disease-related biomarkers	
TGCT	cis	1	rs72922786	chr11:65562852	RNASEH2C	chr11:65485146-65488409:-	0.46	4.16	5.81E-5	Atopic dermatitis	
TGCT	cis	1	rs72934944	chr2:202190610	PPIL3	chr2:201735680-201753999:-	-0.66	-4.43	2.02E-5	Rheumatoid arthritis	
TGCT	cis	1	rs72963850	chr11:94310732	MRE11A	chr11:94150469-94227040:-	-0.38	-4.3	3.43E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
TGCT	cis	1	rs72963868	chr11:94317709	MRE11A	chr11:94150469-94227040:-	-0.38	-4.22	4.65E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
TGCT	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	0.49	5.04	1.59E-6	Diastolic blood pressure	
TGCT	cis	1	rs73069394	chr3:41787233	ULK4	chr3:41288091-42003660:-	0.5	5.65	1.02E-7	Diastolic blood pressure	
TGCT	cis	1	rs73069396	chr3:41787236	ULK4	chr3:41288091-42003660:-	0.5	5.65	1.02E-7	Diastolic blood pressure	
TGCT	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	0.54	5.74	6.57E-8	Diastolic blood pressure	
TGCT	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.26	-5.41	3.02E-7	Longevity	
TGCT	cis	1	rs73077367	chr3:41851959	ULK4	chr3:41288091-42003660:-	0.49	5.52	1.85E-7	Diastolic blood pressure	
TGCT	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	0.46	5	1.92E-6	Diastolic blood pressure	
TGCT	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs73128528	chr20:44582187	WFDC3	chr20:44402847-44420547:-	-0.65	-4.36	2.63E-5	Abdominal aortic aneurysm	
TGCT	cis	1	rs73268545	chr5:150335282	LOC134466	chr5:150310000-150326146:-	0.84	4.24	4.22E-5	Crohn's disease	
TGCT	cis	1	rs73282209	chr5:150174959	LOC134466	chr5:150310000-150326146:-	0.66	4.81	4.24E-6	Crohn's disease	
TGCT	cis	1	rs73282234	chr5:150195924	LOC134466	chr5:150310000-150326146:-	0.66	4.81	4.24E-6	Crohn's disease	
TGCT	cis	1	rs7331734	chr13:25531255	TPTE2P1	chr13:25502895-25542607:-	0.29	4.29	3.55E-5	Obesity-related traits	
TGCT	cis	1	rs7342170	chr11:94314477	MRE11A	chr11:94150469-94227040:-	-0.39	-4.39	2.42E-5	Attention deficit hyperactivity disorder symptoms (interaction)	
TGCT	cis	1	rs7343481	chr20:25300113	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs73509996	chr19:17393449	C19orf62	chr19:17378232-17393811:+	-0.38	-4.29	3.57E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs736344	chr12:110001195	MYO1H	chr12:109826524-109886176:+	0.38	4.17	5.64E-5	HDL cholesterol	
TGCT	cis	1	rs7372217	chr3:41990122	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs7386745	chr8:142359368	LOC731779	chr8:142350648-142354719:+	-0.3	-4.21	4.85E-5	Bipolar disorder and schizophrenia	
TGCT	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.69	7.99	7.44E-13	Eye color traits	
TGCT	cis	1	rs7412746	chr1:150860471	HORMAD1	chr1:150670542-150693352:-	-0.34	-4.54	1.3E-5	Melanoma	
TGCT	cis	1	rs74210981	chr10:102287520	SEC31B	chr10:102246403-102289636:-	-0.3	-4.55	1.27E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.55	-4.17	5.52E-5	Plasma clusterin levels	
TGCT	cis	1	rs7436021	chr4:76905472	NAAA	chr4:76831809-76862166:-	-0.31	-5.82	4.53E-8	Longevity	
TGCT	cis	1	rs74544416	chr8:82657745	CHMP4C	chr8:82644688-82671746:+	-0.45	-4.24	4.37E-5	Epithelial ovarian cancer;Ovarian cancer	
TGCT	cis	1	rs74650218	chr10:102293830	SEC31B	chr10:102246403-102289636:-	-0.3	-4.57	1.16E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs7475154	chr10:131440584	MGMT	chr10:131265454-131565783:+	-0.35	-4.95	2.3E-6	Response to temozolomide	
TGCT	cis	1	rs74768022	chr12:70727654	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs7477246	chr10:102261538	SEC31B	chr10:102246403-102289636:-	-0.3	-4.58	1.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs74783281	chr16:77781601	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs74805725	chr16:77784484	NUDT7	chr16:77756411-77776153:+	0.48	4.68	7.14E-6	Obesity-related traits	
TGCT	cis	1	rs74809484	chr12:70692916	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs74823021	chr12:70728407	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs7487329	chr12:70703805	YEATS4	chr12:69753532-69784575:+	-0.5	-4.41	2.21E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs749050	chr10:97376115	ENTPD1	chr10:97471536-97637022:+	0.28	4.43	2.05E-5	Blood metabolite levels	
TGCT	cis	1	rs74955473	chr5:150174558	LOC134466	chr5:150310000-150326146:-	0.7	5.1	1.2E-6	Crohn's disease	
TGCT	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.68	7.91	1.15E-12	Eye color traits	
TGCT	cis	1	rs75063298	chr10:102213600	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs751096	chr6:33742838	HMGA1	chr6:34204577-34214007:+	-0.26	-4.29	3.55E-5	Body mass index	
TGCT	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.55	-4.17	5.52E-5	Plasma clusterin levels	
TGCT	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.29	4.38	2.43E-5	Homocysteine levels	
TGCT	cis	1	rs75294883	chr5:150196503	LOC134466	chr5:150310000-150326146:-	0.68	4.89	3.01E-6	Crohn's disease	
TGCT	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.55	-4.19	5.15E-5	Plasma clusterin levels	
TGCT	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.28	-4.32	3.14E-5	Homocysteine levels	
TGCT	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.28	-4.36	2.62E-5	Homocysteine levels	
TGCT	cis	1	rs75401536	chr12:70658149	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs7558944	chr2:73810909	ALMS1P	chr2:73872046-73912692:+	0.42	4.97	2.18E-6	Metabolite levels	
TGCT	cis	1	rs7564890	chr2:73641853	ALMS1P	chr2:73872046-73912692:+	0.43	5.14	1.0E-6	Metabolite levels	
TGCT	cis	1	rs7572722	chr2:73724675	ALMS1P	chr2:73872046-73912692:+	0.44	5.18	8.61E-7	Metabolite levels	
TGCT	cis	1	rs757537	chr5:132151071	LEAP2	chr5:132209358-132210581:+	0.56	4.61	9.6E-6	Apolipoprotein A-IV levels	
TGCT	cis	1	rs7576245	chr2:73829678	ALMS1P	chr2:73872046-73912692:+	0.38	4.53	1.33E-5	Metabolite levels	
TGCT	cis	1	rs75796761	chr12:70691851	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs7580825	chr2:73635148	ALMS1P	chr2:73872046-73912692:+	0.41	5.03	1.67E-6	Metabolite levels	
TGCT	cis	1	rs7582606	chr2:73813945	ALMS1P	chr2:73872046-73912692:+	0.42	4.97	2.18E-6	Metabolite levels	
TGCT	cis	1	rs7583255	chr2:73797996	ALMS1P	chr2:73872046-73912692:+	0.42	4.97	2.18E-6	Metabolite levels	
TGCT	cis	1	rs7584575	chr2:73666402	ALMS1P	chr2:73872046-73912692:+	0.39	4.75	5.53E-6	Metabolite levels	
TGCT	cis	1	rs75846246	chr12:70698926	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs7585004	chr2:73666645	ALMS1P	chr2:73872046-73912692:+	0.37	4.46	1.82E-5	Metabolite levels	
TGCT	cis	1	rs7586463	chr2:73798476	ALMS1P	chr2:73872046-73912692:+	0.42	4.97	2.18E-6	Metabolite levels	
TGCT	cis	1	rs75883262	chr19:51422694	SIGLEC11	chr19:50452252-50464429:-	1.04	4.19	5.25E-5	Alzheimer's disease (cognitive decline)	
TGCT	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.53	-4.15	6.04E-5	Plasma clusterin levels	
TGCT	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.81	-7.86	1.46E-12	Triptolide cytotoxicity	
TGCT	cis	1	rs75921373	chr6:26191843	HIST1H3E	chr6:26224427-26226589:+	0.47	4.19	5.14E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs75936301	chr16:77781742	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs7594511	chr2:73681639	ALMS1P	chr2:73872046-73912692:+	0.43	5.14	1.0E-6	Metabolite levels	
TGCT	cis	1	rs7596362	chr2:61204688	C2orf74	chr2:61372243-61391964:+	0.45	4.64	8.62E-6	Crohn's disease;Ulcerative colitis;Inflammatory bowel disease	
TGCT	cis	1	rs7598396	chr2:73652628	ALMS1P	chr2:73872046-73912692:+	0.44	5.39	3.41E-7	Metabolite levels	
TGCT	cis	1	rs7598419	chr2:73798223	ALMS1P	chr2:73872046-73912692:+	0.44	5.15	9.58E-7	Metabolite levels	
TGCT	cis	1	rs76044745	chr12:70739090	YEATS4	chr12:69753532-69784575:+	-0.49	-4.17	5.61E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs7604682	chr2:73788026	ALMS1P	chr2:73872046-73912692:+	0.37	4.43	2.0E-5	Metabolite levels	
TGCT	cis	1	rs7604682	chr2:73788026	TPRKB	chr2:73956957-73964517:-	-0.3	-4.17	5.68E-5	Metabolite levels	
TGCT	cis	1	rs7607014	chr2:73730174	ALMS1P	chr2:73872046-73912692:+	-0.39	-4.68	7.19E-6	Metabolite levels	
TGCT	cis	1	rs761025	chr20:25426968	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs7615952	chr3:125649403	LOC100125556	chr3:125635444-125648865:+	-0.69	-4.55	1.27E-5	Blood pressure (smoking interaction)	
TGCT	cis	1	rs7616044	chr3:125649354	LOC100125556	chr3:125635444-125648865:+	0.73	4.85	3.62E-6	Blood pressure (smoking interaction)	
TGCT	cis	1	rs7616844	chr3:41874343	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs7617397	chr3:41959037	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs7622259	chr3:41881351	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs7624372	chr3:41881107	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs76243942	chr16:77781637	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs763014	chr16:675680	WFIKKN1	chr16:679239-684116:+	0.35	4.75	5.37E-6	Height	
TGCT	cis	1	rs7630741	chr3:48419723	TREX1	chr3:48501186-48509043:+	-0.26	-5.38	3.54E-7	Longevity	
TGCT	cis	1	rs7631057	chr3:41817951	ULK4	chr3:41288091-42003660:-	0.55	5.96	2.36E-8	Diastolic blood pressure	
TGCT	cis	1	rs76315659	chr16:77781650	NUDT7	chr16:77756411-77776153:+	0.45	4.36	2.62E-5	Obesity-related traits	
TGCT	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.49	5.47	2.31E-7	Diastolic blood pressure	
TGCT	cis	1	rs76329209	chr6:26196430	HIST1H3E	chr6:26224427-26226589:+	0.47	4.19	5.14E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs7634377	chr3:48421258	TREX1	chr3:48501186-48509043:+	-0.26	-5.4	3.2E-7	Longevity	
TGCT	cis	1	rs7635522	chr3:48423656	TREX1	chr3:48501186-48509043:+	-0.27	-5.44	2.67E-7	Longevity	
TGCT	cis	1	rs7636044	chr3:48484560	TREX1	chr3:48501186-48509043:+	-0.28	-5.55	1.61E-7	Longevity	
TGCT	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.27	-5.43	2.76E-7	Longevity	
TGCT	cis	1	rs76412521	chr16:77780916	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs76433514	chr5:150306532	LOC134466	chr5:150310000-150326146:-	0.67	4.94	2.41E-6	Crohn's disease	
TGCT	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.49	5.47	2.31E-7	Diastolic blood pressure	
TGCT	cis	1	rs76471037	chr3:41799414	ULK4	chr3:41288091-42003660:-	0.54	5.79	5.34E-8	Diastolic blood pressure	
TGCT	cis	1	rs7648357	chr3:41849670	ULK4	chr3:41288091-42003660:-	0.53	5.73	7.08E-8	Diastolic blood pressure	
TGCT	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	0.49	5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs7650227	chr3:41794937	ULK4	chr3:41288091-42003660:-	0.5	5.46	2.38E-7	Diastolic blood pressure	
TGCT	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.28	-5.67	9.2E-8	Longevity	
TGCT	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.26	5.3	5.01E-7	Longevity	
TGCT	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.36	-4.24	4.35E-5	Tumor biomarkers	
TGCT	cis	1	rs7655841	chr4:129890790	C4orf33	chr4:130014829-130033842:+	0.49	4.67	7.75E-6	Chronic obstructive pulmonary disease (moderate to severe)	
TGCT	cis	1	rs7661070	chr4:39724365	RPL9	chr4:39455747-39460568:-	-0.5	-4.7	6.61E-6	Plasma amyloid beta peptide concentrations (ABx-40)	
TGCT	cis	1	rs76722536	chr6:26192946	HIST1H3E	chr6:26224427-26226589:+	0.53	4.42	2.11E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs76751500	chr16:77785771	NUDT7	chr16:77756411-77776153:+	0.49	4.54	1.3E-5	Obesity-related traits	
TGCT	cis	1	rs7678847	chr4:106987426	TBCK	chr4:106967233-107237861:-	0.36	4.27	3.8E-5	Airflow obstruction	
TGCT	cis	1	rs7683315	chr4:88773095	SPP1	chr4:88896802-88904562:+	0.34	5	1.87E-6	Bone mineral density;Bone mineral density (paediatric, total body less head)	
TGCT	cis	1	rs76872831	chr5:150171559	LOC134466	chr5:150310000-150326146:-	0.65	4.37	2.52E-5	Crohn's disease	
TGCT	cis	1	rs76986350	chr16:77784738	NUDT7	chr16:77756411-77776153:+	0.48	4.68	7.14E-6	Obesity-related traits	
TGCT	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	0.86	21.07	4.04E-43	Birdshot chorioretinopathy	
TGCT	cis	1	rs7724558	chr5:150328866	LOC134466	chr5:150310000-150326146:-	0.64	4.23	4.46E-5	Crohn's disease	
TGCT	cis	1	rs77247684	chr21:46916033	MCM3AP	chr21:47655048-47705236:-	-0.79	-4.33	3.07E-5	Alzheimer disease and age of onset	
TGCT	cis	1	rs77307893	chr12:70753177	YEATS4	chr12:69753532-69784575:+	-0.5	-4.51	1.48E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs77335224	chr10:104636276	SFXN2	chr10:104474298-104498946:+	-0.82	-4.9	2.88E-6	Hypertension;Systolic blood pressure;Diastolic blood pressure	
TGCT	cis	1	rs77397439	chr12:70707346	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs77464790	chr16:77777609	NUDT7	chr16:77756411-77776153:+	0.44	4.23	4.39E-5	Obesity-related traits	
TGCT	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.86	-10.21	3.31E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.3	5.11	1.16E-6	Folate pathway vitamin levels	
TGCT	cis	1	rs7751316	chr6:87255654	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs77528108	chr16:77782435	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs7755318	chr6:87231711	SNHG5	chr6:86386726-86388451:-	-0.4	-4.16	5.95E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs7756935	chr6:46675025	PLA2G7	chr6:46672054-46703151:-	-0.2	-4.52	1.42E-5	Lipoprotein-associated phospholipase A2 activity and mass	
TGCT	cis	1	rs7759071	chr6:49433198	CENPQ	chr6:49431096-49460820:+	-0.46	-6.24	6.15E-9	Homocysteine levels	
TGCT	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.83	-9.78	3.66E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs7760708	chr6:87253612	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.86	-10.21	3.31E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.82	-9.61	9.84E-17	Response to antipsychotic treatment	
TGCT	cis	1	rs7773007	chr6:87252468	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs7773987	chr6:135707486	AHI1	chr6:135605112-135818903:-	0.43	7.56	7.47E-12	Selective IgA deficiency	
TGCT	cis	1	rs7774688	chr6:49387292	CENPQ	chr6:49431096-49460820:+	-0.44	-5.71	7.66E-8	Homocysteine levels	
TGCT	cis	1	rs7777389	chr7:143744802	ARHGEF35	chr7:143883677-143892736:-	-0.39	-4.53	1.33E-5	Obesity-related traits	
TGCT	cis	1	rs7781669	chr7:21584820	DNAH11	chr7:21582833-21941455:+	-0.47	-5.05	1.48E-6	Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)	
TGCT	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.31	-4.77	4.91E-6	Tuberculosis	
TGCT	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.44	4.86	3.43E-6	Tuberculosis	
TGCT	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.32	-4.94	2.45E-6	Tuberculosis	
TGCT	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.44	4.75	5.38E-6	Tuberculosis	
TGCT	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.31	-4.7	6.58E-6	Tuberculosis	
TGCT	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.45	4.9	2.9E-6	Tuberculosis	
TGCT	cis	1	rs78012445	chr6:26195080	HIST1H3E	chr6:26224427-26226589:+	0.47	4.19	5.14E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs78036474	chr16:77785721	NUDT7	chr16:77756411-77776153:+	0.49	4.59	1.04E-5	Obesity-related traits	
TGCT	cis	1	rs7820159	chr8:8576215	FLJ10661	chr8:8086092-8102386:+	0.48	4.41	2.17E-5	Obesity-related traits	
TGCT	cis	1	rs7843488	chr8:8576217	FLJ10661	chr8:8086092-8102386:+	0.48	4.41	2.17E-5	Obesity-related traits	
TGCT	cis	1	rs78509050	chr12:70753369	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs78515849	chr16:77781998	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs78599153	chr16:77782054	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs78623713	chr16:77782739	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs78724141	chr8:82659661	CHMP4C	chr8:82644688-82671746:+	-0.42	-4.22	4.61E-5	Epithelial ovarian cancer;Ovarian cancer	
TGCT	cis	1	rs78740005	chr8:82659306	CHMP4C	chr8:82644688-82671746:+	-0.45	-4.24	4.25E-5	Epithelial ovarian cancer;Ovarian cancer	
TGCT	cis	1	rs78780050	chr16:77781788	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs78839411	chr16:77781514	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs78841515	chr16:77785455	NUDT7	chr16:77756411-77776153:+	0.49	4.59	1.04E-5	Obesity-related traits	
TGCT	cis	1	rs78900394	chr16:77784109	NUDT7	chr16:77756411-77776153:+	0.48	4.68	7.14E-6	Obesity-related traits	
TGCT	cis	1	rs7905961	chr10:102297391	SEC31B	chr10:102246403-102289636:-	-0.32	-4.87	3.32E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs79112827	chr16:77782558	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs79116314	chr16:77782432	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs7917792	chr10:97365627	ENTPD1	chr10:97471536-97637022:+	0.3	4.72	6.08E-6	Blood metabolite levels	
TGCT	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.86	10.34	1.6E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs79224766	chr12:70686179	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs79264785	chr6:26194121	HIST1H3E	chr6:26224427-26226589:+	0.47	4.19	5.14E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs79270274	chr16:77777624	NUDT7	chr16:77756411-77776153:+	0.44	4.23	4.39E-5	Obesity-related traits	
TGCT	cis	1	rs79282796	chr16:77784282	NUDT7	chr16:77756411-77776153:+	0.48	4.68	7.14E-6	Obesity-related traits	
TGCT	cis	1	rs79318564	chr15:84786150	LOC388152	chr15:84867600-84898920:-	-0.39	-5.51	1.95E-7	Schizophrenia	
TGCT	cis	1	rs79409507	chr16:77781480	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs79442859	chr5:150171210	LOC134466	chr5:150310000-150326146:-	0.65	4.37	2.52E-5	Crohn's disease	
TGCT	cis	1	rs7947378	chr11:18381327	GTF2H1	chr11:18343816-18388590:+	0.42	4.32	3.19E-5	Pancreatic cancer	
TGCT	cis	1	rs7953014	chr12:109998097	MYO1H	chr12:109826524-109886176:+	0.38	4.26	3.89E-5	HDL cholesterol	
TGCT	cis	1	rs7954144	chr12:110015893	MYO1H	chr12:109826524-109886176:+	0.38	4.16	5.76E-5	HDL cholesterol	
TGCT	cis	1	rs79548696	chr3:41803385	ULK4	chr3:41288091-42003660:-	0.54	5.79	5.34E-8	Diastolic blood pressure	
TGCT	cis	1	rs79704582	chr16:77781159	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs79780973	chr5:150174810	LOC134466	chr5:150310000-150326146:-	0.7	5.1	1.2E-6	Crohn's disease	
TGCT	cis	1	rs79831012	chr10:102237059	SEC31B	chr10:102246403-102289636:-	-0.3	-4.82	4.06E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs79868973	chr6:26189312	HIST1H3E	chr6:26224427-26226589:+	0.47	4.19	5.14E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs79885511	chr16:77781539	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs79903423	chr12:70701812	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs79917044	chr16:77784411	NUDT7	chr16:77756411-77776153:+	0.48	4.68	7.14E-6	Obesity-related traits	
TGCT	cis	1	rs80024915	chr12:70747210	YEATS4	chr12:69753532-69784575:+	-0.49	-4.2	5.04E-5	Amyotrophic lateral sclerosis (age of onset)	
TGCT	cis	1	rs80076579	chr4:106991115	TBCK	chr4:106967233-107237861:-	0.36	4.26	3.93E-5	Airflow obstruction	
TGCT	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.42	-8.16	2.99E-13	IgG glycosylation	
TGCT	cis	1	rs80259160	chr6:26190199	HIST1H3E	chr6:26224427-26226589:+	0.47	4.19	5.14E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs80279339	chr16:77782062	NUDT7	chr16:77756411-77776153:+	0.45	4.43	2.06E-5	Obesity-related traits	
TGCT	cis	1	rs80313145	chr6:26194965	HIST1H3E	chr6:26224427-26226589:+	0.49	4.35	2.76E-5	Renal underexcretion gout;Gout	
TGCT	cis	1	rs8031576	chr15:90380214	AP3S2	chr15:90373832-90456222:-	-0.64	-6.06	1.46E-8	Type 2 diabetes	
TGCT	cis	1	rs8032104	chr15:63400584	TPM1	chr15:63334838-63364111:+	0.45	4.86	3.41E-6	HDL cholesterol	
TGCT	cis	1	rs8036197	chr15:75370232	SCAMP5	chr15:75287901-75313836:+	0.32	4.42	2.11E-5	Blood trace element (Zn levels)	
TGCT	cis	1	rs8054842	chr16:672799	WFIKKN1	chr16:679239-684116:+	0.35	4.75	5.45E-6	Height	
TGCT	cis	1	rs8070454	chr17:38160754	GSDMA	chr17:38119226-38134019:+	-0.61	-7.82	1.87E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs807669	chr22:19154522	SLC25A1	chr22:19163095-19166301:-	-0.42	-5.14	1.02E-6	Metabolite levels	
TGCT	cis	1	rs807670	chr22:19154608	SLC25A1	chr22:19163095-19166301:-	-0.35	-4.35	2.73E-5	Metabolite levels	
TGCT	cis	1	rs8078723	chr17:38166879	GSDMA	chr17:38119226-38134019:+	-0.61	-7.78	2.22E-12	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
TGCT	cis	1	rs8106929	chr19:52368467	ZNF577	chr19:52359056-52394145:-	-0.31	-4.47	1.75E-5	Breast cancer	
TGCT	cis	1	rs8108477	chr19:52364902	ZNF577	chr19:52359056-52394145:-	-0.31	-4.47	1.75E-5	Breast cancer	
TGCT	cis	1	rs8108583	chr19:52364977	ZNF577	chr19:52359056-52394145:-	-0.31	-4.47	1.75E-5	Breast cancer	
TGCT	cis	1	rs8109345	chr19:52364933	ZNF577	chr19:52359056-52394145:-	-0.31	-4.47	1.75E-5	Breast cancer	
TGCT	cis	1	rs8111316	chr19:52369069	ZNF577	chr19:52359056-52394145:-	-0.31	-4.41	2.2E-5	Breast cancer	
TGCT	cis	1	rs8111720	chr19:5585823	KDM4B	chr19:4969124-5153606:+	0.69	4.23	4.5E-5	vWF and FVIII levels	
TGCT	cis	1	rs8125868	chr20:25324410	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs8170	chr19:17389704	C19orf62	chr19:17378232-17393811:+	-0.38	-4.28	3.61E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
TGCT	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.26	4.14	6.28E-5	Multiple sclerosis	
TGCT	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	0.78	8.65	2.04E-14	Type 2 diabetes	
TGCT	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.77	8.42	7.27E-14	Type 2 diabetes	
TGCT	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	0.8	9.1	1.69E-15	Type 2 diabetes	
TGCT	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	0.76	8.26	1.71E-13	Type 2 diabetes	
TGCT	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	0.78	8.65	2.04E-14	Type 2 diabetes	
TGCT	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	0.78	8.65	2.04E-14	Type 2 diabetes	
TGCT	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-0.78	-8.73	1.27E-14	Type 2 diabetes	
TGCT	cis	1	rs848602	chr2:36778372	FEZ2	chr2:36779404-36825332:-	0.42	4.49	1.62E-5	Height	
TGCT	cis	1	rs854572	chr7:94954696	PON1	chr7:94927671-95025687:-	0.51	5.14	1.0E-6	Paraoxonase activity	
TGCT	cis	1	rs8589	chr6:49403282	CENPQ	chr6:49431096-49460820:+	-0.45	-5.92	2.87E-8	Homocysteine levels	
TGCT	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-0.77	-8.73	1.31E-14	Type 2 diabetes	
TGCT	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	0.78	8.65	2.04E-14	Type 2 diabetes	
TGCT	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	0.8	8.01	6.5E-13	Type 2 diabetes	
TGCT	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	0.78	8.65	2.04E-14	Type 2 diabetes	
TGCT	cis	1	rs873063	chr8:8572447	FLJ10661	chr8:8086092-8102386:+	0.46	4.23	4.43E-5	Obesity-related traits	
TGCT	cis	1	rs873064	chr8:8572380	FLJ10661	chr8:8086092-8102386:+	0.46	4.23	4.43E-5	Obesity-related traits	
TGCT	cis	1	rs873686	chr4:185638876	MLF1IP	chr4:185615220-185655286:-	0.59	8.03	5.83E-13	Kawasaki disease	
TGCT	cis	1	rs8758	chr10:97366107	ENTPD1	chr10:97471536-97637022:+	0.29	4.52	1.43E-5	Blood metabolite levels	
TGCT	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.79	-11.74	6.03E-22	Cognitive function	
TGCT	cis	1	rs877710	chr12:109993976	MYO1H	chr12:109826524-109886176:+	0.38	4.26	3.89E-5	HDL cholesterol	
TGCT	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.43	-4.39	2.4E-5	Rheumatoid arthritis	
TGCT	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.3	-4.59	1.06E-5	Homocysteine levels	
TGCT	cis	1	rs883648	chr8:8569521	FLJ10661	chr8:8086092-8102386:+	0.48	4.49	1.58E-5	Obesity-related traits	
TGCT	cis	1	rs884613	chr20:25288505	NINL	chr20:25433338-25566153:-	0.41	6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.82	-9.44	2.56E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs885000	chr8:8568875	FLJ10661	chr8:8086092-8102386:+	0.48	4.49	1.58E-5	Obesity-related traits	
TGCT	cis	1	rs888192	chr12:109995097	MYO1H	chr12:109826524-109886176:+	-0.38	-4.26	3.89E-5	HDL cholesterol	
TGCT	cis	1	rs8897	chr3:49460407	SEMA3F	chr3:50192848-50226507:+	0.27	4.16	5.86E-5	Menarche (age at onset)	
TGCT	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.26	5.46	2.48E-7	Longevity	
TGCT	cis	1	rs910997	chr20:25267301	NINL	chr20:25433338-25566153:-	-0.41	-6.19	7.92E-9	Liver enzyme levels (alkaline phosphatase)	
TGCT	cis	1	rs918814	chr2:23948466	C2orf84	chr2:24397531-24414566:+	-0.38	-4.2	5.07E-5	Obesity-related traits	
TGCT	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.26	5.2	7.97E-7	Longevity	
TGCT	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.8	9.15	1.26E-15	Type 2 diabetes	
TGCT	cis	1	rs9289275	chr3:125648659	LOC100125556	chr3:125635444-125648865:+	0.69	4.63	8.81E-6	Blood pressure (smoking interaction)	
TGCT	cis	1	rs9296404	chr6:42925803	GNMT	chr6:42928500-42931617:+	-0.63	-7.44	1.4E-11	Plasma homocysteine levels (post-methionine load test)	
TGCT	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.92	12.66	3.24E-24	Plasma homocysteine levels (post-methionine load test)	
TGCT	cis	1	rs9296616	chr6:49414235	MUT	chr6:49398994-49431031:-	0.3	5.04	1.58E-6	Folate pathway vitamin levels	
TGCT	cis	1	rs9296617	chr6:49428360	MUT	chr6:49398994-49431031:-	0.31	5.31	4.78E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs9307050	chr4:76905649	NAAA	chr4:76831809-76862166:-	-0.31	-5.82	4.53E-8	Longevity	
TGCT	cis	1	rs9309473	chr2:73743982	ALMS1P	chr2:73872046-73912692:+	0.44	5.17	8.93E-7	Metabolite levels	
TGCT	cis	1	rs931058	chr5:150333698	LOC134466	chr5:150310000-150326146:-	0.79	4.97	2.16E-6	Crohn's disease	
TGCT	cis	1	rs9311288	chr3:41804581	ULK4	chr3:41288091-42003660:-	0.55	6.06	1.45E-8	Diastolic blood pressure	
TGCT	cis	1	rs9311423	chr3:48420308	TREX1	chr3:48501186-48509043:+	-0.26	-5.4	3.2E-7	Longevity	
TGCT	cis	1	rs9311676	chr3:58470351	PDHB	chr3:58413355-58419565:-	-0.29	-4.84	3.8E-6	Systemic lupus erythematosus	
TGCT	cis	1	rs9312648	chr4:55241581	PDGFRA	chr4:54243820-55164411:+	0.24	4.71	6.55E-6	Response to amphetamines	
TGCT	cis	1	rs9329165	chr8:8576642	FLJ10661	chr8:8086092-8102386:+	-0.52	-4.84	3.72E-6	Obesity-related traits	
TGCT	cis	1	rs9329166	chr8:8576655	FLJ10661	chr8:8086092-8102386:+	0.48	4.69	7.12E-6	Obesity-related traits	
TGCT	cis	1	rs9344629	chr6:87274275	SNHG5	chr6:86386726-86388451:-	0.42	4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs9357512	chr6:46642875	PLA2G7	chr6:46672054-46703151:-	0.2	4.95	2.34E-6	Lipoprotein-associated phospholipase A2 activity and mass	
TGCT	cis	1	rs9359707	chr6:87291101	SNHG5	chr6:86386726-86388451:-	0.45	4.51	1.49E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs9362333	chr6:87291329	SNHG5	chr6:86386726-86388451:-	0.45	4.51	1.49E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs9369898	chr6:49382193	CENPQ	chr6:49431096-49460820:+	-0.44	-5.71	7.66E-8	Homocysteine levels	
TGCT	cis	1	rs9381784	chr6:49398115	CENPQ	chr6:49431096-49460820:+	0.41	5.15	9.91E-7	Homocysteine levels	
TGCT	cis	1	rs938295	chr1:16087260	CLCNKA	chr1:16345370-16360544:+	0.44	4.33	3.02E-5	Gut microbiota (bacterial taxa)	
TGCT	cis	1	rs9395493	chr6:49427409	CENPQ	chr6:49431096-49460820:+	-0.47	-6.36	3.4E-9	Homocysteine levels	
TGCT	cis	1	rs939558	chr3:41976040	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs9419897	chr10:102246125	SEC31B	chr10:102246403-102289636:-	-0.28	-4.42	2.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs9420782	chr10:102235015	SEC31B	chr10:102246403-102289636:-	-0.29	-4.48	1.63E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs9420785	chr10:102240451	SEC31B	chr10:102246403-102289636:-	-0.28	-4.42	2.09E-5	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs9420797	chr10:102331147	SEC31B	chr10:102246403-102289636:-	-0.31	-4.79	4.68E-6	Palmitoleic acid (16:1n-7) plasma levels	
TGCT	cis	1	rs9463473	chr6:49380121	MUT	chr6:49398994-49431031:-	0.33	5.29	5.27E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs9463474	chr6:49380199	MUT	chr6:49398994-49431031:-	0.33	5.29	5.27E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs9463475	chr6:49380899	MUT	chr6:49398994-49431031:-	-0.32	-5.32	4.55E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs9463477	chr6:49386446	MUT	chr6:49398994-49431031:-	0.33	5.29	5.29E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs9463478	chr6:49386564	CENPQ	chr6:49431096-49460820:+	-0.44	-5.71	7.66E-8	Homocysteine levels	
TGCT	cis	1	rs9463479	chr6:49393275	MUT	chr6:49398994-49431031:-	0.33	5.29	5.29E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs9463480	chr6:49400795	MUT	chr6:49398994-49431031:-	0.32	5.23	6.88E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs9472819	chr6:46653789	PLA2G7	chr6:46672054-46703151:-	0.21	4.9	2.88E-6	Lipoprotein-associated phospholipase A2 activity and mass	
TGCT	cis	1	rs9473549	chr6:49380020	MUT	chr6:49398994-49431031:-	0.32	5.13	1.04E-6	Folate pathway vitamin levels	
TGCT	cis	1	rs9473550	chr6:49385182	CENPQ	chr6:49431096-49460820:+	-0.42	-5.3	5.03E-7	Homocysteine levels	
TGCT	cis	1	rs9473552	chr6:49387154	MUT	chr6:49398994-49431031:-	0.33	5.29	5.29E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs9473553	chr6:49395977	MUT	chr6:49398994-49431031:-	0.33	5.29	5.29E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs9473555	chr6:49409487	MUT	chr6:49398994-49431031:-	0.32	5.28	5.54E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs9473560	chr6:49427918	MUT	chr6:49398994-49431031:-	0.31	5.31	4.78E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs9473561	chr6:49428755	MUT	chr6:49398994-49431031:-	0.31	5.31	4.78E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs9473563	chr6:49453651	MUT	chr6:49398994-49431031:-	0.31	5.16	9.23E-7	Folate pathway vitamin levels	
TGCT	cis	1	rs949887	chr6:87251992	SNHG5	chr6:86386726-86388451:-	-0.42	-4.31	3.24E-5	Gut microbiome composition (winter)	
TGCT	cis	1	rs950169	chr15:84706461	LOC388152	chr15:84867600-84898920:-	-0.38	-5.42	2.89E-7	Schizophrenia	
TGCT	cis	1	rs951366	chr1:205685352	PM20D1	chr1:205797154-205819245:-	-0.4	-4.17	5.66E-5	Menarche (age at onset)	
TGCT	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.77	8.6	2.61E-14	Response to antipsychotic treatment	
TGCT	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.79	-9.15	1.29E-15	Response to antipsychotic treatment	
TGCT	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.81	-9.35	4.21E-16	Response to antipsychotic treatment	
TGCT	cis	1	rs9593	chr12:109994870	MYO1H	chr12:109826524-109886176:+	0.38	4.26	3.89E-5	HDL cholesterol	
TGCT	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.86	-10.21	3.31E-18	Response to antipsychotic treatment	
TGCT	cis	1	rs9653557	chr2:73795962	ALMS1P	chr2:73872046-73912692:+	0.42	4.97	2.18E-6	Metabolite levels	
TGCT	cis	1	rs9665626	chr10:104300638	SFXN2	chr10:104474298-104498946:+	0.74	4.46	1.77E-5	Schizophrenia	
TGCT	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.68	7.91	1.15E-12	Eye color traits	
TGCT	cis	1	rs9689	chr1:25688276	RHCE	chr1:25688741-25756683:-	0.59	8.65	2.03E-14	Erythrocyte sedimentation rate	
TGCT	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.68	7.91	1.15E-12	Eye color traits	
TGCT	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.7	8.05	5.4E-13	Eye color traits	
TGCT	cis	1	rs9783347	chr11:18384938	GTF2H1	chr11:18343816-18388590:+	0.42	4.25	4.16E-5	Pancreatic cancer	
TGCT	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.26	-5.41	3.02E-7	Longevity	
TGCT	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.29	5.66	9.7E-8	Longevity	
TGCT	cis	1	rs9815103	chr3:48414215	TREX1	chr3:48501186-48509043:+	-0.26	-5.52	1.89E-7	Longevity	
TGCT	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs9817615	chr3:48470756	TREX1	chr3:48501186-48509043:+	-0.29	-5.74	6.56E-8	Longevity	
TGCT	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	0.47	5.11	1.17E-6	Diastolic blood pressure	
TGCT	cis	1	rs9820192	chr3:41889281	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs9825741	chr3:41761828	ULK4	chr3:41288091-42003660:-	-0.5	-5.82	4.58E-8	Diastolic blood pressure	
TGCT	cis	1	rs9826058	chr3:41762062	ULK4	chr3:41288091-42003660:-	0.49	5.6	1.28E-7	Diastolic blood pressure	
TGCT	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.26	-5.41	3.02E-7	Longevity	
TGCT	cis	1	rs9828398	chr3:41895893	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs9830064	chr3:41881801	ULK4	chr3:41288091-42003660:-	0.47	5.32	4.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs9830469	chr3:41762535	ULK4	chr3:41288091-42003660:-	0.49	5.6	1.28E-7	Diastolic blood pressure	
TGCT	cis	1	rs9834098	chr3:41833493	ULK4	chr3:41288091-42003660:-	0.52	5.66	9.82E-8	Diastolic blood pressure	
TGCT	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.28	-5.63	1.13E-7	Longevity	
TGCT	cis	1	rs9838965	chr3:41927938	ULK4	chr3:41288091-42003660:-	-0.49	-5.61	1.23E-7	Diastolic blood pressure	
TGCT	cis	1	rs9839399	chr3:41928044	ULK4	chr3:41288091-42003660:-	-0.49	-5.61	1.23E-7	Diastolic blood pressure	
TGCT	cis	1	rs9840037	chr3:41827522	ULK4	chr3:41288091-42003660:-	0.52	5.66	9.82E-8	Diastolic blood pressure	
TGCT	cis	1	rs9840532	chr3:41885697	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs9842305	chr3:41998412	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.43	4.55	1.26E-5	Diastolic blood pressure	
TGCT	cis	1	rs9847006	chr3:41755359	ULK4	chr3:41288091-42003660:-	0.49	5.35	3.97E-7	Diastolic blood pressure	
TGCT	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.47	4.86	3.49E-6	Diastolic blood pressure	
TGCT	cis	1	rs9848754	chr3:41753647	ULK4	chr3:41288091-42003660:-	0.45	4.21	4.78E-5	Diastolic blood pressure	
TGCT	cis	1	rs9849509	chr3:48483432	TREX1	chr3:48501186-48509043:+	-0.28	-5.55	1.61E-7	Longevity	
TGCT	cis	1	rs9852303	chr3:41759525	ULK4	chr3:41288091-42003660:-	0.49	5.6	1.28E-7	Diastolic blood pressure	
TGCT	cis	1	rs9854833	chr3:41775577	ULK4	chr3:41288091-42003660:-	0.43	4.37	2.61E-5	Diastolic blood pressure	
TGCT	cis	1	rs9854838	chr3:41805670	ULK4	chr3:41288091-42003660:-	0.55	6.06	1.45E-8	Diastolic blood pressure	
TGCT	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	0.47	5.11	1.17E-6	Diastolic blood pressure	
TGCT	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	0.47	5.11	1.17E-6	Diastolic blood pressure	
TGCT	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	0.49	5.79	5.39E-8	Diastolic blood pressure	
TGCT	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	0.54	5.7	8.14E-8	Diastolic blood pressure	
TGCT	cis	1	rs9863915	chr3:41762002	ULK4	chr3:41288091-42003660:-	0.49	5.6	1.28E-7	Diastolic blood pressure	
TGCT	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.45	4.54	1.27E-5	Diastolic blood pressure	
TGCT	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.26	-5.41	3.02E-7	Longevity	
TGCT	cis	1	rs9865127	chr3:41807448	ULK4	chr3:41288091-42003660:-	0.55	6.06	1.46E-8	Diastolic blood pressure	
TGCT	cis	1	rs9865780	chr3:41895802	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs9866092	chr3:41895967	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs9866759	chr3:41758418	ULK4	chr3:41288091-42003660:-	0.49	5.6	1.28E-7	Diastolic blood pressure	
TGCT	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.47	-5.16	9.54E-7	Diastolic blood pressure	
TGCT	cis	1	rs9869207	chr3:41878661	ULK4	chr3:41288091-42003660:-	0.47	5.37	3.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs9869282	chr3:41756064	ULK4	chr3:41288091-42003660:-	0.49	5.35	3.97E-7	Diastolic blood pressure	
TGCT	cis	1	rs9869440	chr3:41763155	ULK4	chr3:41288091-42003660:-	0.48	5.44	2.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.43	4.6	9.97E-6	Diastolic blood pressure	
TGCT	cis	1	rs9874975	chr3:41764300	ULK4	chr3:41288091-42003660:-	0.48	5.44	2.63E-7	Diastolic blood pressure	
TGCT	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.43	4.37	2.61E-5	Diastolic blood pressure	
TGCT	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	0.54	5.7	8.14E-8	Diastolic blood pressure	
TGCT	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.28	-5.55	1.61E-7	Longevity	
TGCT	cis	1	rs9876960	chr3:41985812	ULK4	chr3:41288091-42003660:-	-0.49	-5.74	6.83E-8	Diastolic blood pressure	
TGCT	cis	1	rs9881491	chr3:48487911	TREX1	chr3:48501186-48509043:+	-0.27	-5.47	2.29E-7	Longevity	
TGCT	cis	1	rs9882329	chr3:41767154	ULK4	chr3:41288091-42003660:-	0.47	5.49	2.16E-7	Diastolic blood pressure	
TGCT	cis	1	rs9883759	chr3:48463618	TREX1	chr3:48501186-48509043:+	-0.28	-5.67	9.47E-8	Longevity	
TGCT	cis	1	rs9883927	chr3:48463711	TREX1	chr3:48501186-48509043:+	-0.29	-5.75	6.26E-8	Longevity	
TGCT	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.69	7.99	7.44E-13	Eye color traits	
TGCT	cis	1	rs9925964	chr16:31129895	MYST1	chr16:31128985-31142713:+	-0.29	-4.35	2.79E-5	Body mass index	
TGCT	cis	1	rs9976479	chr21:43836083	ZNF295	chr21:43406941-43430496:-	0.18	4.3	3.43E-5	Type 1 diabetes	
TGCT	cis	1	rs9990702	chr4:88772316	SPP1	chr4:88896802-88904562:+	-0.35	-5.15	9.63E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
TGCT	cis	1	rs9995007	chr4:76897791	NAAA	chr4:76831809-76862166:-	-0.31	-5.82	4.53E-8	Longevity	
TGCT	cis	1	rs9998898	chr4:88772189	SPP1	chr4:88896802-88904562:+	-0.35	-5.15	9.63E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
TGCT	cis	1	rs9998975	chr4:88772233	SPP1	chr4:88896802-88904562:+	-0.35	-5.15	9.63E-7	Bone mineral density;Bone mineral density (paediatric, total body less head)	
TGCT	trans	1	rs10037055	chr5:176691279	LOC388955	chr2:63849182-63850159:-	-0.64	-9.97	1.29E-17	Migraine without aura	
TGCT	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.59	7.44	1.4E-11	Educational attainment	
TGCT	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.58	7.18	5.25E-11	Educational attainment	
TGCT	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.6	7.57	6.83E-12	Educational attainment	
TGCT	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.59	7.3	2.85E-11	Educational attainment	
TGCT	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.59	7.44	1.36E-11	Educational attainment	
TGCT	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.56	-6.98	1.53E-10	Educational attainment	
TGCT	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.59	7.56	7.46E-12	Educational attainment	
TGCT	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.59	7.3	2.85E-11	Educational attainment	
TGCT	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.6	7.6	5.77E-12	Educational attainment	
TGCT	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.59	7.3	2.85E-11	Educational attainment	
TGCT	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.59	7.3	2.85E-11	Educational attainment	
TGCT	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.6	7.57	6.83E-12	Educational attainment	
TGCT	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.59	7.44	1.39E-11	Educational attainment	
TGCT	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.57	7.13	6.76E-11	Educational attainment	
TGCT	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.6	7.57	6.83E-12	Educational attainment	
TGCT	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.6	7.57	6.83E-12	Educational attainment	
TGCT	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.61	7.61	5.47E-12	Educational attainment	
TGCT	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.59	7.3	2.85E-11	Educational attainment	
TGCT	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.59	7.3	2.85E-11	Educational attainment	
TGCT	trans	1	rs6886255	chr5:176718361	LOC388955	chr2:63849182-63850159:-	0.68	10.78	1.31E-19	Migraine without aura	
TGCT	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.58	7.26	3.57E-11	Educational attainment	
TGCT	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.58	-7.35	2.24E-11	Educational attainment	
TGCT	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.59	7.3	2.85E-11	Educational attainment	
TGCT	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.59	7.3	2.85E-11	Educational attainment	
TGCT	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.58	7.26	3.57E-11	Educational attainment	
TGCT	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.59	7.44	1.4E-11	Educational attainment	
TGCT	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.59	7.3	2.85E-11	Educational attainment	
TGCT	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.59	7.44	1.4E-11	Educational attainment	
TGCT	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.59	7.44	1.4E-11	Educational attainment	
TGCT	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.59	7.44	1.4E-11	Educational attainment	
TGCT	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.59	-7.35	2.15E-11	Educational attainment	
TGCT	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.57	7.32	2.59E-11	Educational attainment	
TGCT	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.6	7.57	6.83E-12	Educational attainment	
TGCT	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.6	7.57	6.83E-12	Educational attainment	
TGCT	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.59	7.44	1.4E-11	Educational attainment	
TGCT	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.58	7.26	3.57E-11	Educational attainment	
TGCT	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.6	7.57	6.83E-12	Educational attainment	
TGCT	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.58	-7.39	1.82E-11	Educational attainment	
TGCT	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.6	7.61	5.54E-12	Educational attainment	
TGCT	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.6	7.67	4.14E-12	Educational attainment	
TGCT	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.59	7.44	1.4E-11	Educational attainment	
TGCT	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.59	-7.46	1.22E-11	Educational attainment	
TGCT	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.59	7.3	2.85E-11	Educational attainment	
TGCT	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.59	7.3	2.85E-11	Educational attainment	
TGCT	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.59	7.44	1.36E-11	Educational attainment	
